STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[10-Q] Nature's Miracle Holding Inc. Quarterly Earnings Report

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
10-Q
Rhea-AI Filing Summary

Nature’s Miracle Holding Inc. (NMHI)$72,377 from $3.1 million a year earlier, as gross profit was essentially breakeven and operating expenses of $1.3 million drove an operating loss of $1.3 million. After $0.8 million of net other expense, mainly interest and financing costs, the company posted a quarterly net loss of $2.2 million, and a nine‑month net loss of $6.0 million.

Cash and cash equivalents were just $61,450 with a working capital deficit of about $19.0 million, total liabilities of $30.2 million, and a stockholders’ deficit of $8.9 million as of September 30, 2025. Management discloses that recurring losses, negative operating cash flow of $1.8 million for the nine months, and heavy debt raise “substantial doubt” about the company’s ability to continue as a going concern.

During the period the company used equity, preferred stock and convertible notes for financing and completed a $17.5 million related‑party acquisition of Zak Properties’ Ohio real estate, increasing property and equipment to $17.1 million from $4.2 million. NMHI also notes access to a $20 million equity line and several new funding agreements, but future financing remains uncertain.

Positive
  • Balance sheet strengthened by asset acquisition under common control: the Zak Properties purchase added net assets of $12.9 million, increasing property and equipment to $17.1 million and reducing the stockholders’ deficit versus year‑end 2024.
  • Multiple committed financing sources available: management cites an effective $20 million equity line of credit, a $2 million related‑party convertible note and additional preferred‑share purchase agreements that, if funded, could provide several million dollars of incremental liquidity.
Negative
  • Severe revenue contraction and continued losses: Q3 2025 revenue dropped to $72,377 from $3.1 million a year earlier, with a nine‑month net loss of $6.0 million indicating the core business is not currently covering operating and financing costs.
  • Going‑concern uncertainty and thin liquidity: cash of $61,450, a working capital deficit of roughly $19.0 million, and total liabilities of $30.2 million versus $22.1 million of assets led management to conclude there is substantial doubt about the company’s ability to continue as a going concern.
  • High leverage and expensive short‑term funding: the company relies on numerous high‑interest merchant cash advances and other short‑term loans, contributing to interest expense of over $2.0 million for the nine months ended September 30, 2025.
  • Related‑party asset deal increases debt load: the $17.5 million acquisition of Zak Properties from an entity controlled by the CEO added a $3.0 million convertible note and preferred stock, heightening balance‑sheet complexity while the operating business remains loss‑making.

Insights

NMHI shows collapsing revenue, heavy leverage and a going‑concern warning.

Nature’s Miracle reported Q3 2025 revenue of only $72,377, down sharply from $3,052,727 a year earlier, with a gross profit close to zero. Operating expenses of $1,331,949 produced an operating loss of $1,331,523, and after sizable interest and financing costs, the nine‑month net loss reached $5,961,537. This indicates the core controlled‑environment agriculture business is currently not covering its cost base.

The balance sheet shows total assets of $22,054,710 against total liabilities of $30,186,035, leaving a stockholders’ deficit of $8,944,930 as of September 30, 2025. Cash was only $61,450 with a working capital deficit of about $19.0 million, and management explicitly states that recurring losses and negative operating cash flow of $1,805,482 raise “substantial doubt” about the ability to continue as a going concern.

The company completed a related‑party asset acquisition of Zak Properties for $17,500,000, funded with Series B and C preferred stock valued at $14,440,000 and a $3,000,000 convertible note, which lifted property and equipment to $17,131,049. At the same time, NMHI is relying on high‑cost short‑term lenders and convertible notes, and highlights a $20,000,000 equity line plus several recent securities purchase agreements as potential liquidity sources. Actual outcomes will depend on the company’s ability to draw on these facilities and stabilize revenues.

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q

 

(Mark One)

 QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2025

 

or

 

 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

FOR THE TRANSITION PERIOD FROM  _________ to __________

 

COMMISSION FILE NUMBER 001-41977

 

NATURE’S MIRACLE HOLDING INC.

(Exact name of registrant as specified in its charter)

 

Delaware   88-3986430
(State or other jurisdiction of
incorporation or organization)
  (I.R.S. Employer
Identification No

 

3281 E. Guasti Rd. #175
OntarioCA 91761
  (909) 218-4601
(Address of principal executive offices) (Zip Code)   (Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act: NONE

 

 Securities registered pursuant to Section 12(g) of the Act:

 

Title of each class   Trading symbol(s)
Common Stock, par value $0.0001 per share   NMHI*
     
Warrants to purchase Common Stock, at an exercise price of $11.50 per share   NMHIW*

 

* The securities of Nature’s Miracle Holding Inc. have been suspended from trading on The Nasdaq Stock Market and are currently trading on the OTC Market.

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes  ☒ No  ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes  ☒ No  ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer Accelerated filer
Non-accelerated filer Smaller reporting company
    Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes  ☐ No  

 

As of November 14, 2025, the registrant had a total of 23,720,724 shares of its common stock, par value $0.0001 per share, issued and outstanding.

 

 

 

 

 

 

INDEX

 

  Page
PART I. FINANCIAL INFORMATION 1
Item 1. Consolidated Condensed Financial Statements (unaudited)
  Consolidated Condensed Balance Sheets 1
  Consolidated Condensed Statements of Operations and Comprehensive Loss 2
  Consolidated Condensed Statements of Stockholders’ Deficit 3
  Consolidated Condensed Statements of Cash Flows 4
  Notes to Financial Statements 5
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 41
Item 3. Quantitative and Qualitative Disclosures About Market Risk 52
Item 4. Controls and Procedures 52
PART II. OTHER INFORMATION 53
Item 1. Legal Proceedings 53
Item 1A. Risk Factors 53
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 53
Item 3. Defaults Upon Senior Securities 54
Item 4. Mine Safety Disclosures 54
Item 5. Other Information 54
Item 6. Exhibits 55
SIGNATURES 56

 

i

 

 

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

 

This Quarterly Report on Form 10-Q contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends impacting the financial condition of our business. Forward-looking statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time those statements are made and/or management’s good faith belief as of that time with respect to future events and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements.

 

Forward-looking statements include all statements that are not historical facts. In some cases, you can identify forward-looking statements by terms such as “may,” “will,” “should,” “could,” “would,” “expect,” “intend,” “seek,” “plan,” “anticipate,” “believe,” “estimate,” “project,” “predict,” “potential,” “might,” “forecast,” “continue,” or the negative of those terms, and similar expressions and comparable terminology intended to reference future periods. Forward-looking statements include, but are not limited to, statements about:

 

  Our ability to effectively operate our business segments;

 

  Our ability to manage our research, development, expansion, growth and operating expenses;

 

  Our ability to evaluate and measure our business, prospects and performance metrics;

 

  Our ability to compete, directly and indirectly, and succeed in a highly competitive and evolving industry;

 

  Our ability to respond and adapt to changes in technology and customer behavior; and

 

  Our ability to protect our intellectual property and to develop, maintain and enhance a strong brand.

 

Should one or more of these risks or uncertainties materialize, or should the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected, intended or planned.

 

Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We cannot guarantee future results, levels of activity, performance or achievements. Accordingly, the forward-looking statements in this Quarterly Report on Form 10-Q should not be regarded as representations that the results or conditions described in such statements will occur or that our objectives and plans will be achieved, and we do not assume any responsibility for the accuracy or completeness of any of these forward-looking statements.

 

ii

 

 

PART I – FINANCIAL INFORMATION

NATURE’S MIRACLE HOLDING INC., SUBSIDIARIES AND VIE

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

 

   As of
September 30,
   As of
December 31,
 
   2025   2024 
   (Unaudited)     
ASSETS        
CURRENT ASSETS        
Cash and cash equivalents  $61,450   $420,131 
Accounts receivable, net   1,221,142    1,829,044 
Accounts receivable - related parties, net   517,904    976,449 
Inventories, net   639,417    1,778,583 
Prepayments and other current assets   149,691    151,431 
Prepayments - related parties   21,662    10,000 
Total Current Assets   2,611,266    5,165,638 
           
NON-CURRENT ASSETS          
Deposits   977,720    428,633 
Right-of-use assets, net   334,675    470,716 
Cost method investment   1,000,000    1,000,000 
Property and equipment, net   17,131,049    4,246,832 
Total Non-Current Assets   

19,443,444

    

6,146,181

 
Total Assets  $22,054,710   $11,311,819 
           
LIABILITIES AND STOCKHOLDERS’ DEFICIT          
           
CURRENT LIABILITIES          
Short-term loans  $2,530,412   $2,668,604 
Short-term loans - related parties   60,000    280,755 
Current portion of long-term debts   381,270    301,076 
Convertible notes   1,536,477    987,639 
Convertible notes - related party   504,315    
-
 
Accounts payable   9,330,634    10,389,978 
Accounts payable - related parties   366,437    308,407 
Other payables and accrued liabilities   5,463,016    3,467,637 
Other payables - related parties   416,489    367,709 
Operating lease liabilities - current   165,450    262,380 
Commitment shares to be issued   

202,280

    - 
Tax accrual   478,635    501,374 
Deferred income - Contract liabilities   72,429    144,790 
Deferred income - Contract liabilities - related party   86,468    86,468 
Total Current Liabilities   21,594,312    19,766,817 
           
NON-CURRENT LIABILITIES          
Long-term debts, net of current portion   5,435,968    5,678,550 
Operating lease liabilities, net of current portion   155,755    205,602 
Long-term convertible notes - related party   3,000,000    
-
 
Total Non-Current Liabilities   8,591,723    5,884,152 
           
Total Liabilities   30,186,035    25,650,969 
           
COMMITMENTS AND CONTINGENCIES   
 
    
 
 
           
Redeemable convertible preferred stock ($0.0001 par value, 800 and nil issued and outstanding at September 30, 2025 and December 31, 2024, respectively), at redemption value   813,605    
-
 
           
SHAREHOLDERS’ DEFICIT          
Preferred stock ($0.0001 par value, 1,000,000 shares authorized, 14,500 and nil shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively)   1    
-
 
           
Common stock ($0.0001 par value,100,000,000 shares authorized,13,453,190 and 2,445,364 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively)*   1,347    246 
Additional paid-in capital   21,766,220    10,396,274 
Accumulated deficit   (30,711,831)   (24,734,689)
Accumulated other comprehensive loss   (667)   (981)
Total Stockholders’ Deficit   (8,944,930)   (14,339,150)
           
Total Liabilities and Stockholders’ Deficit  $22,054,710   $11,311,819 

 

*Giving retroactive effect to reverse recapitalization effected on March 11, 2024 and the 1-for-30 reverse stock split effected on November 21, 2024

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

1

 

 

NATURE’S MIRACLE HOLDING INC., SUBSIDIARIES AND VIE

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

 

   For the Three
Months Ended
   For the Three
Months Ended
   For the Nine Months Ended   For the Nine
Months Ended
 
   September 30,   September 30,   September 30,   September 30, 
   2025   2024   2025   2024 
   (Unaudited)   (Unaudited)   (Unaudited)   (Unaudited) 
                 
REVENUE (including related party revenue of nil and $1,135,628 for the three months ended September 30, 2025 and 2024; $76,038 and $2,129,726 for the nine months ended September 30, 2025 and 2024)  $72,377   $3,052,727   $1,663,205   $8,662,414 
                     
COST OF REVENUE   71,951    2,824,614    1,458,521    7,669,764 
                     
GROSS PROFIT   426    228,113    204,684    992,650 
                     
OPERATING EXPENSES:                    
Selling, general and administrative   1,205,125    2,186,953    3,543,861    5,214,487 
Provision for credit losses   126,824    36,597    306,091    60,988 
Total operating expenses   1,331,949    2,223,550    3,849,952    5,275,475 
                     
LOSS FROM OPERATIONS   (1,331,523)   (1,995,437)   (3,645,268)   (4,282,825)
                     
OTHER INCOME (EXPENSE)                    
Interest expense, net   (559,140)   (738,468)   (2,062,483)   (1,527,443)
Non cash finance expense   (200,000)   
-
    (200,000)   (1,000,000)
Loss on loan extinguishment   (90,062)   (15,131)   (50,062)   (15,131)
Change in fair value of commitment shares to be issued   (2,280)   
-
    

(2,280

)   -

Other income (expense)   12,216    (1,300)   256    2,438 
Total other expense, net   (839,266)   (754,899)   (2,314,569)   (2,540,136)
                     
LOSS BEFORE INCOME TAXES   (2,170,789)   (2,750,336)   (5,959,837)   (6,822,961)
                     
PROVISION FOR INCOME TAXES   
-
    
-
    1,700    2,500 
                     
NET LOSS  $(2,170,789)  $(2,750,336)  $(5,961,537)  $(6,825,461)
                     
OTHER COMPREHENSIVE LOSS                    
Foreign currency translation adjustment   (135)   (35)   259    (68)
COMPREHENSIVE LOSS  $(2,170,924)  $(2,750,371)  $(5,961,278)  $(6,825,529)
                     
WEIGHTED AVERAGE NUMBER OF COMMON STOCK*                    
Basic and diluted   11,264,018    1,008,037    7,306,585    887,420 
                     
LOSS PER SHARE                    
Basic and diluted  $(0.19)  $(2.73)  $(0.82)  $(7.69)

 

*Giving retroactive effect to reverse recapitalization effected on March 11, 2024 and the 1-for-30 reverse stock split effected on November 21, 2024

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

2

 

 

NATURE’S MIRACLE HOLDING INC., SUBSIDIARIES AND VIE

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGE IN STOCKHOLDERS’ DEFICIT

 

   Preferred stock   Common stock   Additional
paid in
   Accumulated   Accumulated other
comprehensive
     
   Shares   Amount   Shares*   Amount   capital   Deficit   loss   Total 
BALANCE, December 31, 2024   
-
   $
-
    2,445,364   $246   $10,396,274   $(24,734,689)  $(981)  $(14,339,150)
Stock compensation expense   -    
-
    84,091    8    84,928    
-
    
-
    84,936 
Shares to be issued for stock compensation   -    -    (834)   -    -    -    -    - 
Shares issued through warrants exercises   -    
-
    1,839,023    184    865,239    
-
    
-
    865,423 
Shares issued through debt-to-equity conversion   -    
-
    568,182    57    (57)   
-
    
-
    
-
 
Foreign currency translation adjustments   -    
-
    -    
-
    
-
    
-
    394    394 
Net loss   -    
-
    -    
-
    
-
    (2,019,811)   
-
    (2,019,811)
BALANCE, March 31, 2025 (Unaudited)   
-
   $
-
    4,935,826   $495   $11,346,384   $(26,754,500)  $(587)  $(15,408,208)
Stock compensation expense   -    
-
    
-
    
-
    60,957    
-
    
-
    60,957 
Shares issued through convertible notes conversion   -    
-
    2,576,943    258    147,617    
-
    
-
    147,875 
Foreign currency translation adjustments   -    
-
    -    
-
    
-
    
-
    (135)   (135)
Net loss   -    
-
    -    
-
    
-
    (1,770,937)   
-
    (1,770,937)
BALANCE, June 30, 2025 (Unaudited)   
-
   $
-
    7,512,769   $753   $11,554,958   $(28,525,437)  $(722)  $(16,970,448)
Preferred stock issued for asset acquisition   14,500    1    
-
    
-
    9,795,483    
-
    
-
    9,795,484 
Stock compensation expense   -    
-
    439,833    44    84,102    
-
    
-
    84,146 
Shares issued through convertible notes conversion   -    
-
    3,867,938    387    109,200    
-
    
-
    109,587 
Shares issued under equity line of credit   -    
-
    1,432,650    143    145,666    
-
    
-
    145,809 
Shares issued for purchase of convertible note   -    
-
    200,000    20    76,811    
-
    
-
    76,831 
Foreign currency translation adjustments   -    
-
    -    
-
    -    
-
    55    55 
Cumulative dividend for Series A and D preferred stock   -            -    -    -    -    (15,605)                     -    (15,605)
Net loss   -    
-
    -    
-
    -    (2,170,789)   
-
    (2,170,789)
BALANCE, September 30, 2025 (Unaudited)   14,500   $1    13,453,190   $1,347   $

21,766,220

   $(30,711,831)  $(667)  $(8,944,930)

 

   Preferred stock   Common stock   Additional paid in   Accumulated   Accumulated other
comprehensive
     
   Shares   Amount   Shares*   Amount   capital   Deficit   loss   Total 
BALANCE, December 31, 2023   
-
   $
-
    742,416   $74   $1,528,926   $(8,247,862)  $(1,075)  $(6,719,937)
Issuance of shares upon the reverse recapitalization   -    
-
    134,476    13    
-
    (2,833,487)   
-
    (2,833,474)
Additional shares issued in connection with reverse recapitalization   -    
-
    5,114    1    (1)   
-
    
-
    
-
 
Stock compensation expense   -    
-
    2,091    
-
    171,897    
-
    
-
    171,897 
Shares to be issued for stock compensation   -    -    (2,091)   -    -    -    -    - 
Foreign currency translation adjustments   -    
-
    -    
-
    
-
    
-
    50    50 
Net loss   -    
-
    -    
-
    
-
    (2,306,806)   
-
    (2,306,806)
BALANCE, March 31, 2024 (Unaudited)   
-
   $
-
    882,006   $88   $1,700,822   $(13,388,155)  $(1,025)  $(11,688,270)
Stock compensation expense   -    
-
    5,416    1    195,907    
-
    
-
    195,908 
Shares to be issued for stock compensation   -    -    (416)   -    -    -    -    - 
Foreign currency translation adjustments   -    
-
    -    
-
    
-
    
-
    (83)   (83)
Net loss   -    
-
    -    
-
    
-
    (1,768,319)   
-
    (1,768,319)
BALANCE, June 30, 2024 (Unaudited)   
-
   $
-
    887,006   $89   $1,896,729   $(15,156,474)  $(1,108)  $(13,260,764)
Stock compensation expense   -    
-
    2,827    
-
    848,075    
-
    
-
    848,075 
Shares to be issued for stock compensation   -    -    (2,827)   -    -    -    -    - 
Shares and warrants issued through public offering   -    
-
    166,667    17    1,003,983    
-
    
-
    1,004,000 
Shares and warrants issued through private placement   -    
-
    6,000    1    58,089    
-
    
-
    58,090 
Forgiveness of related party’s debt   -    
-
    -    
-
    2,135,573    
-
    
-
    2,135,573 
Foreign currency translation adjustments   -    
-
    -    
-
    
-
    
-
    (35)   (35)
Net loss   -    
-
    -    
-
    
-
    (2,750,336)   
-
    (2,750,336)
BALANCE, September 30, 2024 (Unaudited)   -   $
-
    1,059,673   $107   $5,942,449   $(17,906,810)  $(1,143)  $(11,965,397)

 

*Giving retroactive effect to reverse recapitalization effected on March 11, 2024 and the 1-for-30 reverse stock split effected on November 21, 2024

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

3

 

 

NATURE’S MIRACLE HOLDING INC., SUBSIDIARIES AND VIE

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

   For the Nine
Months
Ended
   For the Nine
Months
Ended
 
   September 30,   September 30, 
   2025   2024 
   (Unaudited)   (Unaudited) 
CASH FLOWS FROM OPERATING ACTIVITIES:        
Net loss  $(5,961,537)  $(6,825,461)
Adjustments to reconcile net loss to net cash used in          
operating activities:          
Depreciation expense   97,368    119,580 
Allowance for credit losses   306,091    60,988 
Amortization of operating right-of-use asset   245,412    264,187 
Amortization of debt issuance cost   331,968    140,170 
Loss on loan extinguishment   50,062    15,131 
Gain on disposal of fixed assets   (28,320)   
-
 
Stock compensation expenses   230,039    1,215,880 
Non cash finance expense   200,000    1,000,000 
Change in fair value of commitment shares to be issued   2,280    

-

 
Change in operating assets and liabilities:          
Accounts receivable   760,356    (2,746,275)
Inventories   1,139,166    1,712,545 
Prepayments and other current assets   36,740    (253,705)
Prepayments - related parties   (11,662)   
-
 
Security deposit   371,913    20,000 
Accounts payable   (1,152,227)   1,272,250 
Other payables and accrued liabilities   1,879,962    569,915 
Accrued interest payable - related parties   48,155    52,520 
Operating lease liabilities   (256,148)   (174,886)
Tax accrual   (22,739)   128,791 
Deferred income - Contract liabilities   (72,361)   257,653 
Net cash used in operating activities   (1,805,482)   (3,170,717)
           
CASH FLOWS FROM INVESTING ACTIVITIES:          
Loan to Lakeshore   
-
    (40,000)
Deposit from investment of Future Tech   (721,000)   
-
 
Deposit from licensing fee of Datavault AI   (200,000)   
-
 
Proceeds from disposal of property and equipment   25,959    
-
 
Proceeds from asset acquisition   31,682    - 
Net cash used in investing activities   (863,359)   (40,000)
           
CASH FLOWS FROM FINANCING ACTIVITIES:          
Proceeds from the reverse recapitalization   
-
    1,120,177 
Payments of transaction costs incurred by Lakeshore   
-
    (1,044,980)
Repayments of promissory note - related party of Lakeshore   
-
    (75,000)
Proceeds from issuance of Series A and D preferred stock   738,000    
-
 
Proceeds from exercise of warrants   865,423    
-
 
Shares and warrants issued through public offering   
-
    1,004,000 
Payments of deferred offering costs   
-
    (266,925)
Proceeds from shares issued under equity line of credit   145,809    
-
 
Repayments on long-term loan   (156,372)   (197,743)
Short-term loan borrowing from third parties   447,555    2,977,470 
Repayments on short-term loan from third parties   (819,319)   (1,075,371)
Repayments on short-term loan from related parties   (220,755)   (50,000)
Convertible notes borrowing   1,993,300    797,500 
Repayments on convertible notes   (684,421)   (198,170)
Borrowings from other payables - related parties   63,307    38,184 
Payments on other payables - related parties   (62,682)   
-
 
Net cash provided by financing activities   2,309,845    3,029,142 
           
EFFECT OF FOREIGN EXCHANGE ON CASH   315    (71)
           
CHANGES IN CASH   (358,681)   (181,646)
           
CASH AND CASH EQUIVALENTS, beginning of period   420,131    221,760 
           
CASH AND CASH EQUIVALENTS, end of period  $61,450   $40,114 
           
SUPPLEMENTAL CASH FLOW INFORMATION:          
Cash paid for income tax  $1,700   $3,315 
Cash paid for interest  $370,535   $1,006,605 
           
SUPPLEMENTAL DISCLOSURE OF NON-CASH TRANSACTIONS:          
Right of use assets acquired under new operating leases  $124,372   $398,788 
Reduction of right-of-use asset and operating lease liabilities based on modification  $
-
   $54,800 
Accumulated deficit acquired upon the reverse recapitalization  $
-
   $1,603,020 
Deferred offering cost converted to APIC upon the reverse recapitalization  $
-
   $1,100,857 
Conversion of convertible notes into shares  $257,462   $
-
 
Forgiveness of related party’s debt  $
-
   $2,135,573 
Asset acquisition via preferred stock issuance  $9,795,484   $
-
 
Asset acquisition via convertible note issuance  $3,000,000   $- 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

4

 

 

Nature’s Miracle Holding Inc., Subsidiaries and VIE
Notes to Unaudited Condensed Consolidated Financial Statements

 

Note 1 — Nature of business and organization

 

Nature’s Miracle Holding Inc., which until March 11, 2024 was known as LBBB Merger Corp. (the “Company”, “Nature’s Miracle”) is a company incorporated on August 1, 2022 under Delaware law as a wholly owned subsidiary of the Lakeshore Acquisition II Corp., a Cayman Islands exempted company (“Lakeshore”).

 

On March 11, 2024, Lakeshore merged with and into the Company for the sole purpose of reincorporating Lakeshore into the State of Delaware (“Reincorporation”). Immediately after the Reincorporation, the Company consummated the merger contemplated by the Merger Agreement between the Company and Nature’s Miracle, Inc., a Delaware corporation (“NMI”), resulting in the stockholders of NMI becoming 84.7% stockholders of the Company and the Company becoming the 100% stockholder of NMI. (“the Merger”).

 

Pursuant to the Merger Agreement, at the effective time of the Merger, each share of NMI common stock issued and outstanding immediately prior to the effective time was canceled and automatically converted into the right to receive the applicable pro rata portion of shares of the Company common stock, the aggregate value of which was equal to: (a) $230,000,000 minus (b) the estimated Closing Net Indebtedness (as defined in the Merger Agreement) (the “Merger Consideration”).

 

The Merger is considered as a reverse recapitalization in accordance with Accounting Standards Codification (“ASC”) 805-40. Under this method of accounting, Lakeshore will be treated as the “acquired” company for financial reporting purposes. This determination is primarily based on NMI’s stockholders comprise 84.7% of the voting power of the Company, directors appointed by NMI constituting three of the five members of the Company’s board of directors, NMI’s operations prior to the Merger comprising the only ongoing operations of the Company, and NMI’s senior management comprising all of the senior management of the Company.

 

Accordingly, for accounting purposes, the financial statements of the Company will represent a continuation of the financial statements of NMI with the Merger treated as the equivalent of NMI issuing stock for the net assets of Lakeshore, accompanied by a recapitalization. The net assets of Lakeshore will be stated at historical cost, with no goodwill or other intangible assets recorded. Operations prior to the Merger will be presented as those of NMI in financial statements of the Company. The consolidation of the Company and its subsidiaries have been accounted for at historical cost and prepared on the basis as if the aforementioned transactions had become effective as of the beginning of the first period presented in the accompanying consolidated financial statements in accordance with ASC 805-50-45-5.

 

The Company is a growing agriculture technology company focusing on the greenhouse and cultivation industry and providing products to indoor growers in a CEA (Controlled Environment Agriculture) setting in North America.

 

Reorganization under NMI

 

NMI is a holding company incorporated on March 31, 2022 in Delaware. NMI has no substantial operations other than holding all the outstanding share capital of its subsidiaries. NMI, its subsidiaries and variable interest entity (“VIE”).

 

On June 1, 2022, NMI entered into the Share Exchange Agreements with the stockholders of Visiontech Group, Inc. (“Visiontech”, a California Company), resulting in the stockholders of Visiontech becoming 56.3% stockholders of NMI and NMI becoming the 100% stockholder of Visiontech.

 

The transaction was accounted as a reverse recapitalization in accordance with ASC 805. The process of identifying the accounting acquirer began with a consideration of the guidance in ASC 810-10 related to determining the existence of a controlling financial interest. The general rule provided by ASC 810-10 is that the party that holds directly or indirectly greater than 50% of the voting shares has a controlling financial interest. As such, NMI is treated as the “acquired” company for financial reporting purposes. This determination was primarily based on the stockholders of Visiontech to have a majority of the voting power of the post-combination company, Zhiyi (Jonathan) Zhang, former president of Visiontech, became the President of NMI, the relative size of Visiontech compared to NMI. Accordingly, for accounting purposes and the combination was treated as the equivalent of Visiontech issuing shares for the net assets of NMI, accompanied by a recapitalization. The net assets of NMI are stated at historical cost, with no goodwill or other intangible assets recorded. Operations prior to the business combination would be those of Visiontech.

 

5

 

 

On June 1, 2022, NMI also entered into the Share Exchange Agreements with the stockholders of Hydroman, Inc. (“Hydroman”, a California Company) to acquire 100% of Hydroman by issuing 6,844,000 shares of NMI’s common stock to the stockholders of Hydroman. The transaction was accounted for as a business combination according with ASC 805 where NMI (post combination with Visiontech) is both the legal and accounting acquirer. On November 11, 2024, Hydroman, Inc. changed its name to Hydroman Electric Corporation and will focus on business of electric vehicles distribution.

 

On July 28, 2022, Nature’s Miracle (California), Inc., (“NMCA”), a California corporation wholly owned by NMI was incorporated. NMCA focuses on greenhouse development services and started providing container grow sales in first quarter of 2024.

 

On August 18, 2022, NMI acquired 100% interest of Photon Technology (Canada) Ltd, a Canadian company (“Photon”) for a total consideration of CAD $62,571 that was equivalent to $45,500. The purchase was accounted for as an asset purchase. Wei Yang, stockholder of NMI, was the sole stockholder of Photon prior to the acquisition. Upon completion of the acquisition, NMI has 100% of the equity interest of Photon, and Photon became a wholly-owned subsidiary of NMI. Photon will focus on manufacturing greenhouse and cultivation- related products. There was no material operation as of September 30, 2025.

 

On August 27, 2021, Visiontech and Upland 858 LLC (“Upland”), who share common stockholders with Visiontech, entered into a promissory note agreement. Upland is a special purchase entity set up to purchase and hold a warehouse located in California. Upland promised to pay to Visiontech the sum of $1,574,079, together with simple interest thereon at the rate of 4.9% per annum. All sums of principal and unpaid interest thereon shall be due and payable in full to Visiontech on August 28, 2026. On January 10, 2022, Upland entered into a $3,000,000 commercial loan at a fixed rate of 3.79% with Bank of the West. With the funding from Visiontech and the bank, Upland purchased a warehouse located in California at the price of $4,395,230. On February 1, 2022, Upland leased the warehouse to Visiontech through a single lease agreement. As such, Visiontech is exposed to the variability of the building owned by Upland and Upland is a VIE of Visiontech. Visiontech is the primary beneficiary of Upland since Visiontech has a controlling financial interest in Upland and it has both (1) the power to direct the activities of a VIE that most significantly impact the VIE’s economic performance (power) and (2) the obligation to absorb losses of the VIE that potentially could be significant to the VIE or the right to receive benefits from the VIE that potentially could be significant to the VIE.

 

On August 27, 2022, Upland entered into an assignment and assumption of unsecured promissory note with Zhiyi (Jonathan) Zhang, Vartor Vahe Doudakian and Yang Wei (collectively “Assignees”). Upland transferred to Assignees all of its right, title, duties, liabilities and obligation under the promissory note signed by and among Visiontech and Upland on August 27, 2021 in the original principal amount of $1,574,079. Visiontech also provided the consent to surrender its right to collect from Upland. As the stockholders are de facto agents of Visiontech, Visiontech and its de facto agents continue to bear the risk of losses or the rights to receive benefits from Upland. As such, in accordance with ASC 810, Upland is considered variable interest entity(“VIE”) of Visiontech and the financial statements of Upland was consolidated from the date of control and variable interest existed. See Note 4 for details.

  

On May 10, 2024, NM Data, Inc. (“NM Data”), a Nevada corporation wholly owned by the Company was incorporated. NM Data aimed at entering the data center and Bitcoin mining business.

 

On October 18, 2024, NM Rebate, Inc. (“NM Rebate”), a California corporation wholly owned by the Company was incorporated. NM Rebate focus on energy rebate solutions combined with the supply of LED lights that qualify for energy-saving rebates provided by large utility companies throughout the U.S.

 

On November 18, 2024, the Company filed a certificate of amendment to its amended and restated certificate of incorporation to effect a one-for-thirty (1-for-30) reverse split (the “Reverse Split”). The Reverse Split became effective on November 21, 2024. As a result of the Reverse Split, every 30 shares of the Company’s issued and outstanding common stock were automatically converted into one share of common stock, with no change to the par value per share. All share and per share data has been retroactively restated to reflect the current capital structure and the Reverse Split of the Company.

 

On September 18, 2025, the Company entered into a Membership Interest Purchase Agreement (the “Purchase Agreement”) with Big Lake Capital LLC (“Big Lake”), pursuant to which, the Company agreed to purchase from Big Lake all of the membership interests of Zak Properties, LLC, an Ohio limited liability company (“Zak Properties”), which in turn owns certain real property located in the State of Ohio, commonly known as 405 Madison Ave. The Company’s Chief Executive Officer and Chairman, Tie (James) Li, is the sole member of Zak Properties prior to the sale. For details see related party transaction in Note 6 – Asset acquisition under common control.

 

6

 

 

Note 2 — Going concern

 

In assessing liquidity, the Company monitors and analyzes cash on-hand and operating expenditure commitments. The Company’s liquidity needs are to meet working capital requirements and operating expense obligations. To date, the Company financed its operations primarily through cash flows from operations, debt financing from financial institution and related parties. As of September 30, 2025 and December 31, 2024, the Company had approximately $61,000 and $0.4 million in cash which primarily consists of bank deposits, which are unrestricted as to withdrawal and use. The Company’s working capital deficit was approximately $19.0 million and $14.6 million as of September 30, 2025 and December 31, 2024. The Company’s accumulated deficit and negative operating cash flow for the period ended September 30, 2025 amounted to $30,711,831 and $1,805,482, respectively. The Company’s accumulated deficit and negative operating cash flow for the year December 31, 2024 amounted to $24,734,689 and $5,934,771, respectively.

 

The Company has experienced recurring losses from operations and negative cash flows from operating activities since 2022. In addition, the Company had, and may potentially continue to have, an ongoing need to raise additional cash from outside sources to fund its expansion plan and related operations. Successful transition to attaining profitable operations is dependent upon achieving a level of revenues adequate to support the Company’s cost structure. In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standard Board’s Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that these conditions raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date that these unaudited condensed consolidated financial statements are issued.

 

If the Company is unable to realize its assets within the normal operating cycle of a twelve (12) month period, the Company may have to consider supplementing its available sources of funds through the following sources:

 

  financial support from the Company’s related parties and stockholders;

 

  other available sources of financing from banks and other financial institutions;

 

  equity financing through capital market.

 

The Company has a $20 million equity financing program (“ELOC”) with GHS Investment and this was declared effective by SEC. The Company can draw on this facility for its working capital needs and others. The Company received $151,551 for the three and nine months ended September 30, 2025 under this facility, with approximately $19.8 million of credit still available.

 

The Company has access to investors who are providing convertible note financing for public companies and we have been utilizing the convertible note for part of our financing needs.

 

The shareholder of the Company also offers support for the Company. Big Lake Capital, LLC, a related party controlled by Tie Li (our Chairman and CEO) entered into a $2 million Convertible Promissory Note on April 11, 2025 with the initial tranche of $600,000. The Company has borrowed nil and $652,800 for the three and nine months ended September 30, 2025 under this note, with $1,347,200 of credit still available.

 

The Company entered into a securities purchase agreement for $2 million with Y.K. Capital Management, Inc. on September 19, 2025. For the three and nine months ended September 30, 2025, the Company received an initial payment of $500,000 for the issuance of preferred shares. The remaining proceeds of $1.5 million are expected to be collected subsequent to the period end.

 

On October 1, 2025, the Company entered into another securities purchase agreement with 1800 Diagonal Lending LLC (“Diagonal”) pursuant to which the Company sold to the Diagonal a convertible promissory note in the aggregate principal amount of $112,800 with an original issue discount of $18,800 and closing expenses of $9,000 deducted from funding amount. The note bears an annual interest charge of 15% and maturity date was June 30, 2026. Only upon an occurrence of an event of default under the note, the holder may convert the outstanding unpaid principal amount of the note into shares of common stock of the Company at a discount of 39% of the market price.

 

On October 20, 2025, the Company received an investment of $250,000 from Huanfu Cui, an Asian-based individual investor, which was followed with another $200,000 tranche on October 31, 2025. The investments are based on the Securities Purchase Agreement signed on October 29, 2025. This agreement calls for a total investment of $500,000 issuance of Series F Preferred shares which are convertible into common shares at a fixed price of $0.2813. If fully funded and converted, the Preferred Shares would be the equivalent of 1,777,778 common shares.

 

7

 

 

 The Company can make no assurances that required financings will be available for the amounts needed, or on terms commercially acceptable to the Company, if at all. If one or all of these events does not occur or subsequent capital raises are insufficient to bridge financial and liquidity shortfall, there would likely be a material adverse effect on the Company and would materially adversely affect its ability to continue as a going concern.

 

The unaudited condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern and, accordingly, do not include any adjustments that might result from the outcome of this uncertainty.

 

Note 3 — Basis of presentation and summary of significant accounting policies

 

Basis of presentation

 

The unaudited condensed consolidated financial statements have been prepared in accordance with the generally accepted accounting principles in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the Securities Exchange Commission (“SEC”) for interim reporting. As permitted under those rules, certain footnotes or other financial information that are normally required by U.S. GAAP can be condensed or omitted. These unaudited condensed consolidated financial statements have been prepared on the same basis as its annual consolidated financial statements and, in the opinion of management, reflect all adjustments, consisting only of normal recurring adjustments, which are necessary for the fair statement of the Company’s financial information. These interim results are not necessarily indicative of the results to be expected for the fiscal year ending December 31, 2025, or for any other interim period or for any other future year. All intercompany balances and transactions have been eliminated in consolidation. 

 

Principles of consolidation

 

The unaudited condensed consolidated financial statements include the financial statements of the Company and its subsidiaries, which include its wholly owned subsidiaries and VIE over which the Company exercises control and, when applicable, entities for which the Company has a controlling financial interest or is the primary beneficiary. All transactions and balances among the Company and its subsidiaries and VIE have been eliminated upon consolidation.

 

Use of estimates and assumptions

 

The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts of assets and liabilities reported and disclosures of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the periods presented. Actual results could differ from these estimates.

 

Cash and cash equivalents

 

Cash and cash equivalents consist of amounts held as cash on hand and bank deposits.

 

From time to time, the Company may maintain bank balances in interest bearing accounts in excess of the $250,000 currently insured by the Federal Deposit Insurance Corporation for interest bearing accounts (there is currently no insurance limit for deposits in noninterest bearing accounts). The Company has not experienced any losses with respect to cash. Management believes our Company is not exposed to any significant credit risk with respect to its cash. The amount in excess of the FDIC insurance was $0 as of September 30, 2025.

 

Prepayments and other current assets

 

Prepaid expenses and other current assets primarily include prepaid expenses paid to product providers, and other deposits. Management regularly reviews the aging of such balances and changes in payment and realization trends and records allowances when management believes collection or realization of amounts due are at risk. Accounts considered uncollectable are written off against allowances after exhaustive efforts at collection are made. As of September 30, 2025 and December 31, 2024, no allowance for doubtful account was recorded.

 

Accounts receivable, net

 

Starting from January 1, 2023, the Company adopted ASU No.2016-13 “Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” (“ASC Topic 326”). The Company used a modified retrospective approach, and the adoption does not have an impact on our unaudited condensed consolidated financial statements. During the ordinary course of business, the Company extends unsecured credit to its customers. Accounts receivable are stated at the amount the Company expects to collect from customers. An allowance for expected credit loss is recorded in the period in which loss is determined to be probable based on lifetime expected losses considering historical, current, and forecasted conditions. Amounts deem uncollectible are written off against the allowance after all collection efforts have ceased.

 

8

 

 

Inventory

 

Inventory consists of finished goods ready for sale and is stated at the lower of cost and net realizable value. The Company values its inventory using the weighted average costing method. The Company’s policy is to include as a part of cost of goods sold any freight incurred to ship the product from its vendors to warehouses. Outbound freight costs related to shipping costs to customers are considered periodic costs and are reflected in cost of revenue. The Company regularly reviews inventory and considers forecasts of future demand, market conditions and product obsolescence.

 

If the estimated realizable value of the inventory is less than cost, the Company makes provisions in order to reduce its carrying value to its estimated market value. The Company also reviews inventory for slow moving inventory and obsolescence and records impairment for obsolescence. For the three and nine months ended September 30, 2025, there was no inventory impairment loss recorded. For the three and nine months ended September 30, 2024, there was no inventory impairment loss recorded.

 

Cost method investment

 

The Company accounts for investments with less than 20% of the voting shares and does not have the ability to exercise significant influence over operating and financial policies of the investee using the cost method. The Company records cost method investment at the historical cost in its unaudited condensed consolidated financial statements and subsequently records any dividends received from the net accumulated earrings of the investee as income. Dividends received in excess of earnings are considered a return of investment and are recorded as reduction in the cost of the investments.

 

Cost method investment is evaluated for impairment when facts or circumstances indicate that the fair value of the long-term investments is less than its carrying value. An impairment is recognized when a decline in fair value is determined to be other-than-temporary. The Company reviews several factors to determine whether a loss is other-than-temporary. These factors include, but are not limited to, the: (i) nature of the investment; (ii) cause and duration of the impairment; (iii) extent to which fair value is less than cost; (iv) financial condition and near-term prospects of the investments; and (v) ability to hold the security for a period of time sufficient to allow for any anticipated recovery in fair value. No event had occurred and indicated that other-than-temporary impairment existed and therefore during the three and nine months ended September 30, 2025, the Company did not record any impairment charges for its investments. During the three and nine months ended September 30, 2024, the Company did not record any impairment charges for its investments.

  

Deposits

 

Deposit consists of security deposits for vendors, deposits for acquisition and deposits for licensing fee. To maintain a stable supply for goods and build a long-term relationship, the Company may pay certain amount of funds to its vendors as security deposits which are recorded as non-current assets on the balance sheet depending on its return date. On November 22, 2024, NM Data entered into an investment agreement to acquire 51% of Future Tech Incorporated (“Future Tech”), an Ohio-based company, for the development and construction of a 50MW high density data center and a vertical farming facility in Stryker, Ohio. The closing of the acquisition of Future Tech is subject to Future Tech’s executing an electricity sales and purchase agreement with a certain supplier set forth in the agreement and Future Tech entering into a ten-year lease option to purchase indoor space as set forth in the agreement. As of September 30, 2025, the deposit for acquisition of Future Tech was $721,000. The Company also made a deposit with Datavault AI for licensing fee of $200,000 for certain intellectual properties related to business in the field of tokenization of assets using cryptocurrencies.

 

Property and equipment

 

Property and equipment are stated at historical cost. Depreciation is provided over the estimated useful life of each class of depreciable assets and is computed using the straight-line method over the useful lives of the assets are as follows:

 

   Useful Life
Machinery and equipment  5 years
Computer and peripherals  3 years
Trucks and automobiles  5 years
Buildings  39 years

 

The cost and related accumulated depreciation of assets sold or otherwise retired are eliminated from the accounts and any gain or loss is included in the statements of operations. Expenditures for maintenance and repairs are expensed as incurred, while additions, renewals and betterments, which are expected to extend the useful life of assets, are capitalized.

 

9

 

 

Long-lived assets impairment

 

The Company reviews the impairment of its long-lived assets on an annual basis and whenever events or changes in circumstances indicate that the carrying amount of an asset or group of assets may not be fully recoverable. These events or changes in circumstances may include but are not limited to, a significant deterioration of operating results, a change in the regulatory environment, changes in business plans, or adverse changes in anticipated future cash flows. If an impairment indicator is present, the Company evaluates the recoverability by a comparison of the carrying amount of the assets to future undiscounted net cash flows expected to result from the use and eventual disposition of the assets. If the assets are determined to be impaired, the impairment recognized is the excess of the carrying amount over the fair value of the assets. Fair value is generally determined by the discounted cash flow method. The discount rate used in any estimate of discounted cash flows is the rate commensurate with a similar investment of similar risk. As of September 30, 2025 and 2024, there was no impairment of long-lived assets.

 

Deferred offering costs

 

Deferred offering costs consist primarily of expenses paid to attorneys, consultants, underwriters, and etc. related to its merger transaction. The balance has been offset with the proceeds received after the close of the offering.

  

Fair value measurement

 

The Company adopted ASC Topic 820, Fair Value Measurements and Disclosures which defines fair value, establishes a framework for measuring fair value and expands financial statement disclosure requirements for fair value measurements.

 

ASC Topic 820 defines fair value as the price that would be received from the sale of an asset or paid to transfer a liability (an exit price) on the measurement date in an orderly transaction between market participants in the principal or most advantageous market for the asset or liability. ASC Topic 820 specifies a hierarchy of valuation techniques, which is based on whether the inputs into the valuation technique are observable or unobservable. The hierarchy is as follows:

  

Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.

 

Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments.

 

Level 3 inputs to the valuation methodology are unobservable and significant to the fair value. Unobservable inputs are valuation technique inputs that reflect the Company’s own assumptions about the assumptions that market participants would use in pricing an asset or liability.

 

When available, the Company uses quoted market prices to determine the fair value of an asset or liability. If quoted market prices are not available, the Company measures fair value using valuation techniques that use, when possible, current market-based or independently sourced market parameters, such as interest rates and currency rates.

 

Fair values of financial instruments

 

Financial instruments include cash and cash equivalents, accounts receivable, prepayments, loan receivable, and other current assets, other payable and accrued liabilities, accounts payable — related parties, short term loans and taxes payable. The Company considers the carrying amount of short-term financial instruments to approximate their fair values because of the short period of time between the origination of such instruments and their expected realization. The Company’s long-term debts are measured at amortized cost, no fair value option is elected.

 

Revenue recognition

 

The Company follows Accounting Standards Codification (“ASC”) 606 Revenue Recognition and recognizes revenue from product sales revenues, net of promotional discounts and return allowances, when the following revenue recognition criteria are met: a contract has been identified, separate performance obligations are identified, the transaction price is determined, the transaction price is allocated to separate performance obligations and revenue is recognized upon satisfying each performance obligation. 

 

The Company is a growing agriculture technology company providing CEA hardware products to growers in the controlled environment agriculture industry setting in North America.  Majority of the Company’s products were grow lights and related products for the indoor growing settings. Starting from first quarter of 2024, the Company also provides indoor grow containers to its customers.

 

10

 

 

The Company’s contracts with customers where the amounts charged per product is fixed and determinable, the specific terms of the contracts were agreed on by the Company including payment terms which are typically 30 to 60 days for existing customers and prepaid for most new customers. In certain contracts involving sales to customers that entered into rebate programs who can get rebates with utility companies for using LED lighting, payment term ranges from 60 to 120 days.

 

The Company’s performance obligation is to deliver the products to customers. For indoor grow container products, the Company also involved in customization of the products to suit customer’s specific needs. The provision of customization and configuration to meet certain technical specification per US market and delivery of product is considered one performance obligation as the services provided are not distinct within the context of the contract whereas the customers can only obtain benefit when the services and products are provided together. At times, the Company may charge customers shipping and handling for delivery of products, control of goods does not transfer to the customer before shipment, therefore shipping is not a promised service to the Company and is not considered a separate performance obligation. Any fee charged for shipping would be included in the transaction price for the good. 

 

Transaction prices are mostly fixed. In some contracts, when determining the transaction price, the Company adjusts consideration for the effects of the time value of money if the timing of payments provides the Company with a significant benefit of financing. The Company does not assess whether a contract has a significant financing component if the expectation at contract inception is such that the period between payment by the customers and the transfer of the promised goods or services to the licensees will be one year or less.  For customers that entered into rebate programs with utility companies, transaction price may depend on level of energy saving the products achieved. The Company estimated the amount of consideration using the expected value of the most likely amount depending on which method the Company expects to better predict the amount of consideration to which it will receive with a constraint applied such that a significant reversal of revenue is not probable.

 

The Company transfers the risk of loss or damage upon shipment, therefore, revenue from product sales is recognized at a point in time when control of product transfer to customer and the Company has no further obligation to provide services related to such product evidenced by customer signing acceptances upon receipt of goods. Return allowances, which reduce product revenue by the Company’s best estimate of expected product returns, are estimated using historical experience.

 

The Company evaluates the criteria of ASC 606 — Revenue Recognition Principal-Agent Considerations in determining whether it is appropriate to record the gross amount of product sales and related costs or the net amount earned as commissions. The Company ships the products according to shipping terms on the purchase order or sales order. Once delivery is complete, the Company then sends an invoice to the customer according to the quantity and price of shipment.

 

The Company evaluates the indicators of control in accordance with ASU 2016-08: 1) the Company is the most visible entity to customers and assumes fulfilment risk and risks related to the acceptability of products, including addressing customer inquiries directly and handling of product returns or refunds directly if any. For grow light products, the Company has its own brand for marketing. For indoor grow containers products, the Company is also involved in the design and technical specification of the products to meet requirement in the US market. 2) The Company assumes inventory risk either through storing the products in its own warehouses; or for drop shipments directly from vendors, the Company takes the title from vendors through inspection and acceptance and is responsible for product damage during shipment period prior to acceptance of its customers and is also responsible for product return if the customer is not satisfied with the products. 3) The Company determines the resale price of the products. 4) The Company is the party that directs the use of the inventory and can prevent the vendor from transferring the product to a customer or to redirect the products to a different customer, after evaluating the above scenario, the Company considers itself the principal of these arrangements and records revenue on a gross basis.

 

The Company’s disaggregate revenue stream by products are summarized below:

 

   For the Three Months Ended   For the Nine Months Ended 
   September 30,
 2025
   September 30, 
2024
   September 30, 
2025
   September 30, 
2024
 
   (Unaudited)   (Unaudited)   (Unaudited)   (Unaudited) 
                 
Grow light  $69,293   $2,949,162   $1,302,865   $8,326,412 
Indoor grow containers   
—  
    
—  
    
—  
    143,781 
Grow media and others   3,084    103,565    360,340    192,221 
Total revenues  $72,377   $3,052,727   $1,663,205   $8,662,414 

 

11

 

 

Prepayments received from customers prior to the delivery of goods to customers or picked up by the customers are recorded as contract liability under the account Deferred income — contract liabilities. 

 

Movements of deferred income — contract liabilities (including related party) consisted of the following as of the date indicated:

 

   As of
September 30,
2025
   As of
December 31,
2024
 
Beginning balance  $231,258   $118,909 
Prepayments from customers   235,449    1,054,171 
Recognized as revenues   (307,810)   (941,822)
Ending balance  $158,897   $231,258 

 

The Company periodically provides incentive offers to its customers to encourage purchases. Such offers include current discount offers, such as percentage discounts off current purchases and other similar offers. Current discount offers, when accepted by the Company’s customers, are treated as a reduction to the transaction price of the related transaction.

 

Sales discounts are recorded in the period in which the related sale is recognized. Sales return allowances are recorded and estimated based on historical returns which were generally immaterial to the Company.

 

Estimated warranty are immaterial because suppliers provide a warranty period of 1-5 years for all products, varying depending on the product type. After customers provide their purchase invoices and serial numbers for the return products, the factories will issue the replacement products. Additionally, the factories will also bear the corresponding shipping costs, making the company’s warranty expenses negligible.

 

Cost of revenue

 

Cost of revenue mainly consist of costs for purchases of products and related storage, warehouse rent, outbound freight, delivery fees and payroll related expenses.

 

Segment reporting

 

The Company follows ASC 280, Segment Reporting. The Company’s chief operating decision maker, the Chief Executive Officer, reviews the results of operations when making decisions about allocating resources and assessing the performance of the Company as a whole and hence, the Company has only one reportable segment. The Company does not distinguish between markets or segments for the purpose of internal reporting. Substantially all the Company’s revenues are derived from within the USA. Therefore, no geographical segments are presented. The Company has deposits related to a datacenter in Ohio and recently acquired a real estate asset in Toledo, Ohio (see Note 6 – Asset acquisition under common control).

 

Leases

 

The Company follows ASC 842 — Leases (“ASC 842”), which requires lessees to record right-of-use (“ROU”) assets and related lease obligations on the balance sheet, as well as disclose key information regarding leasing arrangements.

 

12

 

 

ROU assets represent our right to use an underlying asset for the lease terms and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As the Company’s leases do not provide an implicit rate, the Company generally uses its incremental borrowing rate based on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at commencement date. The operating lease ROU asset also includes any lease payments made and excludes lease incentives. Lease expense for lease payments is recognized on a straight-line basis over the lease term.

 

Income taxes

 

The Company accounts for income taxes under the asset and liability method. Deferred tax assets and liabilities are recognized for future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their perspective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which the temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Valuation allowances are recorded, when necessary, to reduce deferred tax assets to the amount expected to be realized.

  

As a result of the implementation of certain provisions of ASC 740, Income Taxes (“ASC 740”), which clarifies the accounting and disclosure for uncertainty in tax position, as defined, ASC 740 seeks to reduce the diversity in practice associated with certain aspects of the recognition and measurement related to accounting for income taxes. The Company follows the provisions of ASC 740 and has analyzed filing positions in each of the federal and state jurisdictions where the Company is required to file income tax returns, as well as open tax years in such jurisdictions. The Company has identified the U.S. federal jurisdiction, and the states of Delaware, as its “major” tax jurisdictions.

 

The Company believes that our income tax filing positions and deductions will be sustained on audit and do not anticipate any adjustments that will result in a material change to its financial position. Therefore, no reserves for uncertain income tax positions have been recorded pursuant to ASC 740. The Company’s policy for recording interest and penalties associated with income-based tax audits is to record such items as a component of income taxes.

 

Stock-based compensation

 

The Company accounts for stock-based compensation awards to employees in accordance with FASB ASC Topic 718, “Compensation – Stock Compensation”, which requires that stock-based payment transactions with employees be measured based on the grant-date fair value of the equity instrument issued and recognized as compensation expense over the requisite service period. To the extent a stock-based award is subject to a performance condition, the amount of expense recorded in a given period, if any, reflects an assessment of the probability of achieving such performance condition, with compensation recognized once the event is deemed probable to occur. Forfeitures are recognized as incurred. 

 

The Company accounts for stock-based compensation awards to non-employees in accordance with FASB ASC Topic 718 amended by ASU 2018-07. Under FASB ASC Topic 718, stock compensation granted to non-employees has been determined as the fair value of the consideration received or the fair value of equity instrument issued, whichever is more reliably measured and is recognized as an expense as the goods or services are received.  

 

Warrants

 

The Company evaluates the public and private warrants as either equity-classified or liability-classified instruments based on an assessment of the warrants’ specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares, among other conditions for equity classification. Pursuant to such evaluation, both public and private warrants are classified in shareholders’ equity.

 

13

 

 

For issued warrants that meet all of the criteria for equity classification and issued with debt instruments, the proceeds from the sale of the debt instruments are allocated to the two elements based on the relative fair values of the debt instrument without the warrants and of the warrants themselves at time of issuance. The portion of the proceeds so allocated to the warrants is accounted for as paid-in capital. The remainder of the proceeds is allocated to the debt instrument portion of the transaction at a discount and amortized over the term of the debt instrument using the effective interest rate method.  

 

Convertible notes

 

Upon adoption of ASU 2020-06 on January 1, 2021, the elimination of the beneficial conversion feature (“BCF”) and cash conversion models in ASC 470-20 that requires separate accounting for embedded conversion features in convertible instruments results in the convertible debt instruments being recorded as a single liability (i.e., there is no separation of the conversion feature, and all proceeds are allocated to the convertible debt instruments as a single unit of account). Unless conversion features are derivatives that must be bifurcated from the host contracts in accordance with ASC 815-15 or, in the case of convertible debt, if the instruments are issued with a substantial premium, in the latter case, ASC 470-20-25-13 requires the substantial premium to be attributable to the conversion feature and recorded in additional paid-in capital (APIC).

  

Commitments and Contingencies

 

In the ordinary course of business, the Company is subject to certain contingencies, including legal proceedings and claims arising out of the business that relate to a wide range of matters, such as government investigations and tax matters. The Company recognizes a liability for such contingency if it determines it is probable that a loss has occurred, and a reasonable estimate of the loss can be made. The Company may consider many factors in making these assessments including historical and specific facts and circumstances of each matter.

 

Related party transactions

 

A related party is generally defined as (i) any person and or their immediate family hold 10% or more of the company’s securities (ii) the Company’s management and or their immediate family, (iii) someone that directly or indirectly controls, is controlled by or is under common control with the Company, or (iv) anyone who can significantly influence the financial and operating decisions of the Company, a transaction is considered to be a related party transaction when there is a transfer of resources or obligations between related parties. Related parties may be individuals or corporate entities. ‘Transactions involving related parties cannot be presumed to be carried out on an arm’s - length basis, as the requisite conditions of competitive, free market dealings may not exist. Representations about transactions with related parties, if made, shall not imply that the related party transactions were consummated on terms equivalent to those that prevail in arm’s-length transactions unless such representations can be substantiated.

  

Loss per share

 

Basic loss per share is computed by dividing net loss attributable to holders of common stock by the weighted average number of common stock outstanding during the year. Diluted loss per share presents the dilutive effect on a per share basis of the potential common stock (e.g., convertible securities, options, and warrants) as if they had been converted at the beginning of the periods presented, or issuance date, if later. Potential common stock that has an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the calculation of diluted loss per share.

 

For the three and nine months ended September 30, 2025 and 2024, diluted EPS equals basic EPS because the Company incurred a net loss.

  

Recently issued accounting pronouncements

 

In December 2023, the FASB issued Accounting Standards Update No. 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures” (“ASU 2023-09”), which modifies the rules on income tax disclosures to require entities to disclose (1) specific categories in the rate reconciliation, (2) the income or loss from continuing operations before income tax expense or benefit (separated between domestic and foreign) and (3) income tax expense or benefit from continuing operations (separated by federal, state and foreign). ASU 2023-09 also requires entities to disclose their income tax payments to international, federal, state and local jurisdictions, among other changes. The guidance is effective for annual periods beginning after December 15, 2024. Early adoption is permitted for annual financial statements that have not yet been issued or made available for issuance. ASU 2023-09 should be applied on a prospective basis, but retrospective application is permitted. The Company is currently evaluating the potential impact of adopting this new guidance on its unaudited condensed consolidated financial statements and related disclosures.

 

14

 

 

In November 2024, the FASB issued ASU 2024-03, Income Statement–Reporting Comprehensive Income–Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses (“ASU 2024-03”), which requires the disaggregation of certain expenses in the notes of the financials, to provide enhanced transparency into the expense captions presented on the face of the income statement. ASU 2024-03 is effective for annual reporting periods beginning after December 15, 2026 and interim periods beginning after December 15, 2027 and may be applied either prospectively or retrospectively. The Company is currently evaluating the impact that ASU 2024-03 will have on its related disclosures.

 

In November 2024, the FASB issued ASU 2024-04, Debt–Debt with Conversion and Other Options (Subtopic 470-20): Induced Conversion of Convertible Debt Instruments (“ASU 2024–04”), which clarifies the requirements for determining whether certain settlements of convertible debt instruments should be accounted for as an induced conversion. ASU 2024-04 is effective for annual reporting periods beginning after December 15, 2025, and interim reporting periods within those annual reporting periods. Early adoption is permitted for all entities that have adopted the amendments in Update 2020-06, which includes the Company. Adoption can be on a prospective or retrospective basis. The Company adopted ASU 2024-04 effective January 1, 2025 on a prospective basis.

 

In July 2025, the FASB issued ASU 2025-05 Financial Instruments – Credit Losses (Subtopic 326) (“ASU 2025-05”), simplifies the Current Expected Credit Loss (CECL) model for receivables and contract assets by offering a practical expedient to use current conditions for forecasts and an accounting policy election to consider post-balance sheet collections, allowing for early adoption for financial statements not yet issued. The guidance is effective for annual reporting periods beginning after December 15, 2025, but early adoption is permitted. The Company plans to adopt the ASU prospectively for the year ended December 31, 2025.

 

Except as mentioned above, the Company does not believe other recently issued but not yet effective accounting standards, if currently adopted, would have a material effect on the Company’s unaudited condensed consolidated balance sheets, statements of operations and comprehensive loss and statements of cash flows.

 

Note 4 — Variable interest entity

 

The Company does not have direct ownership in Upland but has been actively involved in their operations and has the power to direct the activities and significantly impact Upland’s economic performance. The Company also bears the risk of losses from Upland. As such, in accordance with ASC 810, Upland is considered variable interest entity (“VIE”) of the Company and the financial statements of Upland was consolidated from the date of control and variable interest existed.

  

Based on the loan agreement between its creditor and Upland 858 LLC, the loan is a non-recourse debt secured by the assets owned by Upland 858 LLC only and guaranteed by the stockholders of Upland 858 LLC only. Upland 858 LLC’s creditor will have no-recourse to Visiontech which is considered to be the primary beneficiary of the VIE structure but not the legal owner of Upland 858 LLC:

 

Accordingly, the accounts of Upland were consolidated in the accompanying financial statements as VIE of Visiontech from January 2022 when Upland acquired the warehouse in California. 

 

The carrying amount of the assets and liabilities are as follows:

 

   As of
September 30,
2025
 
Cash  $275 
Property and equipment, net   4,091,652 
Total assets  $4,091,927 
      
Current portion of long-term debt  $86,155 
Long-term debt, net of current portion   2,622,930 
Accrued expenses   151 
Intercompany payable to Visiontech   1,333,567 
Total liabilities  $4,042,803 

 

15

 

 

The operating results of VIE included in the unaudited condensed consolidated statements of operations are as follows for the period indicated:

 

   For the
three months ended
September 30,
2025
   For the
nine months ended
September 30,
2025
 
Revenue*  $83,210   $249,631 
Selling, general and administrative   4,401    88,466 
Interest expense   24,633    73,927 
Income tax   
-
    1,700 
Net income  $54,176   $85,538 

 

* Upland generated its revenue from leasing the warehouse to Visiontech. Revenue of Upland was fully eliminated on the unaudited condensed consolidated statements of operations.

 

Note 5 — Reverse recapitalization

 

On March 11, 2024, Lakeshore merged with and into the Company for the sole purpose of reincorporating Lakeshore into the State of Delaware. Immediately after the Reincorporation, the Company consummated the merger between the Company and NMI, resulting in the stockholders of NMI becoming 84.7% stockholders of the Company and the Company becoming the 100% stockholder of Nature’s Miracle. Lakeshore was treated as the “acquired” company for financial reporting purposes. Accordingly, the financial statements of the Company represent the continuation of the financial statements of NMI, with the Merger reflected as the equivalent of NMI issuing ordinary shares for the net assets of Lakeshore, accompanied by a recapitalization. The net assets of Lakeshore were recognized as of the closing date at historical cost, with no goodwill or other intangible assets recorded. Operations prior to the Merger are those of NMI. The shares and corresponding capital amounts and all per share data related to NMI outstanding shares prior to the reverse recapitalization have been retroactively adjusted.

 

The following table presents the number of the Company’s common stock issued and outstanding immediately following the reverse recapitalization:

 

   Common
Stock
 
Lakeshore’s shares outstanding prior to reverse recapitalization   74,717 
Shares issued to private rights   1,172 
Conversion of the Lakeshore’s public shares and rights   26,337 
Shares issued to service providers   26,718 
Shares issued for commitment fee   5,114 
Bonus shares issued to investors   5,533 
Conversion of NMI’s shares into the Company’s ordinary shares   742,415 
Total shares outstanding   882,006 

 

In connection with the reverse recapitalization, the Company has assumed 120,858 warrants outstanding, which consisted of 115,000 public warrants and 5,858 private warrants. Both of the public warrants and private warrants met the criteria for equity classification. (see Note 15 Equity for details)

 

In connection with the reverse recapitalization, the Company raised approximately $1.1 million of proceeds, presented as cash flows from financing activities, which included the contribution of approximately $15.1 million of funds held in Lakeshore’s trust account, net of approximately $13.9 million paid to redeem 41,552 public shares of Lakeshore’s ordinary shares, approximately $1.0 million in transaction costs incurred by Lakeshore, and repayments of a promissory note in the amount of $75,000 issued to Lakeshore’s related party. NMI incurred approximately $1.2 million of transaction costs, which consisted of direct incremental legal and accounting fees in connection with the Merger. The net effect of the above with the net liabilities assumed from Lakeshore of approximately $1.6 million was recorded to the Company’s retained deficit of $2,833,474.

 

16

 

 

The following table reconciles the elements of the reverse recapitalization to the unaudited condensed consolidated statements of cash flows and the changes in shareholders’ equity (deficit):

 

   As of
March 11,
2024
 
Funds held in Lakeshore’s trust account  $15,067,702 
Funds held in Lakeshore’s operating cash account   198 
Less:  amount paid to redeem public shares of Lakeshore’s ordinary shares   (13,947,723)
Proceeds from the reverse recapitalization   1,120,177 
Less:  payments of transaction costs incurred by Lakeshore   (1,044,980)
Less:  repayments of promissory note – related party of Lakeshore’   (75,000)
Less:  notes assumed from Lakeshore   (555,000)
Less:  liability assumed from Lakeshore   (1,547,814)
Less:  transaction costs paid by NMI   (1,230,857)
Add:  receivable assumed from Lakeshore   500,000 
Net liabilities assumed from issuance of common stock upon the Merger, balance classified to retained deficit  $(2,833,474)

 

Note 6 — Asset acquisition under common control

 

On September 18, 2025, the Company entered into a Membership Interest Purchase Agreement with Big Lake, pursuant to which, the Company agreed to purchase from Big Lake all of the membership interests of Zak Properties, which in turn owns certain real property located in the State of Ohio, commonly known as 405 Madison Ave. The Company’s Chief Executive Officer and Chairman, Tie (James) Li, is the sole member of Zak Properties prior to the sale. The purchase price for Zak Properties is $17,500,000, and will be paid by the Company as follows: (i) the Company shall issue 5,000 shares of Series B Preferred Stock (valued at $5,000,000) of the Company which (a) can be converted into Common Stock, par value $0.0001 per share, of the Company at $0.1180 per share and (b) have certain voting rights equal to twenty (20) votes per one (1) share of Series B Preferred Stock; (ii) the Company shall issue 9,500 shares of Series C Preferred Stock (valued at $9,500,000) of the Company which are convertible into shares of Common Stock at $0.1180 per share; and (iii) the Company shall issue a convertible promissory note (the “Note”) in the principal amount of $3,000,000 in favor of Big Lake with a term of two years from the date of issuance and interest in the amount of 10% per annum. The Purchase Agreement includes customary representations, warranties and covenants by the Company and customary closing conditions. The acquisition closed on September 18, 2025.

 

Since Big Lake, Zak Properties and the Company are under common control of Mr. Li and the asset acquired is concentrated in a single identifiable asset which is a building, the acquisition is accounted for as asset acquisition under common control where the assets are transferred at the cost basis on September 18, 2025. The excess of consideration paid over the carrying value was recorded as a reduction in the Company’s additional paid in capital.

 

Fair value of consideration transferred:

 

Series B and C preferred stock  $14,440,000 
Issuance cost of preferred stock   60,000 
Convertible promissory note   3,000,000 
Total  $17,500,000 

 

Carrying value of assets and liabilities transferred:

 

   September 18,
2025
 
Current assets  $66,682 
Property and equipment, net   12,985,266 
Total assets   13,051,948 
Total liabilities   (196,464)
Net assets  $12,855,484 

 

Equity in the Company as a result of the asset acquisition increased as follows:

 

   As of
September 18,
2025
 
Net assets acquired  $12,855,484 
Less: debt incurred   (3,000,000)
Less: cost associated with issuance of Series B and C preferred stock   (60,000)
Increase in equity  $9,795,484 

 

17

 

 

Note 7 — Accounts receivable, net

 

Accounts receivable consisted of the following as of the date indicated:

 

   As of
September 30,
2025
   As of
December 31,
2024
 
Accounts receivable  $2,345,724   $2,744,118 
Less: allowance for credit losses   (1,124,582)   (915,074)
Accounts receivable, net   1,221,142    1,829,044 
           
Accounts receivable - related party  $730,998   $1,092,960 
Less: allowance for credit losses – related party   (213,094)   (116,511)
Accounts receivable – related party, net  $517,904   $976,449 
           
Total accounts receivable  $3,076,722   $3,837,078 
Total allowance for credit losses   (1,337,676)   (1,031,585)
Total accounts receivable, net  $1,739,046   $2,805,493 

 

Provision for credit losses were $126,824 and $36,597 for the three months ended September 30, 2025 and 2024, respectively.

 

Provision for credit losses were $306,091 and $60,988 for the nine months ended September 30, 2025 and 2024, respectively.

 

Movement of allowance:

 

Movement of allowance for expected credit losses (including related party) consisted of the following as of the date indicated:

 

   As of
September 30,
2025
   As of
December 31,
2024
 
Beginning balance  $1,031,585   $669,974 
Addition   306,091    408,569 
Write-off   
-
    (46,958)
Ending balance  $1,337,676   $1,031,585 

 

Note 8 — Cost method investment

 

Cost method investment consists of the following:

 

   As of
September 30,
2025
   As of
December 31,
2024
 
10% Investment of Iluminar  $1,000,000   $1,000,000 
Total  $1,000,000   $1,000,000 

 

On April 11, 2023, one of the Company’s customers, Iluminar Lighting LLC (“Iluminar”) entered into Debt Conversion Agreement with the Company pursuant to which it will convert $1,000,000 of accounts receivable to 1,033,333 shares of Iluminar which is 10% of Iluminar’s outstanding shares. The shares were issued to the Company on March 31, 2023. No identified event or change in circumstances that would have a significant adverse effect on the value of investment and the Company determined no impairment was deemed necessary as of September 30, 2025. 

 

Note 9 — Property and equipment, net

 

Property and equipment, net consist of the following:

 

   As of
September 30,
2025
   As of
December 31,
2024
 
Trucks & Automobiles  $229,898   $285,099 
Machinery & Equipment   74,121    67,847 
Building   12,930,503    3,465,230 
Building improvements   5,820,535    
-
 
Land   1,150,000    930,000 
Subtotal   20,205,057    4,748,176 
Less: accumulated depreciation   (3,074,008)   (501,344)
Total  $17,131,049   $4,246,832 

 

Depreciation expense for the three months ended September 30, 2025 and 2024 amounted to $17,647 and $39,860, respectively.

 

Depreciation expense for the nine months ended September 30, 2025 and 2024 amounted to $97,368 and $119,580, respectively. 

 

18

 

 

Note 10 — Loans payable

 

Short-term loans:

 

   As of
September 30,
2025
   As of
December 31,
2024
 
Factor H (1)  $646,978   $685,172 
Factor I (2)   166,573    207,921 
Factor J (3)   38,255    28,838 
Factor K (4)   55,663    66,404 
Factor L(5)   149,170    
-
 
Jie Zhang (6)   100,000    100,000 
Peng Zhang (7)   560,000    560,000 
RedOne Investment Limited (“RedOne”) (8)    230,000    230,000 
Agile Capital Funding, LLC (9)   387,142    480,798 
ClassicPlan Premium Financing, Inc. (10)   
-
    9,471 
Maximcash Solutions LLC (11)   124,248    300,000 
Other loans   72,383    
-
 
Total short-term loans  $2,530,412   $2,668,604 

 

Short-term loans consist of account receivable factoring agreements, subordinated business loan and third parties loans as of September 30, 2025 and December 31, 2024.

 

(1) On October 23, 2023, the Merchants entered into a standard merchant cash advance agreement with Factor H. The Company sold $768,500 of its accounts receivable balances on a recourse basis for credit approved accounts. The net purchase price of $503,500 was remitted to the Company, after the deduction of the total fees of $26,500. The Company agreed to pay a weekly installment of $22,814.84 for 32 weeks with a final extra payment of $38,500. The effective interest rate of this agreement was 85.36%. For the three and nine months ended September 30, 2024, the Company paid $181,950 and $409,443 principal of the loan.

 

On May 2, 2024, the Merchants entered into another standard merchant cash advance agreement with Factor H. The Company sold $1,240,150 of its accounts receivable balances on a recourse basis for credit approved accounts. The net purchase price of $807,500 was remitted to the Company, after the deduction of the total fees of $42,500. The Company agreed to pay a weekly installment of $41,000 for 31 weeks. The effective interest rate of this agreement was 93.05%. The Company use this loan to pay off $175,314 previous loan with Factor H that dated on October 23, 2023. For the three and nine months ended September 30, 2024, the Company paid $240,656 and $310,781 principal of the loan.

 

On November 18, 2024, the Merchants entered into another standard merchant cash advance agreement with Factor H. The Company sold $1,167,200 of its accounts receivable balances on a recourse basis for credit approved accounts. The net purchase price of $752,000 was remitted to the Company, after the deduction of the total fees of $48,000. The Company agreed to pay a weekly installment of $32,000 for 37 weeks. The effective interest rate of this agreement was 94.98%. The Company use this loan to pay off $566,150 previous loan with Factor H that dated on May 2, 2024. For the three and nine months ended September 30, 2025, the Company paid $5,000 and $38,194 principal of the loan.

 

(2) On August 29, 2024, the Merchants entered into a standard merchant cash advance agreement with Factor I. The Company sold $213,000 of its accounts receivable balances on a recourse basis for credit approved accounts. The net purchase price of $142,500 was remitted to the Company, after the deduction of the total fees of $7,500. The Company agreed to pay a weekly installment of $8,192 for 26 weeks. The effective interest rate of this agreement was 84.22%. For the three and nine months ended September 30, 2024, the Company paid $15,015 and $15,015 principal of the loan.

 

On December 12, 2024, the Merchants entered into another standard merchant cash advance agreement with Factor I. The Company sold $319,500 of its accounts receivable balances on a recourse basis for credit approved accounts. The net purchase price of $213,750 was remitted to the Company, after the deduction of the total fees of $11,250. The Company agreed to pay a weekly installment of $13,313 for 24 weeks. The effective interest rate of this agreement was 84.03%. The Company use this loan to pay off $90,116 previous loan with Factor I that dated on August 29, 2024. For the three and nine months ended September 30, 2025, the Company paid $0 and $79,287 principal of the loan.

 

On July 31, 2025, Factor I filed a settlement agreement for Stay of Prosecution in the Seventeenth Judicial Court in Broward County, Florida, pursuant to which both parties agreed to pay a weekly installment of $10,000 for 18 weeks commencing on August 5, 2025 to December 2, 2025, followed by a final installment of $6,572 on December 9, 2025. The Company used this settlement agreement to pay off a $163,063 previous loan with Factor I dated on December 12, 2024, resulting in a $23,509 loss on debt settlement. For the three and nine months ended September 30, 2025, the Company paid $20,000 and $20,000 principal of the loan. The loan was paid off in October 2025.

 

19

 

 

(3) On September 27, 2024, the Merchants entered into a standard merchant cash advance agreement with Factor J. The Company sold $72,500 of its accounts receivable balances on a recourse basis for credit approved accounts. The net purchase price of $47,470 was remitted to the Company, after the deduction of the total fees of $2,530. The Company agreed to pay a weekly installment of $3,021 for 24 weeks. The effective interest rate of this agreement was 88.98%. For the three and nine months ended September 30, 2025, the Company paid $0 and $28,838 principal of the loan.

 

On February 11, 2025, the Merchants entered into another standard merchant cash advance agreement with Factor J. The Company sold $94,250 of its accounts receivable balances on a recourse basis for credit approved accounts. The net purchase price $61,070 was remitted to the company, after the deduction of the total fees $3,930. The Company agreed to pay a weekly installment of $6,732 for 14 weeks. The effective interest rate of this agreement was 89.54%. The Company use this loan to pay off $18,125 previous loan with Factor J that dated on February 10, 2025. For the three and nine months ended September 30, 2025, the Company paid $2,368 and $22,815 principal of the loan.

 

(4) On September 30, 2024, the Merchants entered into a standard merchant cash advance agreement with Factor K. The Company sold $181,250 of its accounts receivable balances on a recourse basis for credit approved accounts. The net purchase price of $115,955 was remitted to the Company, after the deduction of the total fees of $9,045. The Company agreed to pay a weekly installment of $7,552 for 24 weeks. The effective interest rate of this agreement was 94.36%. For the three and nine months ended September 30, 2025, the Company paid $0 and $66,404 principal of the loan.

 

On February 11, 2025, the Merchants entered into another standard merchant cash advance agreement with Factor K. The company sold $147,000 of its accounts receivable balances on a recourse basis for credit approved accounts. The net purchase price $92,605 was remitted to the company, after the deduction of the total fees $7,395. The Company agreed to pay a weekly installment of $10,500 for 14 weeks. The effective interest rate of this agreement was 96.04%. The Company use this loan to pay off $37,760 previous loan with Factor K that dated on September 30, 2024. For the three and nine months ended September 30, 2025, the Company paid $0 and $23,785 principal of the loan.

 

On July 16, 2025, Factor K filed a complaint in Court in Monroe County, New York referring to an outstanding balance of $100,588 after payments of $46,551 on its loan agreement with the Company, dated February 11, 2025. The total claimed amount is $129,463 plus interest from June 30, 2025 and attorney fees. On July 22, 2025, Factor K and the Company entered into a Stipulation of Settlement Agreement pursuant to which each party agreed to a settlement amount and remittance schedule that commencing on July 23, 2025 through November 11, 2025. The Company used this settlement agreement to pay off a $95,500 previous loan with Factor K dated on December 12, 2024, resulting in a $33,963 loss on debt settlement. For the three and nine months ended September 30, 2025, the Company paid $73,800 and $73,800 principal of the loan. The loan was paid off in October 2025.

 

(5) On February 7, 2025, the Merchants entered into a standard merchant cash advance agreement with Wave advance Inc (the “Factor L”). The Company sold $183,750 of its accounts receivable balances on a recourse basis for credit approved accounts. The net purchase price of $107,500 was remitted to the Company, after the deduction of the total fees of $8,750. The Company agreed to pay a weekly installment of $13,125 for 14 weeks. The effective interest rate of this agreement was 113.58%. For the three and nine months ended September 30, 2025, the Company paid $0 and $116,250 principal of the loan.

 

On February 25, 2025, the Merchant entered into another standard merchant cash advance agreement with Factor L. The Company sold $280,770 of its accounts receivable balance on a recourse basis for credit approved accounts. The net purchase price $177,630 was remitted to the company, after the deduction of the total fees of $13,370. The Company agreed to pay a weekly installment of $17,550 for 16 weeks. The effective interest rate of this agreement was 95.63%. The Company use this loan to pay off $157,500 previous loan with Factor L that dated on February 7, 2025 resulting in $20,000 of gain on debt settlement. For the three and nine months ended September 30, 2025, the Company paid $0 and $39,067 principal of the loan.

 

On August 1, 2025, the Company and Factor L signed a settlement agreement that required payments from August 5 to October 27, 2025, for an aggregate amount of $201,170. The Company agreed to pay a weekly installment of $18,000 for 11 weeks from August 5, 2025 to October 20, 2025, followed by a final installment of $3,170 on October 27, 2025. The Company use this settlement agreement to pay off a $198,670 previous loan with Factor I dated on February 25, 2025, resulting in a $2,500 loss on debt settlement. For the three and nine months ended September 30, 2025, the Company paid $52,000 and $52,000 principal of the loan.

 

These receivable purchase agreements were accounted for as secured borrowing under ASC 860 since there is no legal, actual, effective transfer of the receivables to the Factors. Rather, the Factors only have generally claim against the receivable pools not a particular receivable. As of September 30, 2025 and December 31, 2024, outstanding balance amounted to $1,056,639 and $988,336, respectively.

 

(6) On October 30, 2023, NMI entered into a loan agreement with an independent third party pursuant to which the Company borrowed a principal amount of $100,000 with an annual interest rate of 12% for a term of one year. The loan was originally extended to April 15, 2025, subsequently extended to July 16, 2025, then extended to November 16, 2025. The loan balance as of September 30, 2025 and December 31, 2024 was $100,000 and $100,000, respectively.

 

20

 

 

(7) On March 7, 2024, the Company’s subsidiary Nature’s Miracles entered into a loan agreement with Peng Zhang, a 2.5% shareholder of the Company. The amount of the loan is $1,405,000 with 10% interest and is due on March 7, 2025. For the year ended December 31, 2024, Nature’s Miracles made a payment of $500,000 toward the loan. On November 19, 2024, the Company entered into a debt-to-equity conversion agreement, under which Peng Zhang agreed to convert the $345,000 of loan balance into 130,682 shares of the Company’s common stock at a conversion price of $2.64 per share. The loan was originally extended to July 16, 2025, then extended to November 16, 2025. As of September 30, 2025 and December 31, 2024, the loan balance was $560,000 and $560,000.

 

(8) On February 10, March 28, June 5, June 27, September 22, December 22, 2023 and February 20, 2024, Lakeshore entered into seven promissory notes with RedOne to which Lakeshore borrowed an aggregate principal amount of $380,000 with zero interest rate. On July 11, 2023, Lakeshore entered into a loan agreement with Deyin Chen (Bill) to which Lakeshore borrowed a principal amount of $125,000 with an annual interest rate of 8%. This loan was extended to March 11, 2024 with interest waived pursuant to a Side Letter to the loan agreements dated December 8, 2023. A payment of $75,000 was made upon close of the Merger on March 11, 2024 and the loan balance of $50,000 owed to Deyin Chen (Bill) was assigned to RedOne and the Company assumed the outstanding balance. The loan bears interest of 8% per annum. $50,000 was paid on July 29, 2024 and $150,000 was paid on November 11, 2024.

 

The balance of $230,000, originally due by December 11, 2024, was revised to be paid in two equal installments: the first installment of $115,000 no later than March 31, 2025, and the second installment of $115,000 no later than June 30, 2025. Both installments were extended to July 15, 2025, subsequently extended to September 10, 2025.

 

(9) On June 6, 2024, the Merchants entered into a subordinated business loan and security agreement with Agile Capital Funding, LLC and Agile Lending, LLC for the principal amount of $288,750, including the administrative agent fee of $13,750. The Company agreed to pay a weekly installment of $15,056 for 28 weeks. The effective interest rate of this agreement was 90.22%. The collateral consists of the Company’s right, title and interest in and to including the Company’s financial assets, goods, accounts, equipment, inventory, contract rights or rights to payment of money. The Company received the net proceeds on June 7, 2024. For the three and nine months ended September 30, 2024, the Company paid $255,808 and $275,000 principal of the loan.

 

On September 25, 2024, the Merchants entered into another subordinated business loan and security agreement with Agile Capital Funding, LLC and Agile Lending, LLC for the principal amount of $315,000, including the administrative agent fee of $15,000. The Company agreed to pay a weekly installment of $16,425 for 28 weeks. The effective interest rate of this agreement was 90.22%. The Company use this loan to pay off $195,806 previous loan with Agile Capital Funding, LLC and Agile Lending, LLC that dated on June 6, 2024. For the three and nine months ended September 30, 2024, the Company paid $0 and $0 principal of the loan. 

 

On November 21, 2024, the Merchants entered into another subordinated business loan and security agreement with Agile Capital Funding, LLC and Agile Lending, LLC for the principal amount of $575,000, including the administrative agent fee of $28,750. The Company agreed to pay a weekly installment of $29,982 for 28 weeks. The effective interest rate of this agreement was 90.80%. The Company use this loan to pay off $331,388 previous loan with Agile Capital Funding, LLC and Agile Lending, LLC dated on September 25, 2024. For the three and nine months ended September 30, 2025, the Company paid $16,880 and $93,656 principal of the loan. 

 

(10) On December 1, 2024, Visiontech and ClassicPlan Premium Financing, Inc., entered into a premium financing agreement with a total gross policy premium and related fees of $15,465 and financed $10,559 of it. Visiontech needs to pay a monthly installment of $1,286 for nine months with the last installment due on August 1, 2025. The effective interest rate of this loan was 22.57%. During the three and nine months ended September 30, 2025, the Company paid $2,505 and $9,471 principal of the loan.

 

21

 

 

(11) On December 30, 2024, the Merchants entered into a business loan and security agreement (the “Agreement”) with Maximcash Solutions LLC (the “Maxim”). Under the Agreement, the Maxim loaned $311,000 to the Company, which includes an $11,000 origination fee deducted at the time of funding. This loan carries an interest rate of 51.64% and an annual percentage rate of 59.40%. The loan matures on January 14, 2026. The Company will repay the Loan in 26 biweekly payments of $15,430, with a total repayment amount of $401,190 over a 12-month term. The loan is secured by all present and after-acquired property of the Company. As security to the loan, the Company shall issue 311,000 shares of its common stock to Maximin in the event of a loan default. For the three and nine months ended September 30, 2025, the Company paid $47,617 and $175,752 principal of the loan.

 

On July 8, 2025, Maxim filed a complaint against the Company in the Third Judicial Court of Utah pertaining to the loan agreement dated December 30, 2024 as a result of a failure to make the required repayment pursuant to the loan agreement. The claimed amount was $230,738 plus daily interest and attorney fees resulting in a $30,089 loss on debt settlement. On August 6, 2025, the Company entered into a Standstill Agreement with Maxim, which expired on October 6, 2025 to further negotiate the term of the loan. On August 7, the Company wired an interest payment of $61,720 to Maxim as agreed in the Standstill Agreement.

 

Interest expenses for short term loans amounted to $60,027 and $376,794 for the three months ended September 30, 2025 and 2024, respectively.

 

Interest expenses for short term loans amounted to $1,040,742 and $805,009 for the nine months ended September 30, 2025 and 2024, respectively.

 

Short-term loans — related parties: refer to Note 12 Related Party transactions.

 

Long-term debts:

 

Long-term debts consist of three auto loans, one building loan, and one secured business loan as of September 30, 2025 and December 31, 2024.

  

The outstanding amount of the auto loans were $48,295 and $80,238 as of September 30, 2025 and December 31, 2024, respectively. On February 27, 2021, the Company purchased a vehicle for $68,802 and financed $55,202 of the purchase price through an auto loan. The loan requires monthly installment payment of $1,014 with the last installment due on February 28, 2026. The Company subsequently sold the auto and paid off the loan on September 18, 2025. On June 8, 2021, the Company purchased the second vehicle for $86,114 and financed $73,814 of the purchase price through auto loan. The loan requires monthly installment payment of $1,172 with the last installment due on June 23, 2027. On September 28, 2022, the Company purchased the third vehicle for $62,230 and financed $56,440 of the purchase price through auto loan. The loan requires a monthly installment payment of $1,107 with the last installment due on September 28, 2027. During the three and nine months ended September 30, 2025, the Company made total payments of $8,090 and $25,928 towards the auto loans, respectively. During the three and nine months ended September 30, 2024, the Company made total payments of $7,743 and $24,723 towards the auto loans, respectively.

 

Minimum required principal payments towards the Company’s auto loans as of September 30, 2025 are as follows:

 

Twelve months ended September 30,  Repayment 
2026  $25,292 
2027   23,003 
Total  $48,295 

 

The outstanding amount of the building loan was $2,709,084 and $2,771,645 as of September 30, 2025 and December 31, 2024, respectively. On January 10, 2022, the Company purchased one building and land for $4,395,230 and financed $3,000,000 of the purchase price through Bank of the West. The loan requires monthly installment payment of $15,165 with the last installment due on January 10, 2032. During the three and nine months ended September 30, 2025, the Company made total payments of $20,863 and $62,561 towards the loan, respectively. During the three and nine months ended September 30, 2024, the Company made total payments of $20,113 and $60,070 towards the loan, respectively.

 

Minimum required principal payments towards the Company’s building loan as of September 30, 2025 are as follows:

 

Twelve months ended September 30,  Repayment 
2026  $86,155 
2027   89,298 
2028   92,307 
2029   95,925 
2030   99,425 
Thereafter   2,245,974 
Total  $2,709,084 

 

22

 

 

The outstanding amount of the secured business loan was $3,059,859 and $3,127,742 as of September 30,2025 and December 31, 2024, respectively. On June 14, 2023, the Company’s subsidiaries Visiontech and Hydroman entered into a secured business loan agreement with Newtek Business Services Holdco 6, Inc. for a principal sum of up to $3,700,000 with a maturity date of July 1, 2033. The loan is secured by the Company’s building and guaranteed by the Company’s major stockholders. During the three and nine months ended of September 30, 2025, the Company made total payments of $0 and $67,883 towards the loan, respectively. During the three and nine months ended September 30, 2024, the Company made total payments of $39,199 and $112,951 towards the loan, respectively.

 

Minimum required principal payments towards the Company’s secured business loan as of September 30, 2025 are as follows:

 

Twelve months ended September 30,  Repayment 
2026  $269,824 
2027   241,046 
2028   283,844 
2029   334,239 
2030   393,583 
Thereafter   1,537,323 
Total  $3,059,859 

 

Interest expenses for long term loans amounted to $149,363 and $157,506 for the three months ended September 30, 2025 and 2024, respectively.

 

Interest expenses for long term loans amounted to $453,696 and $477,809 for the nine months ended September 30, 2025 and 2024, respectively.

   

Note 11 — Convertible notes

 

The Company entered into a series of convertible note agreements with investors as described below. The Company also determined that the embedded conversions in the notes meets the scope exception to be considered indexed to a reporting’s own stock based on the two-step approach in accordance with ASC 815-40-15 and does not require to be separately accounted for as a derivative. As a result, the Company classified all the convertible notes as a debt instrument in its entirely.

 

On July 3, 2024, the Company entered into four convertible note agreements total of $410,000 from four investors. Each note bears 12% interest per annum and matures in 6 months. The Company shall repay the principal and accumulated interest after six months. If the investors choose to convert, the number of shares will be calculated by dividing the principal plus accumulated interest by $13.26. On November 19, 2024, the Company entered into four debt-to-equity conversion agreements, under which four investors agreed to convert a total of $410,000 into 155,303 shares of the Company’s common stock at a conversion price of $2.64 per share. However, the Company failed to complete the registration of the converted shares within 45 calendar days as required by the conversion agreements, the investors has elected to decline the conversion and has elected to reinstate the original debt liability in accordance with the original agreement and extended the maturity date to June and September 2025, with $230,000 maturing in June 2025 and $180,000 maturing in September 2025. The maturity due in June 2025 has been extended to November 30, 2025, based on loan extension agreements executed between the Company and two investors on August 12, 2025. The balance of these Notes were $410,000 and $410,000 as of September 30, 2025 and December 31, 2024.

 

On July 17, 2024, the Company entered into a securities purchase agreement with a certain investor pursuant to which the Company sold, in a private placement, a $180,000 convertible note with an original issue discount of $27,500, and a warrant to purchase up to 7,250 shares of common stock at an exercise price of $26.10 per share. The interest on the note was 12% per annum and the maturity date of the note was 12 months from July 17, 2024. The note can be converted into a fixed price of $12.00 per share. As consideration for entering into the securities purchase agreement, the Company issued a total of 6,000 shares to the investor on July 19, 2024. The warrant was exercisable on July 17, 2024 until five years from July 17, 2024. Approximately $58,090 from the convertible note proceeds was allocated to issuance of ordinary shares and warrants based on relative fair value. On July 30, 2024, the note was terminated as a result of the Company’s full payment of the note’s principal and accrued interest in the total amount of $212,400. As a result, all obligations under the note have been satisfied, and the note is no longer outstanding.

 

23

 

 

On August 13, 2024, the Company entered a securities purchase agreement with 1800 Diagonal Lending LLC (“Diagonal”), in connection with the issuance of a promissory note in the aggregate principal amount of $181,700, including an original issue discount of $23,700, closing expenses of $8,000 deducted from funding amount. The maturity date was June 15, 2025 and the interest rate of the note was 12% per annum. The initial funding was scheduled to be paid in 10 equal monthly installments of $20,350. Only upon an occurrence of an event of default under the note, the holder may convert the outstanding unpaid principal amount of the note into shares of common stock of the Company at a discount of 25% of the market price. On April 16 and April 21, 2025, an aggregate of $20,000 and $23,701 of convertible note principal and accrued interest were converted into 222,222 and 263,342 shares of common stock, respectively. As of September 30, 2025 and December 31, 2024, the balance of this note was $0 and $92,045, respectively.

 

On September 18, 2024, the Company entered into another securities purchase agreement with Diagonal pursuant to which the Company sold to the Diagonal a convertible promissory note in the aggregate principal amount of $107,880 with an original issue discount of $14,880. The note bears a one-time interest charge of 13% and maturity date was July 15, 2025. Accrued, unpaid interest and outstanding principal, subject to adjustment, is required to be paid in five payments, with the first payment of $60,952 due on March 15, 2025, and the remaining four payments of $15,238 due on the fifteenth day of each month thereafter. Only upon an occurrence of an event of default under the note, the holder may convert the outstanding unpaid principal amount of the note into shares of common stock of the Company at a discount of 25% of the market price. On May 5, May 9, and June 4, 2025, an aggregate of $22,160, $22,160 and $5,894 of convertible note principal and accrued interest were converted into 295,466, 295,466 and 148,090 shares of common stock, respectively. As of September 30, 2025 and December 31, 2024, the balance of this note were $0 and $85,000, respectively.

 

On October 14, 2024, the Company issued and sold to Diagonal a promissory note in the principal amount of $101,200 (reflecting a purchase price of $88,000 and an original issue discount of $13,200). The note bears a one-time interest charge of 14% of the principal amount. Accrued, unpaid interest and outstanding principal will be due in ten payments, each in the amount of $11,537. The first payment will be due November 15, 2024 with nine subsequent payments due on the 15th of each month thereafter. Only upon occurrence of an event of default under the note, the note will be convertible into common stock at a conversion price equal to 75% multiplied by the lowest trading price for the common stock during the ten trading days prior to the conversion date. On June 5, June 10, and June 12, 2025, an aggregate of $13,890, $13,590 and $11,630 of convertible note principal and accrued interest were converted into 324,912, 348,461 and 298,215 shares of common stock, respectively. As of September 30, 2025 and December 31, 2024, the balance of this note was $0 and $65,182, respectively.

  

On November 18, 2024, the Company signed one convertible note agreement of $90,000 from one investor. The note bears 12% interest per annum and matures in 6 months. The Company shall repay the principal and accumulated interest after six months. If the investors choose to convert, the number of shares will be calculated by dividing the principal plus accumulated interest by $29.31. On November 19, 2024, the Company entered into a debt-to-equity conversion agreement, under which the investor agreed to convert the $90,000 into 34,091 shares of the Company’s common stock at a conversion price of $2.64 per share. However, the Company failed to complete the registration of the converted shares within 45 calendar days as required by the conversion agreements, the investors has elected to decline the conversion and has elected to reinstate the original debt liability in accordance with the original agreement and extended the maturity date to September 2025. As of September 30, 2025 and December 31, 2024, the balance of this note was $90,000 and $90,000.

 

On December 17, 2024, the Company entered into a securities purchase agreement with a certain investor pursuant for a $180,000 convertible note with an original issue discount of $20,000. The note bears an annual rate of 12% and the maturity date of this note shall be December 17, 2025. The note can be converted into a fixed price of $2.50 per share. Net proceeds to the Company amounted to $150,000 (after deducting the fee paid to escrow agent of $10,000). The Company has also agreed to issue 118,000 shares of common stock for commitment fee, and a warrant to purchase up to 138,462 shares of common stock. As of December 31, 2024, the balance of this note was $164,483 and the shares and warrants were not issued. On January 21, 2025, the Company and investor mutually rescinded the above note and released the Company from all of its obligations. The Company returned the $160,000 to the investor on January 15, 2025. The Company recognized the difference between the debt’s reacquisition price of $160,000 and net carrying amount of $180,000 and recognized $0 and $20,000 as a gain for the three and nine months ended September 30, 2025.

 

On December 12, 2024, the Company entered into a convertible promissory note with Diagonal in the principal amount of $101,200 (reflecting a purchase price of $88,000 and an original issue discount of $13,200). The note bears 14% interest per annum and maturity date is December 15, 2025. Only upon an occurrence of an event of default under the note, the holder may convert the outstanding unpaid principal amount of the note into shares of common stock of the Company at a discount of 25% of the market price. On June 20, 2025, an aggregate of $14,850 of convertible note principal and accrued interest were converted into 380,769 shares of common stock. In July 2025, an aggregate of $109,587 of convertible note principal and accrued interest were converted into 3,867,938 shares of common stock. As of September 30, 2025 and December 31, 2024, the balance of this note was $0 and $80,929, respectively.

 

On March 26, 2025, the Company signed a convertible note with Black Ice Advisors, LLC, face value of the note is $111,111, interest at 10%. The maturity date of this note was on March 26, 2026. Principal and accrued interest can be converted into shares of common stock of the Company at a 35% discount to lowest trading price with a 20 day look back. The note can be prepaid within 6 months at 120% of principal and accrued interest. The net funds provided was $95,000 after deducting legal fees. As of September 30, 2025, the principal and accrued interest of the note were paid off.

 

24

 

 

On May 7, 2025, the Company entered into another securities purchase agreement with Diagonal pursuant to which the Company sold to the Diagonal a convertible promissory note in the aggregate principal amount of $140,250 with an original issue discount of $12,750 and closing expenses of $7,500 deducted from funding amount. The note bears an annual interest charge of 14% and maturity date was February 28, 2026. Only upon an occurrence of an event of default under the note, the holder may convert the outstanding unpaid principal amount of the note into shares of common stock of the Company at a discount of 35% of the market price. As of September 30, 2025, the balance of this note was $129,955.

 

On June 10, 2025, the Company entered into another securities purchase agreement with Diagonal pursuant to which the Company sold to the Diagonal a convertible promissory note in the aggregate principal amount of $126,260 with an original issue discount of $19,260 and closing expenses of $7,000 deducted from funding amount. The note bears an annual interest charge of 12% and maturity date was August 15, 2026. Only upon an occurrence of an event of default under the note, the holder may convert the outstanding unpaid principal amount of the note into shares of common stock of the Company at a discount of 35% of the market price. As of September 30, 2025, the principal and accrued interest of the note were paid off.

 

During the third quarter of 2025, the Company entered into another three securities purchase agreements with Diagonal pursuant to which the Company issued the following convertible promissory notes to the Diagonal: i) principal amount of $97,350 issued on July 23, 2025 with an original issue discount of $14,850 and closing expenses of $7,500 deducted from funding amount, which bears an annual interest charge of 12% and matures on April 30, 2026. Only upon an occurrence of an event of default under the note, the holder may convert the outstanding unpaid principal amount of the note into shares of common stock of the Company at a discount of 39% of the market price. As of September 30, 2025, the principal and accrued interest of the note were paid off; ii) principal amount of $90,200 issued on July 30, 2025 with an original issue discount of $8,200 and closing expenses of $7,000 deducted from funding amount, which bears an annual interest charge of 14% and matures on May 30, 2026. Only upon an occurrence of an event of default under the note, the holder may convert the outstanding unpaid principal amount of the note into shares of common stock of the Company at a discount of 39% of the market price. As of September 30, 2025, the balance of this note was $78,100; iii) principal amount of $155,610 issued on September 19, 2025 with an original issue discount of $22,610 and closing expenses of $8,000 deducted from funding amount, which bears an annual interest charge of 13% and matures on July 30, 2026. Only upon an occurrence of an event of default under the note, the holder may convert the outstanding unpaid principal amount of the note into shares of common stock of the Company at a discount of 35% of the market price. As of September 30, 2025, the balance of this note was $126,072.

 

During the third quarter of 2025, the Company entered into the following two convertible promissory notes with CFI Capital LLC: i) principal amount of $120,000 issued on July 10, 2025 with an original issue discount of $12,000 and closing expenses of $4,000 deducted from funding amount. The note bears 6% interest per annum and matures on July 10, 2026, and ii) principal amount of $130,000 issued on September 18, 2025 with an original issue discount of $13,000 and closing expenses of $4,000 deducted from funding amount. The note bears 6% interest per annum and matures on September 18, 2026. Principal and accrued interest can be converted into shares of common stock of the Company at a 40% discount to lowest trading price with a 15 day look back at any time after the sixth monthly anniversary of these two convertible notes. The notes can be prepaid within 6 months at 105% of principal and accrued interest. As of September 30, 2025, the aggregate balance of the two convertible promissory notes was $221,153.

 

On July 30, 2025, the Company entered into a securities purchase agreement with Labrys Fund II, L.P., pursuant to which the Company sold to Labrys Fund II, L.P. a convertible promissory note in the aggregate principal amount of $230,000 with an original issue discount of $30,000 and closing expenses of $4,250 deducted from funding amount. The note bears an annual interest charge of 14% and matures on July 30, 2026. Only upon an occurrence of an event of default under the note, the holder may convert the outstanding unpaid principal amount of the note into shares of common stock of the Company at a discount of 25% of the market price. As of September 30, 2025, the balance of this note was $201,568.

 

On August 5, 2025, the Company entered into a securities purchase agreement with FirstFire Global Opportunities Fund LLC, pursuant to which the Company sold a convertible promissory note in the aggregate principal amount of $172,500 with an original issue discount of $22,500 and closing expenses of $6,000 deducted from funding amount. The note bears an annual interest charge of 10% and matures on August 5, 2026. As consideration for entering into the securities purchase agreement, the Company issued a total of 200,000 shares to the investor on August 5, 2025. Principal and accrued interest can be converted into shares of common stock of the Company at a 25% discount to lowest trading price with a 10 day look back at any time on or following the issue date of the convertible note. As of September 30, 2025, the balance of this note was $122,834.

 

On August 4, 2025, the Company entered into a securities purchase agreement with AES Capital Management LLC, pursuant to which the Company sold a convertible promissory note in the aggregate principal amount of $37,500 with an original issue discount of $3,750 and closing expenses of $3,000 deducted from funding amount. The note bears an annual interest charge of 8% and matures on August 4, 2026. Principal and accrued interest can be converted into shares of common stock of the Company at a 40% discount to lowest trading price with a 15 day look back at any time after the sixth monthly anniversary of the convertible note. As of September 30, 2025, the balance of this note was $31,804.

 

On August 4, 2025, the Company entered into a securities purchase agreement with Lambda Venture Partners LLC, pursuant to which the Company sold a convertible promissory note in the aggregate principal amount of $82,500 with an original issue discount of $7,250 and closing expenses of $3,000 deducted from funding amount. The note bears an annual interest charge of 8% and matures on August 4, 2026. Principal and accrued interest can be converted into shares of common stock of the Company at a 35% discount to the average of the three lowest trading prices with a 10 day look back at any time on or following the issue date of the convertible note. As of September 30, 2025, the balance of this note was $73,640.

 

25

 

 

On August 15, 2025, the Company entered into a securities purchase agreement with Actus Fund LLC, pursuant to which the Company sold a convertible promissory note in the aggregate principal amount of $100,000 with closing expenses of $9,000 deducted from funding amount and a warrant to purchase up to 500,000 shares of common stock at an exercise price of $0.20 per share. The note bears an annual interest charge of 12% and matures on August 15, 2026. The warrant was exercisable from August 15, 2025 through August 15, 2030. Approximately $46,664 from the convertible note proceeds was allocated to the issuance of warrants based on relative fair value. Principal and accrued interest can be converted into shares of common stock of the Company at a 30% discount to the volume-weighted average price of a 5 day look back at any time on or following the issue date of the convertible note. As of September 30, 2025, the balance of this note was $51,351.

 

Interest expenses in connection with the convertible notes for the three and nine months ended September 30, 2025 amounted to $343,294 and $545,955, respectively.

 

Note 12 — Related party transactions

 

Purchases and accounts payable – related parties:

 

UniNet Global Inc. (“Uninet”), a vendor whose stockholder is Zhiyi (Jonathan) Zhang who is also one of the stockholders and management of the Company, sold certain products to Visiontech. On September 24, 2024, the Company entered into a trade payable forgiveness agreement with Visiontech, Uninet and NMI, relating to the cancellation of a portion of outstanding trade payables owed by Visiontech to Uninet. Visiontech owed Uninet a trade payable in the amount of $2,713,073 as of June 30, 2024. Pursuant to the trade payable forgiveness agreement, Uninet agreed to cancel the outstanding trade payable of $2,135,573, leaving a remaining balance of $577,500 still payable by Visiontech to Uninet. The debt forgiveness was recorded as an increase in additional paid in capital of $2,135,573 as a result of related party transaction. On November 19, 2024, the Company entered into a debt-to-equity conversion agreement with Visiontech, Uninet, and NMI, under which the remaining balance of $577,500 to be converted into 218,750 shares of common stock for Jonathan Zhang at a conversion price of $2.64 per share. As of September 30, 2025 and December 31, 2024, the outstanding accounts payable amount due to Uninet was $0 and $0.

 

On April 11, 2023, one of the Company’s customers and vendors, Iluminar Lighting LLC (“Iluminar”) entered into Debt Conversion Agreement with the Company pursuant to which it will convert $1,000,000 of accounts receivable to 1,033,333 shares of Iluminar which is 10% of Iluminar’s outstanding shares. For the three and nine months ended September 30, 2025, the purchases made from Iluminar was $0 and $58,031, respectively. For the three and nine months ended September 30, 2024, the purchases made from Iluminar was $0 and $1,160, respectively. As of September 30, 2025 and December 31, 2024, the accounts payable amount due to Iluminar was $366,437 and $308,407, respectively.

 

Revenue and accounts receivable - related party:

 

For the three and nine months ended September 30, 2025, the sales revenue from Iluminar was $0 and $76,038, respectively. For the three and nine months ended September 30, 2024, the sales revenue from Iluminar was $1,135,628 and $2,129,726. As of September 30, 2025 and December 31, 2024, the account receivable, net from Iluminar was $517,904 and $976,449, respectively. 

 

Prepayments - related party:

 

As of September 30, 2025 and December 31, 2024, the prepayments from Jonathan was $10,000 and $10,000, respectively and the prepayments from Mr. Tie (James) Li was $11,662 and $0, respectively. 

 

Deferred income – contract liabilities - related party:

 

As of September 30, 2025 and December 31, 2024, the deferred income - contract liabilities from Iluminar was $86,468 and $86,468, respectively. 

 

Other payables — related parties

 

In 2022, Nature’s Miracle Inc. (Cayman) (“NMCayman”), former stockholders of NMI, currently under common control of Mr. Tie (James) Li, the Company’s CEO, paid a total amount of $345,000 of legal and audit fee for the Company. As of September 30, 2025 and December 31, 2024, the outstanding amount due to NMCayman was $170,000 and $170,000, respectively.

 

In 2021, Yang Wei, former shareholder of the Visiontech and current shareholder of the Company, paid a total amount of $23,813 of normal business operating fee for the Company. As of September 30, 2025 and December 31, 2024, the outstanding amount due to Yang Wei was $23,813 and $23,813, respectively.

 

In 2022, Zhiyi (Jonathan) Zhang, paid a total amount of $27,944 of normal business operating fee for the Company. On May 19, 2023, September 4, 2023, and July 1, 2024, Zhiyi (Jonathan) Zhang paid another $1,000, $557, $8,184 for normal business operating expenses, respectively. Furthermore, in 2024, Mr. Zhang contributed an additional $10,936 toward Company expenses. On October 11, 2023, the Company paid off $28,501 of the balance. In 2025, the Company paid another $3,000 of the balance. As of September 30, 2025 and December 31, 2024, the outstanding amount due to Zhiyi (Jonathan) Zhang was $20,645 and $20,120.

 

26

 

 

In September 2024, James Li paid a total amount of $30,000 of normal business operating fee for the NMCA and NMCA paid it back to James in November 2024. In 2025, James Li paid $6,300 of normal business operating fee for NMCA and NMCA paid it back in 2025, so as of September 30, 2025, the outstanding amount due to James Li was $0.

  

As of September 30, 2025, Nature’s Miracle Holding Inc. has an outstanding amount due to Mr. Tie (James) Li and Zhiyi (Jonathan) Zhang for $25,100 and $25,000 of board fees.

 

As of September 30, 2025 and December 31, 2024, accrued interest expense from related parties, were $110,484 and $103,776, respectively, which were included in other payable related parties on the Company’s balance sheets (see Short-term loans — related parties for detail).

 

Short-term loans — related parties

 

   As of
September 30,
2025
   As of
December 31,
2024
 
Zhiyi Zhang (1)  $60,000   $60,000 
Tie Li (2)   
-
    185,000 
NMCayman (3)   
-
    35,755 
Total short-term loans – related parties  $60,000   $280,755 

 

(1) On November 29, 2022, Visiontech signed a loan with Zhiyi (Jonathan) Zhang, one of the stockholders of the Company, for the principal amount of $100,000 with 8% interest rate. This loan is originally required to be paid in full before May 29, 2023, the Company initially extended it to November 15, 2023, further extended to February 15, 2024, subsequently further extended to August 15, 2024, April 15, 2025 and October 16, 2025 and finally extended to December 1, 2025. During the year ended December 31, 2023, the Company paid $40,000 to Zhiyi Zhang. The loan balance as of September 30, 2025 and December 31, 2024 was $60,000 and $60,000. As of September 30, 2025 and December 31, 2024, accrued interest of this loan was $15,669 and $12,079, respectively.

 

(2) In December 2022, the Company signed two loans with Tie (James) Li, the Company’s CEO, for the total principal amount of $610,000 with 8% interest rate. This loan is originally required to be paid in full before June 1, 2023, the Company initially extended it to November 15, 2023. The Company made $500,000 payments towards the loan on June 16, 2023 and paid each $50,000 on July 29, 2024 and January 14, 2025. The $110,000 loan was further extended to February 15, 2024, subsequently extended to August 15, 2024 and April 15, 2025, and finally extended to October 16, 2025. The Company made $10,000 payments towards the loan on July 31, 2025 resulting in its full settlement. The loan balance as of September 30, 2025 and December 31, 2024 was $0 and $60,000, respectively. Accrued interest on this loan as of September 30, 2025 and December 31, 2024 was $1,012 and $547, respectively.

 

On July 11, 2023, Lakeshore signed one loan with Tie (James) Li for a principal amount of $125,000 with 8% interest rate. This loan was required to be paid in full before November 11, 2023. On December 8, 2023, Lakeshore entered into a side letter to this loan agreement to extend the repayment to March 11, 2024 and agree to waive any and all interest and penalties that may have accrued commencing on November 11, 2023. This loan was subsequently extended to September 15, 2024 and April 15, 2025, and finally extended to October 16, 2025. The Company made $100,000 payments towards the loan on January 14, 2025, and $25,000 payments towards the loan on July 15 and July 25, 2025 resulting in its full settlement. The loan balance as of September 30, 2025 and December 31, 2024 was $0 and $125,000, respectively. As of September 30, 2025, accrued interest on this loan was $3,512.

 

(3) On January 17, 2023, the Company and NMCayman entered into a loan agreement for the principal amount of $318,270 with 8% interest rate. This loan is originally required to be paid in full before July 17, 2023, the Company initially extended it to November 15, 2023, further extended to February 15, 2024, subsequently extended to August 15, 2024 and April 15, 2025, and finally extended to October 16, 2025. On November 19, 2024, the Company entered into a debt-to-equity conversion agreement with NMCayman, under which $299,714 balance of this debt and $277,786 balance of another debt (see below) will be converted into 218,750 shares of common stock for James at a conversion price of $2.64 per share. The Company made $18,556 payments towards the loan in July 2025 resulting in its full settlement. As of September 30, 2025 and December 31, 2024, the loan balance was $0 and $18,556, respectively. As of September 30, 2025 and December 31, 2024, accrued interest on this loan was $47,042 and $46,180, respectively.

 

On January 17, 2023, the Company and NMCayman entered into a loan agreement for the principal amount of $294,985 with 8% interest rate. This loan is originally required to be paid in full before July 17, 2023, the Company initially extended it to November 15, 2023, further extended to February 15, 2024, subsequently extended to August 15, 2024 and April 15, 2025, and finally extended to October 16, 2025. On November 19, 2024, the Company entered into a debt-to-equity conversion agreement with NMCayman, under which $277,786 balance of this debt and $299,714 balance of another debt will be converted into 218,750 shares of common stock for James at a conversion price of $2.64 per share. The Company made $17,199 payments towards the loan in July 2025 resulting in its full settlement. As of September 30, 2025 and December 31, 2024, the loan balance was $0 and $17,199, respectively. As of September 30, 2025 and December 31, 2024, the accrued interest on this loan was $43,248 and $42,449, respectively.

 

Interest expense for short-term loan - related parties amounted to $1,521 and $18,316 for the three months ended September 30, 2025 and 2024, respectively. 

 

Interest expense for short-term loan – related parties amounted to $6,708 and $52,519 for the nine months ended September 30, 2025 and 2024, respectively.

 

27

 

 

Convertible notes — related party

 

On April 11, 2025, the Company signed a convertible promissory note agreement with Big Lake. Big Lake is a related party controlled by Tie “James” Li, Chairman and CEO of the Company. The agreement calls for up to $2,000,000 in financing with an initial tranche of $600,000. The amount funded can be converted into shares of the Company at a conversion price equal to 110% of the end of the trading date. The rate of interest is 10% and the note matures in one year. As consideration for entering into the convertible promissory note agreement, the Company issued warrants to purchase up to 10,101,010  shares of common stock at an exercise price the same as conversion price of $0.198 - the price equal to 110% of the reported closing price of the Company’s Common Stock on the closing date of the Initial Tranche, if the Company draws down the full amount of the note. As of September 30, 2025, the balance of this note was $504,315 and the balance of accrued interest was $30,762.

 

In connection with the acquisition of Zak Properties as stated in Note 6 – Asset acquisition under common control, the Company issued a convertible promissory note in the aggregate principal amount of $3,000,000 as consideration of the acquisition of Zak Properties. The note bears an annual interest charge of 10% with a maturity date of September 18, 2027. Principal and accrued interest can be converted into shares of common stock of the Company at a 20% discount to lowest trading prices with a 20 day look back at any time on or following the issue date of the convertible note. As of September 30, 2025, the balance of this note was $3.0 million and the balance of accrued interest was $10,685.

 

Note 13 — Income taxes

 

As of September 30, 2025 and December 31, 2024, the Company’s deferred tax asset had a full valuation allowance recorded against it. The effective tax rate for the three and nine months ended September 30, 2025, were 0.00% and (0.03) %, respectively. The effective tax rate for the three and nine months ended September 30, 2024 were 0.00% and 0.00%, respectively. The effective tax rate differs from the federal and state statutory tax rate of 21.0% primarily due to the valuation allowance on the deferred tax assets. The Company continues to maintain a full valuation allowance against its deferred tax assets due to historical losses and uncertainty around future taxable income.

 

Note 14 – Series A and D preferred shares subject to possible redemption

 

On May 7, 2025, the Company entered into a Securities Purchase Agreement (the “SPA”) where the Company sold to GHS Investments, LLC, a Nevada limited liability company (the “Investor”) 250 shares of Series A Preferred Stock, $0.0001 par value per share (the “Series A Shares”) at a purchase price of $1,000 per Series A Share for an aggregate purchase price of $250,000. The Series A Shares have a face value of $1,200 per share and are convertible into shares of Common Stock (the “Conversion Shares”) at a conversion price of $0.112 in accordance with the certificate of designations to be filed with the State of Delaware. The Series A Shares carry cumulative dividends of twelve percent (12%) per annum, payable quarterly. On the earlier of the (1) 120th calendar day following the Closing and (2) the date the Common Stock is listed on a national exchange (the “Corporation Redemption Payment Date”), the Corporation shall have the obligation to redeem the preferred stock for an amount equal to 100% of the outstanding stated value of the preferred stock, plus any accrued but unpaid dividends, plus all other amounts due to the Holder. 

 

On September 19, 2025, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with Y. K. Capital Management, Inc. (the “Series D Investor”), whereby the Series D Investor agreed to purchase 2,000 shares of Series D preferred stock, $0.0001 par value per share (the “Series D Shares”), at a purchase price of $1,000 per Series D Share. On the initial closing, the Series D Investor purchased five hundred (500) Series D Shares for a purchase price of $500,000. The second closing will be for the purchase of five hundred (500) Series D Shares for the aggregate purchase price of $500,000 before October 30, 2025 and the third and final closing will be for the purchase of one thousand (1,000) Series D Shares for the aggregate purchase price of $1,000,000 prior to the Company’s application for uplisting to the NYSE or Nasdaq.

 

28

 

 

The Series D Shares have a stated value of $1,000 per share (the “Stated Value”) and shall bear dividends at the rate of 8% per annum, for so long as the Series D Shares have not been redeemed or converted. The Series D Shares are convertible into shares of Common Stock of the Company at a conversion price of $0.1180 (the “Conversion Price”) as set forth in in the Certificate of Designations, to be filed with the State of Delaware (the “Certificate of Designations”). The Series D Investor shall not convert into Common Stock any amount of Series D Shares which would render the holder having more than 4.99% of the total outstanding shares of common stock of the Company. On the earlier of the (1) 120th calendar day following the Closing and (2) the date the Common Stock is listed on a national exchange (the “Corporation Redemption Payment Date”), the Corporation shall have the obligation to redeem the Preferred Stock for an amount equal to 100% of the outstanding Stated Value of the Preferred Stock, plus any accrued but unpaid dividends, plus all other amounts due to the Holder. 

 

On October 10, 2025, the Company entered into another Securities Purchase Agreement (the second SPA) with the Investor, whereby the Investor agreed to purchase 50 shares of the Company’s existing Series A Shares, in consideration of the Series A Investor’s consent for the Company to enter into previously disclosed transactions including: (A) creating the Series B Convertible Preferred Stock, Series C Convertible Preferred Stock and Series D Convertible Preferred Stock, (B) issuing 5,000 shares of the Series B Stock (which contain 20-1 super voting rights), 9,500 shares of the Series C Stock in a transaction pursuant to which the Company will acquire certain assets owned by James Li, the Company’s Chief Executive Officer, and (C) issuing a convertible promissory note in favor of an affiliate of James Li in the aggregate principal amount of $3,000,000.

 

The Series A Shares have a stated value of $1,200 per share, and bear dividends at the rate of 12% per annum, for so long as the Series A Shares have not been redeemed or converted. The Series A Shares are convertible into shares of Common Stock of the Company at a conversion price of $0.112.

 

The Company accounts for its Series A and D preferred shares in accordance with the guidance in ASC Topic 480, “Distinguishing Liabilities from Equity” (ASC 480). Series A and D preferred shares subject to mandatory redemption (if any) will be classified as a liability instrument and will be measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) will be classified as temporary equity. At all other times, ordinary shares will be classified as shareholders’ equity. In accordance with ASC 480-10-S99, the Company classifies the Series A and D preferred shares outside of permanent equity as the shares are subject to possible redemption after 120 days of closing. The Company recorded the Series A and D preferred shares as temporary equity with accrued dividend included in redemption value.

 

As of September 30, 2025, the Series A and D preferred shares subject to possible redemption reflected in the balance sheets are reconciled in the following table:

 

January 1, 2025     
Series A preferred shares  $310,000 
Series D preferred shares   500,000 
Shares issuance cost   (12,000)
Cumulative dividend   15,605 
Balance as of September 30, 2025  $813,605 

 

The Company issued 300 Series A and 500 Series D shares in October 2025.

 

29

 

 

Note 15 — Equity

 

Reverse recapitalization

 

The total number of shares which the Company shall have the authority to issue is one hundred and one million (101,000,000) shares of two classes of capital stock to be designated respectively preferred stock (“Preferred Stock”) and common stock (“Common Stock”). The total number of shares of Common Stock the Company shall have authority to issue is 100,000,000 shares, par value $0.0001 per share. The total number of shares of Preferred Stock the Company shall have authority to issue is 1,000,000 shares, par value $0.0001 per share. The Preferred Stock authorized by this Certificate of Incorporation may be issued in series. As a result of the Merger as described in Note 1, all share and per share data has been retroactively restated to reflect the current capital structure of the Company.

 

Shares issued in connection with the Company’s Merger on March 11, 2024:

 

   Common
Stock
 
Lakeshore’s shares outstanding prior to reverse recapitalization   74,717 
Shares issued to private rights   1,172 
Conversion of the Lakeshore’s public shares and rights   26,337 
Shares issued to service providers   26,718 
Shares issued for commitment fee   5,114 
Bonus shares issued to in connection with Lakeshore loans *   2,200 
Bonus shares issued to in connection with NMI loans *   3,333 
Conversion of NMI’s shares into the Company’s ordinary shares   742,415 
Total shares outstanding   882,006 

 

* In connection with the Merger, the Company, Lakeshore and NMI further entered into a Letter Agreement on November 15, 2023, a total of 4,168 shares of the Company’s common stock will be issued upon closing of the Merger in connection with certain transactions relating to the Merger: (i) 1,667 shares to Tie (James) Li and 1,667 shares to Zhiyi (Jonathan) Zhang (or 3,334 shares in the aggregate) in connection with their guarantees of the repayment of the Newtek Loan, which was loaned to a subsidiary of NMI with the principal amount of $3,700,000; (ii) 417 shares to Tie (James) Li and 417 shares to Deyin (Bill) Chen (or 834 shares in the aggregate) in connection with their loans to Lakeshore, each with the principal amount of $125,000 under separate but similar loan agreements); At the Close of Merger, additional shares of 533 and 833 were issued to Tie (James) Li and Prosperity Spring International Investment Management in connection with their loans to Lakeshore.

 

The shares were valued $300 per share, of which $1.0 million (3,334 shares awarded pertaining to loan guarantee for the Newtek loan) was expensed as finance expense in the Company unaudited condensed consolidated statements of operations during the year ended December 31, 2024. $660,000 was expensed in Lakeshore’s statements of operations and carried over as retained deficit after the Merger. The shares in connection with the loans have been issued during the close of the Merger.

 

* On April 10, 2023, Lakeshore entered into a standby equity purchase agreement (as amended by amendment No. 1 to the agreement dated June 12, 2023 and amendment No. 2 to the agreement dated December 11, 2023, the “SEPA”) with YA II PN, Ltd. (“Yorkville”). Pursuant to the SEPA, Lakeshore has the right, but not the obligation, to sell to Yorkville up to $60,000,000 of shares of common stock at Lakeshore’s request any time during the commitment period commencing on the sixth (6th) trading day following the date of closing of the reverse recapitalization and terminating on the earliest of (i) the first day of the month following the 36-month anniversary of the effective date and (ii) the date on which Yorkville will have made payment of any advances requested pursuant to the SEPA for the shares of common stock equal to the commitment amount of $60,000,000.

 

The Company has paid YA Global II SPV, LLC, a subsidiary of Yorkville, a structuring fee in the amount of $25,000. In addition, no later than ten trading days following the closing of the reverse recapitalization, Lakeshore agreed to pay a commitment fee in an amount equal to $300,000 by the issuance to Yorkville of such number of shares of common stock that is equal to the commitment fee divided by the lower of (i) the average VWAP for the seven consecutive trading days immediately after the close of the reverse recapitalization and (ii) $10.00 per share. The 5,114 shares at $58.66 per share had been issued on November 22, 2024.

 

Reverse Split

 

On November 18, 2024, the Company filed a certificate of amendment to its amended and restated certificate of incorporation to effect a one-for-thirty (1-for-30) reverse split (the “Reverse Split”). The Reverse Split became effective on November 21, 2024. As a result of the Reverse Split, every 30 shares of the Company’s issued and outstanding common stock were automatically converted into one share of common stock, with no change to the par value per share. All share and per share data has been retroactively restated to reflect the Reverse Split of the Company.

 

30

 

 

Stock compensation

 

In connection with the Merger, the Company adopted the Equity Incentive Plan (the “2024 Incentive Plan”).

 

The 2024 Incentive Plan will provide for grants of stock options, stock appreciation rights, restricted stock, restricted stock units, and other stock or equity-related cash-based awards. Directors, officers and other employees of the Company and its subsidiaries, as well as others performing consulting or advisory services for the Company, will be eligible for grants under the 2024 Incentive Plan.

 

The 2024 Incentive Plan provides for the future issuance of shares of the Company’s Common Stock, representing 10% of the number of shares of the Company’s Common Stock outstanding following the Business Combination (after giving effect to the Redemption). The 2024 Incentive Plan also provides for an annual increase on January 1 for each of the first ten (10) calendar years during the term of the 2024 Incentive Plan by the lesser of (a) Five percent (5%) of all classes of the Company’s common stock outstanding on each December 31 immediately prior to the date of increase or (b) such number of Shares determined by the Board.

 

Pursuant to board resolution dated August 23, 2023, the Company is to grant a one-time award of 333 shares of common stock of the company to Charles Hausman, a Director of the Company; a one-time award of 1,667 shares of the company to Tie “James” Li and a one-time award of 1,667 shares of the company to Zhiyi Zhang, both executives of the Company. The above awards are vested immediately upon consummation of the business combination with Lakeshore.

 

Pursuant to board resolution dated September 20, 2023, the Company approved a stock grant to Mr. Darin Carpenter, Chief Operating Officer of the Company, pursuant to which Mr. Carpenter will be issued 3,334 shares of the Company’s common stock over a two-year service period upon consummation of the business combination Lakeshore.

 

On August 1, 2024, the Company and Darin Carpenter entered into the mutual termination of employment agreement and intent to transition to project-based work (the “Agreement”), in which it was agreed that Mr. Carpenter shall resign from his position as Chief Operating Officer of the Company effective as of July 31, 2024. Pursuant to the Agreement, the Company and Mr. Carpenter agreed that Mr. Carpenter will provide services as a consultant to the Company on a per project basis as needed. In addition, the Company agreed to fully vest 3,334 shares of common stock that was issuable to Mr. Carpenter pursuant to the Employment Agreement dated as of September 17, 2023, by and between the Company and Mr. Carpenter. The Company also agreed to pay Mr. Carpenter the equivalent of two months of salary. The 3,334 shares had been issued on February 25, 2025.

 

Shares award to Mr. Hausman and Mr. Carpenter per Letter Agreement stated above has a fair value of $1.1 million.

 

Pursuant to board resolution dated March 24, 2024, certain key employees were approved for stock incentives including George Yutuc (Chief Financial Officer), Kirk Collins (Director of Sales), and Amber Wang (Controller). Each can receive shares that vest over time of 3,334, 1,667 and 1,667 shares, respectively. Each of these employees have signed an employment agreement that reflects such shares and unique vesting schedules. The fair value of the shares to be issued was approximately $178,000 at $26.70 per share.

  

On April 2, 2024, the Company entered into an investor relations consulting agreement with MZHCI LLC (“MZHCI”) pursuant to which MZHCI will provide investor relations services to the company and the agreement has a term of six months. The Company will pay $14,000 cash per month and to issue MZHCI 5,000 shares of restricted common stock, 2,500 shares will be vested immediately upon signing the agreement and 2,500 shares will vest on October 1, 2024. The fair value of the shares was approximately $143,000 at $28.50 per share. The 5,000 shares were issued on May 7, 2024.

 

Pursuant to board resolution dated October 25, 2024, the Company approved the issuance of 13,334 restricted shares of common stock, par value $0.0001 per share to Alta Waterford LLC for service provided related to digital advertising and social media platform. The shares shall be issued pursuant to the 2024 Incentive Plan. The fair value of the shares was approximately $58,000 at $4.37 per share. The shares were issued on November 21, 2024.

 

Pursuant to board resolution dated November 18, 2024, the Company approved the issuance of 75,757 restricted shares of common stock, par value $0.0001 per share to PX SPAC Capital Inc. for one-year service to be provided related to business consulting and advisory. The shares shall be issued pursuant to the 2024 Incentive Plan. The fair value of the shares granted was approximately $200,000 at $2.64 per share. Stock compensation expenses for the three and nine months ended September 30, 2025 amounted to $50,411 and $149,588, respectively.

 

On July 22, 2025, the Company entered into a two-month consulting agreement with Root Ventures LLC. In exchange for curation services to be provided under the agreement, the Company issued 439,833 restricted shares of common stock (valued at approximately $22,519 based on a fair value of $0.0512 per share) on July 25, 2025, as consideration for the services.

 

For the three months ended September 30, 2025 and 2024, the Company recorded stock compensation expenses of $84,146 and $848,075, respectively. Those stock compensation expenses are included in the Company’s operating expenses.

 

For the nine months ended September 30, 2025 and 2024, the Company recorded stock compensation expenses of $230,039 and $1,215,880, respectively. Those stock compensation expenses are included in the Company’s operating expenses.

 

31

 

 

Common stock issued with private placement

 

On July 19, 2024, the Company issued a total of 6,000 shares to the investor pursuant to a securities purchase agreement (See Note 11 on Convertible notes for detail). The fair value of the shares was approximately $81,000 at $13.5 per share.

 

Public Offering

 

On July 29, 2024, the Company closed an underwriting public offering for the sale of 166,667 units at a public offering price of $7.2 per unit, with each unit consisting of: (i) one share of common stock and (ii) one warrant to purchase one share of common stock, for aggregate net proceeds of $1.0 million after deducting underwriting discounts and other offering expenses. Pursuant to the terms of an underwriting agreement dated as of the offering date, the Company agreed to grant EF Hutton LLC, the underwriter, 25,000 warrants, representing 15% of the warrants sold as part of the units in this offering.

 

On November 7, 2024, the Company entered into an underwriting agreement with D. Boral Capital LLC as the underwriter, relating to a firm commitment underwritten public offering of (i) 837,788 units at a public offering price of $3.354 per Unit, with each Unit consisting of one share of common stock, par value $0.0001 per share, of the Company, one Series A warrant to purchase one share of common stock at an exercise price of $3.354 per share and one Series B warrant to purchase such number of shares of common stock as determined on the reset date, at an exercise price of $0.003 per shares, and (ii) 56,667 pre-funded units (the “Pre-Funded Units”) at a public offering price of $3.351 per Pre-Funded Unit, with each Pre-Funded Unit consisting of one pre-funded warrant (the “Pre-Funded Warrants”) exercisable for one share of common stock at an exercise price of $0.003 per share, one Series A Warrant and one Series B Warrant. The Pre-Funded Warrants was exercised on November 12, 2024. Net proceeds to the Company amounted to approximately $2.5 million. 

 

On May 7, 2025, the Company entered into the equity financing agreement (or the “EPFA”), with GHS Investments, LLC, a Nevada limited liability company (the “Investor”), in connection with an equity line of credit (“ELOC”) for up to $20,000,000 (the “Commitment Amount”), pursuant to the EPFA. On July 25, 2025, the Company entered into the (the “Amended EPFA”) with the “investor, which amends and supersedes the previously disclosed Equity Financing Agreement (“EPFA”), dated as of May 6, 2025, by and between the Company and the Investor, in connection with an equity line of credit (“ELOC”) for up to $20,000,000 (the “Commitment Amount”), for a period of 24 months from the effective date of the registration statement (the “Registration Statement”) registering the shares of Common Stock relating to the EPFA (the “Term”), or July 15, 2027. During the Term, the Company has the right, but not the obligation, from time to time at its sole discretion, to direct Investor, by delivery of an irrevocable written notice (“Purchase Notice”) to purchase shares of the Company’s Common Stock (each a “Purchase”). The maximum dollar amount of each Purchase will not exceed two hundred percent (200%) of the average daily trading dollar volume for the Common Stock during the ten (10) consecutive trading days preceding the Purchase Notice. Prior to the Amended EPFA, no Purchase would be made in an amount equaling less than ten thousand dollars ($10,000) or greater than five hundred thousand dollars ($500,000). The parties entered into the Amended EPFA solely to increase such Purchase amount from $500,000 to $2,000,000. The Company also agrees to issue one percent (1%) of the total Commitment Amount at a fixed price equaling ninety-five (95%) of the VWAP for the trading day preceding the execution of Agreements as an equity incentive (“Commitment Shares”). The Company accounted for the Commitment Shares as finance expense to obtain the ELOC. The Company has not issued the shares as of September 30, 2025. The change in fair value of the shares to be issued on July 25, 2025 to September 30, 2025 is recorded in the Company’s statement of operations. Fair value is determined using the quoted market price of the Company’s shares which is a level 1 input.

 

For the three and nine months ended September 30, 2025, the Company sold 1,432,650 share of its common stock, net proceeds to the Company amounted to $145,809.

 

Preferred shares

 

In connection with the acquisition of Zak Properties as stated in Note 6– Asset acquisition under common control, the purchase price for Zak Properties is $17,500,000, and paid by the Company as follows:

 

(i)the Company shall issue 5,000 shares of Series B Preferred Stock (valued at $5,000,000) of the Company which (a) can be converted into Common Stock, par value $0.0001 per share, at $0.1180 per share and (b) have certain voting rights equal to twenty (20) votes per one (1) share of Series B Preferred Stock;

 

(ii)the Company shall issue 9,500 shares of Series C Preferred Stock (valued at $9,500,000) of the Company which (a) convertible into shares of Common Stock at $0.1180 per share, and (b) same voting right as common stock.

 

The Company issued 5,000 Series B and 9,500 Series C shares in October 2025.

 

Shares issued through debt-to-equity conversion

 

Refer to Note 10 — Loans payable and Note 12 — Related party transactions for detail.

 

32

 

 

Shares issued through convertible notes conversion

 

Refer to Note 11 — Convertible notes for detail.

 

Warrants:

 

Warrants issued prior to reverse recapitalization

 

In connection with the reverse recapitalization, the Company has assumed 120,858 warrants outstanding, which consisted of 115,000 public warrants and 5,858 private warrants. Both of the public warrants and private warrant met the criteria for equity classification.

 

Each whole warrant entitles the holder to purchase one ordinary share at a price of $345 per share, subject to adjustment as described below, commencing 30 days after the completion of its initial business combination, and expiring five years from after the completion of an initial business combination. No fractional warrant will be issued and only whole warrants will trade.

  

The Company may redeem the warrants at a price of $0.3 per warrant upon 30 days’ notice, only in the event that the last sale price of the ordinary shares is at least $540 (as adjusted for share sub-divisions, share dividends, reorganizations and recapitalizations) per share for any 20 trading days within a 30-trading day period ending on the third day prior to the date on which notice of redemption is given. If the Company redeems the warrants as described above, management will have the option to require all holders that wish to exercise warrants to do so on a “cashless basis.”

 

Warrants issued with July convertible notes

 

On July 17, 2024, the Company issued a total of 7,250 warrants in connection with a securities purchase agreement, granting the option to purchase up to 7,250 shares of common stock at an exercise price of $26.10 per share. The warrant is exercisable on July 17, 2024 until five years from July 17, 2024. The fair value of the warrants was approximately $4,600 at $0.60 per warrant.

 

The issuance of the warrants described above were deemed exempt from registration under Section 4(a)(2) of the Securities Act or Regulation D promulgated thereunder in that the issuance of securities were made to an accredited investor and did not involve a public offering. The recipient of such securities represented its intention to acquire the securities for investment purposes only and not with a view to or for sale in connection with any distribution thereof.

 

The total number of these warrant shares is subject to adjustments for stock splits, recapitalizations and reorganizations. If the Company issues or sells any shares of common stock or other securities for a price per share, exercise price, or conversion price, as the case may be, that is less than the current exercise price of the warrant, subject to exceptions, the exercise price of the warrant will be adjusted to match the price per share, exercise price, or conversion price, in the issuance, as applicable.

 

Series A Warrants issued in July Public offering

 

On July 29, 2024, the Company issued a total 191,667 Series A warrants, each entitling the holder to purchase one share of common stock at a public offering price of $7.2 per unit.

 

The Series A warrants are immediately exercisable on the date of issuance at an exercise price of $7.2 per share and expires five years from the closing date of the offering (See above Public Offering for detail).

 

The Series A warrants are exercisable at any time after their original issuance up to the date that is five years after their original issuance. The Series A warrants will be exercisable, at the option of each holder, in whole or in part by delivering to us a duly executed exercise notice accompanied by payment in full in immediately available funds for the number of shares of Common Stock subscribed for upon such exercise (except in the case of a cashless exercise as discussed below). If a registration statement registering the issuance of the shares of Common Stock underlying the Series A warrants under the Securities Act is not effective or available, the holder may, in its sole discretion, elect to exercise the Series A warrants through a cashless exercise, in which case the holder would receive upon such exercise the net number of shares of Common Stock determined according to the formula set forth in the Series A warrants.

 

33

 

 

The exercise price per whole share of Common Stock issuable upon exercise of Series A warrants is $7.2 per share. The exercise price and number of shares of Common Stock issuable upon exercise will adjust in the event of certain stock dividends and distributions, stock splits, stock combinations, reclassifications, dilutive issuances or similar events. In addition, with respect to Series A warrants, subject to certain exemptions outlined in the Series A warrants, if we sell, enter into an agreement to sell, or grant any option to purchase, or sell, enter into an agreement to sell, or grant any right to reprice, or otherwise dispose of or issue (or announce any offer, sale, grant or any option to purchase or other disposition) any shares of Common Stock, at an effective price per share less than the exercise price of the Series A warrants then in effect, the exercise price of the Series A warrants shall be reduced to equal the effective price per share in such dilutive issuance, provided, however, in no event shall the exercise price of the Series A warrants be less than $1.5.

 

In November 2024, a total of 46,800 Series A warrants were exercised to subscribe for common stocks for a total consideration of approximately $0.3 million.

 

Warrants and Pre-Funded Warrants issued in November Public offering 

 

On November 12, 2024, the Company issued a total 894,454 Series A warrants, including 56,667 Series A warrants from Pre-Funded Unit, 894,454 Series B warrants, including 56,667 Series B warrants from Pre-Funded Unit, and 56,667 Pre-Funded warrants.

 

The Series A Warrants was exercisable commencing upon warrant stockholder approval (“Warrant Stockholder Approval”, see define below), have an exercise price of $3.354 per share (subject to certain anti-dilution and share combination event protections) and have a term of 5 years from the date of the Warrant Stockholder Approval.

 

The Series B Warrants was exercisable commencing upon Warrant Stockholder Approval, will have an exercise price of $0.003 per share and will have a term of 2 years from the date of Warrant Stockholder Approval.

 

The purchase price of each Pre-Funded Unit is $3.351, and the exercise price of each Pre-Funded Warrant included in the Pre-Funded Unit is $0.003 per share. The Pre-Funded Warrants will be immediately exercisable and may be exercised at any time until all of the Pre-Funded Warrants are exercised in full. This offering also relates to the shares of common stock issuable upon exercise of any Pre-Funded Warrants and Warrants sold in this offering. (See above Public Offering for detail).

 

The exercise price and number of shares of common stock issuable under the Series A Warrants are subject to adjustment and the number of shares of common stock issuable under the Series B Warrants will be determined following the 10th trading day after the date of Warrant Stockholder Approval (the “Reset Date”), and to be determined pursuant to 80% of the lowest daily average trading price of the common stock during the reset period (“Reset Period”), the period commencing on the first (1st) Trading Day after the date of Stockholder Approval and ending on the tenth (10th) trading day after the date of stockholder approval, subject to a minimum price of $0.6708 per share, such that the maximum number of shares of common stock underlying the Series A Warrants would be an aggregate of approximately 4,472,272 (determined by dividing the offering amount of $3,000,000 by the minimum exercise price of $0.6708) and the maximum number of shares of common stock underlying the Series B Warrants would be an aggregate of approximately 3,577,818 (determined by subtracting the 837,788 Units and 56,667 Pre-Funded Units offered from 4,472,272).

 

Warrant Stockholder Approval. Under Nasdaq listing rules, the Warrants may not be exercised unless and until the Company obtain the approval of its stockholders. While the Company intends to promptly seek stockholder approval, there is no guarantee that the Warrant Stockholder Approval will ever be obtained. If the Company is unable to obtain the Warrant Stockholder Approval, the Warrants may not be exercised and will have substantially less value. In addition, the Company will incur substantial cost, and management will devote substantial time and attention, in attempting to obtain the Warrant Stockholder Approval.

 

Warrants issued with convertible note – related party

 

In connection with the convertible note issued to Big Lake, the Company has issued to the note holder and an investor of the holder, warrants to purchase up to 10,101,010 shares of common stock at an exercise price of $0.198 pursuant to the warrant agreement dated April 11, 2025, if the Company draws down the full amount of the note. The warrants can be exercised in whole or in part, via cash or cashless exercise, until April 11, 2027, unless extended with holder’s consent. The warrants were valued at a fair value of $1,516,325 at $0.150 per share.

 

Warrants issued with August 2025 convertible note

 

In connection with the convertible note issued to Auctus Fund, LLC on August 15, 2025, the Company granted the note holder warrants to purchase 500,000 shares of common stock at an initial exercise price of $0.20 per share, adjustable under certain conditions, with an exercise period of five years. The warrants were valued at a fair value of $87,492 at $0.175 per share.

 

34

 

 

In December 2024, a total of 430,859 Series B warrants were exercised to subscribe for common stocks for a total consideration of approximately $43

 

On January 13, 2025, the exercise price for the Series A warrant has been reset to $0.6708. Total issuance number for Series A warrants and Series B warrants had been adjusted to 1,848,201 and 549,107.

 

In January 2025, a total of 1,289,916 Series A warrants and 549,107 Series B warrants were exercised for 1,839,023 shares of common stocks for a total consideration of $865,423.  

 

The summary of warrants activity is as follows:

 

   Warrants
Outstanding
   Common Stock
Issuable
   Weighted
Average
Exercise
Price
   Average
Remaining
Contractual
Life
(in years)
 
              US$      
December 31, 2024   1,631,025    1,631,025   $28.21    3.94 
Adjustment   1,039,258    1,039,258   $0.47    4.37 
Granted   
-
    
-
   $
-
    - 
Forfeited   
-
    
-
   $
-
    - 
Exercised   (1,839,023)   (1,839,023)  $0.47    - 
March 31, 2025   831,260    831,260   $52.09    4.47 
Granted   
-
    
-
   $
-
    - 
Forfeited   
-
    
-
   $
-
    - 
Exercised   
-
    
-
   $
-
    - 
June 30, 2025   831,260    831,260   $52.09    4.22 
Granted   500,000    500,000   $0.20    4.88 
Forfeited   
-
    
-
   $
-
    - 
Exercised   
-
    
-
   $
-
    - 
September 30, 2025   1,331,260    1,331,260   $32.60    4.31 

 

Note 16 — Concentration of risk

 

Credit risk

 

Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable.

 

As of September 30, 2025 and December 31, 2024, $59,473 and $414,938, respectively, were deposited with various major financial institutions in the United States. The amount in excess of the FDIC insurance was $0 as of September 30, 2025 and December 31, 2024.

 

Accounts receivable is typically unsecured and derived from revenue earned from customers, thereby exposing the Company to credit risk. The risk is mitigated by the Company’s assessment of its customers’ creditworthiness and its ongoing monitoring of outstanding balances. The Company maintains reserves for estimated credit losses, and such losses have generally been within expectations.

 

35

 

 

Customer and vendor concentration risk

 

During the three and nine months ended September 30, 2025 and during the three and nine months ended September 30, 2024, the major customers of the Company are as below. Iluminar is a related party of the Company since April 11, 2023, as disclosed in Note 12— Related party transactions.

 

   For the
Three Months
ended
September 30,
2025
   For the
Nine Months
ended
September 30,
2025
   As of
September 30,
2025
 
   Percentage
of
Revenue
   Percentage
of
Revenue
   Percentage
of
Account
Receivable
 
Customer A   <10%   <10%   34%
Customer C   43%   34%   <10%
Customer M   15%   <10%   <10%
Customer N   11%   <10%   <10%
Iluminar   <10%   <10%   30%

 

 

   For the
Three Months
ended
September 30,
2024
   For the
Nine Months
ended
September 30,
2024
   As of
December 31,
2024
 
   Percentage
of
Revenue
   Percentage
of
Revenue
   Percentage of
Account
Receivable
 
Iluminar   37%   25%   35%
Customer A   15%   21%   31%
Customer C   <10%   10%   <10%

 

During the three and nine months ended September 30, 2025 and during the three and nine months ended September 30, 2024, the major vendors of the Company are as below. Both Megaphoton and Uninet Global Inc. are related parties of the Company (Megaphoton is no longer a related party of the Company after April 2023), as disclosed in Note 12— Related party transactions, and all purchases from Uninet Global Inc. are products originally manufactured by Megaphoton Inc.

 

   For the
Three Months
ended September  30,
2025
   For the
Nine Months
ended
September  30,
2025
   As of
September 30,
2025
 
   Percentage of
Purchase
   Percentage of
Purchase
   Percentage of
Account
Payable
 
Vendor A   <10%   <10%   10%
Vendor E   <10%   54%   <10%
Iluminar   <10%   42%   <10%
Megaphoton Inc.   <10%   <10%   55%

 

   For the
Three  Months
ended September 30,
2024
   For the
Nine Months
ended
September 30,
2024
   As of
December 31,
2024
 
   Percentage of
Purchase
   Percentage of
Purchase
   Percentage of
Account
Payable
 
Vendor A   31%   42%   20%
Vendor B   25%   <10%   <10%
Vendor E   18%   31%   <10%
Vendor F   11%   <10%   <10%
Megaphoton Inc.   <10%   <10%   49%

 

36

 

 

Note 17 — Lease

 

The Company follows ASC 842 Leases. The Company has entered into lease agreements for vehicles, offices and warehouses space in California, Pennsylvania and Texas. $334,675 and $470,716 of operating lease right-of-use assets and $321,205 and $467,982 of operating lease liabilities were reflected on the September 30, 2025 and December 31, 2024 financial statements, respectively.

 

On May 15, 2021, Hydroman entered into a lease agreement of the warehouse in California. The lease term was from May 16, 2021 to May 15, 2022. The lease payments are $22,375 per month. On May 16, 2022, Hydroman extended the lease of the warehouse in California. The new leasing term was from June 16, 2022 to June 15, 2025 and an extra month from May 16, 2022 to June 15, 2022 free of charge. The lease payments are $29,088 per month for the period commencing June 16, 2022 and ending June 15, 2023, $29,960 per month for the period commencing June 16, 2023 and ending June 15, 2024, $30,859 per month for the period commencing June 16, 2024 and ending June 15, 2025. The Company did not renew the lease.

 

On May 28, 2023, Visiontech entered into a lease agreement for a vehicle. The leasing term began on May 28, 2023 and terminated on April 28, 2025 with a first installment of $15,000 and then continuously monthly payment of $1,550.

 

On April 11, 2024, the Company entered into a lease agreement for an office located in California. The lease term was from May 1, 2024 to April 30, 2027. The lease payments are $8,528 per month for the period commencing May 1, 2024 and ending April 30, 2025, $8,784 per month for the period commencing May 1, 2025 and ending April 30, 2026, $9,047 per month for the period commencing May 1, 2026 and ending April 30, 2027.

 

On July 20, 2024, Visiontech entered into a lease agreement for another vehicle. The leasing term began on September 3, 2024 and will terminate on August 3, 2028 with a first installment of $16,100 and then continuously monthly payment of $2,403.

 

On March 11, 2025, NMI entered into a lease agreement for a vehicle. The leasing term began on March 11, 2025 and will terminate on February 11, 2028 with a first installment of $2,800 and then continuously monthly payment of $1,765.

 

On August 8, 2025, NMI entered into a lease agreement for another vehicle. The leasing term began on August 8, 2025 and will terminate on July 8, 2028 with a first installment of $25,827 and then continuously monthly payment of $686.

 

As of September 30, 2025 and December 31, 2024, the weighted-average remaining operating lease term of its existing leases is approximately 2.17 and 2.04 years, respectively. As of September 30, 2025 and December 31, 2024, the average discount rate of its existing leases is approximately 6.96% and 7.14%, respectively.

 

   For the Three Months Ended   For the Nine Months Ended 
   September 30,
2025
   September 30,
2024
   September 30, 
2025
   September 30, 
2024
 
Lease cost  (Unaudited)   (Unaudited)   (Unaudited)   (Unaudited) 
Operating lease cost (included in Cost of Revenue and Other Expense in the Company’s Statement of Operations)  $52,847   $119,263   $265,447   $287,508 
Other information                    
Cash paid for amounts included in the measurement of lease liabilities   67,701    81,974    122,612    198,208 

 

 

The supplemental balance sheet information related to leases for the period is as follows:

 

   As of
September 30,
2025
   As of
December 31,
2024
 
Operating leases          
Right of use asset   334,675    470,716 
           
Lease Liability – current portion   165,450    262,380 
Lease Liability – net of current portion   155,755    205,602 
Total operating lease liabilities  $321,205   $467,982 

 

37

 

 

Maturities of the Company’s lease liabilities are as follows:

 

Twelve months ended September 30,  Operating
Lease
 
2026  $182,078 
2027   121,573 
2028   42,113 
Less: Imputed interest/present value discount   (24,559)
Present value of lease liabilities  $321,205 

 

Note 18 — Commitment and Contingencies

 

The Company may, from time to time, be involved in legal matters arising in the ordinary course of its business. While the Company is not presently subject to any material legal proceedings, there can be no assurance that such matters will not arise in the future or that any such matters in which the Company is involved, or which may arise in the ordinary course of the Company’s business, will not at some point proceed to litigation or that such litigation will not have a material adverse effect on the business, financial condition or results of operations of the Company.

 

On August 22, 2023, two separate lawsuits were filed against NMI and two of its wholly-owned subsidiaries: Visiontech Group Inc., a California corporation, and Hydroman Inc., a California corporation (collectively referred to as the “Defendants”) by Megaphoton. Megaphoton, a manufacturer and producer of artificial lighting equipment for use in agriculture and industrial applications, filed the lawsuits against the Defendants in Los Angeles Superior Court, asserting that the Defendants have breached a contract/guarantee agreement by failing to pay a total of $6,857,167, as per the terms of these agreements. NMI believes that there is no merit in the complaint and has filed a counter-suit against Megaphoton in Orange County Court, California, seeking affirmative relief on September 22, 2023. On March 5, 2024, Megaphoton filed requests to dismiss the cases against Hydroman and Visiontech in the Superior Court of Los Angeles. Megaphoton refiled in federal court; the Company argue forged signature, fraud and damage with bad product qualities.

 

On March 1, 2024, NMI was notified of a complaint in San Bernardino Superior Court by Vien Le, its former CFO, who was employed approximately 2 months. The lawsuit claims wrongful discharge, untimely payment of wages and other related items. The Company has retained counsel and believes it will successfully defend against this lawsuit.

 

On October 22, 2024, Growterra, LLC (“Growterra”) filed a complaint against the Company and the Company’s chief executive officer in the Court of Common Pleas, Hamilton County, Ohio, alleging that it purchased lighting products from the Company, under which the Company would provide Growterra software, IP, and design documentation related to hydroponic containers and identify Growterra as an additional insured on the Company’s product liability insurance. Growterra alleges the Company failed to perform these obligations. Growterra is alleging breach of contract, fraud, and misappropriation of trade secrets as well as related causes of action. Growterra does not state an amount of damages but is also seeking rescission. The Company has been negotiating with Growterra and feels it can defend itself successfully. The Company has filed a motion to compel discovery responses against Growterra LLC due to their failure to produce documents in discovery. In response, Growterra filed a partial motion for summary judgment on liability only, arguing they should not have to comply with their discovery obligations. The Company has argued to the court that Growterra must respond to discovery before any other motions are heard. The Company is awaiting the Court’s decision.

 

On October 30, 2024, Visiontech filed a cross-complaint against Beverly Hills View, Inc. (“BHV”) in Los Angeles Superior Court. This action responded to an initial lawsuit filed by BHV on August 29, 2024, in which BHV claimed that the lighting products received were unsuitable for its cannabis growing operation and claiming damages of $2,500,000.

 

On November 22, 2024, NM Data entered into an investment agreement to acquire 51% of Future Tech for total of $3 million. Future Tech is an Ohio-based company, for the development and construction of a 50MW high density data center and a vertical farming facility in Stryker, Ohio. The closing of the acquisition of FutureTech is subject to Future Tech’s executing an electricity sales and purchase agreement with a certain supplier set forth in the agreement and Future Tech entering into a ten-year lease option to purchase indoor space as set forth in the agreement. Through the date of the report, $721,000 was paid to Future Tech with $2.3 million still to be paid based on closing.

 

38

 

 

Nasdaq Stock Market LLC (“Nasdaq”) Notification Letters

 

On January 13, 2025, the Company received notice from Nasdaq indicating that the Nasdaq Hearings Panel (the “Panel”) has determined to delist the Company’s securities from Nasdaq based upon the Company’s non-compliance with Listing Rule 5550(b)(1), Nasdaq’s minimum shareholders’ equity rule. As a result of the Panel’s decision, Nasdaq suspended trading in the Company’s securities effective at the open of trading on Wednesday, January 15, 2025.

 

Note 19 — Segment information

 

The Company conducts business as a single operating segment for indoor agriculture technology that provides products to indoor growers which is based upon the Company’s organizational and management structure, as well as information used by the Chief Executive Officer (“CODM”) to allocate resources and other factors. The accounting policies of the segment are the same as those described in Note 3.

 

The key measure of segment profitability that the CODM uses to allocate resources and assess performance is segment profit or loss, as reported on the statements of operations. The following table presents the significant revenue and expense categories of the Company’s single operating segment:

 

   For the Three Months Ended   For the Nine Months Ended 
   September 30,
2025
   September 30,
2024
   September 30,
2025
   September 30,
2024
 
   (Unaudited)   (Unaudited)   (Unaudited)   (Unaudited) 
Revenues  $72,377   $3,052,727   $1,663,205   $8,662,414 
Less:                    
Cost of revenues   71,951    2,824,614    1,458,521    7,669,764 
Operating expenses:                    
Salary and benefits expenses   257,347    473,629    928,898    1,449,580 
Professional fees   459,614    552,696    1,219,820    1,484,835 
Stock-based compensation   84,146    848,075    230,039    1,215,880 
Other selling, general and administrative   404,018    312,553    1,165,104    1,064,192 
Provision for credit losses   126,824    36,597    306,091    60,988 
Other expenses (income):                    
Interest expense, net   559,140    738,468    2,062,483    1,527,443 
Non cash finance expense   200,000    
-
    200,000    1,000,000 
Loss on loan extinguishment   90,062    15,131    50,062    15,131 
Other segment (income) expense   (9,936)   1,300    2,024    (2,438)
Income taxes   
-
    
-
    1,700    2,500 
Net loss  $(2,170,789)  $(2,750,336)  $(5,961,537)  $(6,825,461)

 

Note 20 — Subsequent events 

 

The Company evaluated subsequent events and transactions that occurred after September 30, 2025 up through November 14, 2025 which is the date of these unaudited condensed consolidated financial statements are available to be issued. Based on this review, except as disclosed below, the Company did not identify any other subsequent events that would require adjustment or disclosure in the unaudited condensed consolidated financial statements.

 

On October 1, 2025, the Company entered into another securities purchase agreement with 1800 Diagonal Lending LLC (“Diagonal”) pursuant to which the Company sold to Diagonal a convertible promissory note in the aggregate principal amount of $112,800 with an original issue discount of $18,800 and closing expenses of $9,000 deducted from funding amount. The note bears an annual interest charge of 15% and maturity date of June 30, 2026. Only upon an occurrence of an event of default under the note, the holder may convert the outstanding unpaid principal amount of the note into shares of common stock of the Company at a discount of 39% of the market price.

 

39

 

 

On October 8, 2025, the Company filed Certificate of Designations and related amendments with the State of Delaware. Such filing provided for new classes of preferred stock in Series A, Series B, Series C and Series D. The Company is authorized to issue up to 1,000,000 shares of preferred stock. 300 are designated for Series A, 5,000 for Series B, 9,500 for Series C, and 2,000 for Series D.

 

On October 10, 2025, the Company signed a Securities and Purchase Agreement with GHS Investments LLC (“Investor”) which awarded 50 additional Series A Preferred Shares to the Investor. Such shares are for consideration of the consent to the creation and issuance of Series B and C preferred stock to a real estate holding entity and its agreement to sell its assets to the Company on September 22, 2025 (see Note 6 – Asset acquisition under common control). In addition to the issuance of Series B and C Preferred Shares, the Company issued a convertible promissory note in the amount of $3,000,000. Each Series A Preferred Share has a stated value of $1,200 and par value of $0.0001 per share.

 

On October 10, 2025, the Company was notified that a lawsuit has been filed in the State of New York by Agrify Corp. The complaint alleges breach of contract in a purchase order of L.E.D. lights. The purchase order originally was part of a termination agreement of a merger agreement. The Company has always stated that the specific L.E.D. products mentioned in the purchase agreement were not in compliance with government requirements and cannot be re-sold. Agrify seeks damages of approximately $481,000 plus fees and costs. The Company is defending the action. Based on consultation with external counsel, an unfavorable outcome is reasonably possible; however, the Company cannot reasonably estimate a loss or range of loss at this time. Accordingly, no accrual has been recorded as of September 30, 2025, and the Company will update this disclosure as additional information becomes available.

 

On October 28, 2025, the Company filed form PRE 14C with the Securities and Exchange Commission that based on a record date of October 16, 2025, shareholders shall be mailed a vote to approve the adoption of a Reverse Stock Split and Capital Increase Amendment. The range of the Reverse Split is 1:5 to 1:20. The Common Shares authorized shall be increased from 100,000,000 to 1,000,000,000.

 

On October 20, 2025, the Company received an investment of $250,000 from Huanfu Cui, an Asian-based individual investor, which was followed with another $200,000 tranche on October 31, 2025. The investments are based on the Securities Purchase Agreement signed on October 29, 2025 with the Company. Mr. Cui shall invest up to $500,000 and shall be issued Series F Preferred Shares that have a fixed conversion price of $0.2813. The $450,000 received amounts are the equivalent of 1,599,715 common shares if converted and 1,777,778 if another $50,000 is received by the Company.

 

On November 6, 2025, GHS Investments LLC converted 46 Series A Preferred Stock, $1,200 each and was issued 690,000 shares of common stock.

 

40

 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following discussion and analysis are intended as a review of significant factors affecting our financial condition and results of operations for the periods indicated. The discussion should be read in conjunction with our unaudited condensed consolidated financial statements and the related notes included elsewhere in this Quarterly Report on Form 10-Q and the audited financial statements and the other information set forth in the Annual Report on Form 10-K for the fiscal year ended December 31, 2024 filed with the Securities and Exchange Commission (the “SEC”) on April 16, 2025. In addition to historical information, the following Management’s Discussion and Analysis of Financial Condition and Results of Operations contains forward-looking statements that involve risks and uncertainties. Our actual results could differ significantly from those anticipated in these forward-looking statements as a result of certain factors discussed herein and any other periodic reports filed and to be filed with the SEC.

 

Management’s Discussion and Analysis of Financial Condition and Results of Operation.

 

The following Management’s Discussion and Analysis should be read in conjunction with our unaudited condensed financial statements and the related notes included elsewhere in this Quarterly Report on Form 10-Q and the audited financial statements and the other information set forth in the Annual Report on Form 10-K for the fiscal year ended December 31, 2024 filed with Securities and Exchange Commission (the “SEC”) on April 16, 2025. The Management’s Discussion and Analysis (“MD&A”) contains forward-looking statements that involve risks and uncertainties, such as statements of our plans, objectives, expectations and intentions. Any statements that are not statements of historical fact are forward-looking statements. When used, the words “believe,” “plan,” “intend,” “anticipate,” “target,” “estimate,” “expect,” and the like, and/or future-tense or conditional constructions (“will,” “may,” “could,” “should,” etc.), or similar expressions, identify certain of these forward-looking statements. These forward-looking statements are subject to risks and uncertainties that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements in this form. Our actual results and the timing of events could differ materially from those anticipated in these forward-looking statements as a result of several factors. 

 

Overview

 

We are a growing agriculture technology company providing products to indoor growers in a CEA (Controlled Environment Agriculture) setting in North America. Our main products are commercial grade LED lights and related equipment designed for indoor growers. For over 10 years, the Company has utilized manufacturing relationships in China to provide quality and cost-efficient products in this space. In the 4th quarter 2024, we renamed a subsidiary to Hydroman Electric Inc. for the purpose of entering electric vehicle (“EV”) market as we aim to distribute EV medium sized trucks to customers in Latin America and also develop indoor growing systems within these EV trucks. In 2024, the Company also started investments in Future Tech Inc., a Bitcoin mining and data center business. In 2025, the Company made announcements to enter the field of Digital Treasury Management with an emphasis on XRP as a base cryptocurrency and its applications on tokenization of real-world assets.

 

We focus on the greenhouse and cultivation industry and aim at providing integrated greenhouse solutions, including grow lights, dehumidifiers, coco and grow media for vertical farming and multiple growing system. These systems enable year-round cultivation of crops, avoids harsh environments with very cold or hot climate. Many states focused on farming are limited to grow crops are certain months such as Spring to Fall only, and or are too far from production states too have fresh produce year-round. There are cost advantages also as vertical farming systems produces a much higher yield per acre of land. In most cases, water consumption is much lower, up to 90%. Many indoor growers can locate closer to large population centers which can significantly reduce cost of trucking, and lead time whilst reducing carbon emissions as well. 

 

We operate mainly through two subsidiaries in California, Visiontech and Hydroman. Visiontech is known for the brand “eFinity” and provides high-efficiency and high-quality grow lights, grow media, fixtures and other related equipment; Hydroman supplies commercial greenhouse developers and owners with professional lighting technology and equipment. On November 11, 2024, Hydroman, Inc. changed its name to Hydroman Electric Corporation and will focus on business of electric vehicles distribution.

 

41

 

 

In its first expansion plan, the Company has added additional products to our offering. These include organic and non-organic fertilizers, organic plant growth additives, and dehumidifiers. We have diverse suppliers including from countries such as India, Holland and Turkey. Additional equipment is being considered as well. These are value add components that will help growers increase yield, but more importantly reduce failures and dramatically improve growing environments such. The new products are a natural complement to its our base of LED grow lights.

 

The Company also seeks to enter the joint ventures in other industry verticals to utilize excess space available for vertical farming. 

 

Trends and Expectations

 

The following factors have been important to our business, and we expect them to impact our results of operations and financial condition in future periods:

 

Product and Brand Development

 

We plan to increase investments in product and brand development. We actively evaluate and pursue acquisitions of product brand names and improvements on existing products. We continue to work with our suppliers in improving lighting products to be both of the highest quality and simultaneously cost effective for the customer. The Company invests in trips abroad to source and partner with manufacturing companies. We expect to develop additional manufacturing relationships and suppliers in Europe in the near future. 

 

The Company is also developing proprietary “all in one” automated and robotic indoor growing systems that are under design and testing phases.

 

The Company utilizes its vast network in the industry and recent publicity in listing on Nasdaq in acquiring leads for potential partnerships in sourcing, research and development of new product and business acquisitions.

 

Regulatory Environment

 

The importation of LED lighting and distribution of such equipment in the United States and Canada does not require strict government disclosures and technical inspections. The Company obtains local business permits to store in our main warehouses, obtain licenses to resell, and follows guidelines on packaging. Certain utility companies in the U.S. have programs that award rebates to heavy usage customers, some of which are in the indoor farming business. These customers are required to install LED lights with a minimum 50,000 hours life. There is also a performance requirement set by DesignLights Consortium, a non-profit energy improvement agency.

 

Sourcing 

 

The Company has long-term relationships with suppliers in Asia. Our top three suppliers of LED equipment are American Agricultural Innovation Technology Inc., Solislike-Tech Co., Ltd., Dongguan ZSC Lighting Co., Ltd. Each supplier provides us net 30 to net 90-day terms. The Company has also been approached by established lighting companies based in Japan and Germany. On grow feed, fertilizers and nutrients, our potential suppliers are based in Europe and some in Asia. Our grow container product was jointly developed and manufactured by a company based in Shenzhen, China.

 

On April 24, 2023, we entered into a strategic cooperation agreement with Sinoinnovo Technology (Guangdong) Co., Ltd. (“Sinoinnovo”), a company incorporated under the laws of China, pursuant to which Nature’s Miracle will source from Sinoinnovo its grow light systems for distribution in the U.S. and Europe. Both companies will also cooperate jointly to set up advanced manufacturing capabilities in China and the U.S.

 

 On October 28, 2025 we entered into a licensing agreement with Datavault AI (Nasdaq: DVLT), a leader in patented data tokenization and monetization. This agreement calls for Nature’s Miracle to license Datavault AI’s Carbon Credit Tokenization System.

 

Asset acquisition of Zak Properties, LLC

 

On September 18, 2025, the Company entered into a Membership Interest Purchase Agreement (the “Purchase Agreement”) with Big Lake Capital LLC (“Big Lake”), pursuant to which, the Company agreed to purchase from Big Lake all of the membership interests of Zak Properties, LLC, an Ohio limited liability company (“Zak Properties”), which in turn owns certain real property located in the State of Ohio, commonly known as 405 Madison Ave. with equity and debt financing. The Company’s Chief Executive Officer and Chairman, Tie (James) Li, is the sole member of Zak Properties prior to the sale. As such we recorded the acquisition of the property at cost. Nature’s Miracle issued 5,000 Series B and 9,500 Series C Preferred Shares to Big Lake and also signed a new note of $3 million.

 

We acquired Zak Properties in order to strengthen our balance sheet, generate rental income to provide us a steadier stream of cashflow, and to have the ability to obtain real estate loans to augment our capital needs.

 

42

 

 

RESULTS OF OPERATIONS

 

For the Three Months ended September 30, 2025 and 2024

 

The following table presents certain combined statement of operations information and presentation of that data as a percentage of change from year to year.

 

   For the
Three Months
Ended September 30,
       Percentage 
   2025   2024   Change   Change 
Revenues  $72,377   $3,052,727   $(2,980,350)   (97.6)%
Cost of revenues   71,951    2,824,614    (2,752,663)   (97.5)%
Gross profit   426    228,113    (227,687)   (99.8)%
Selling, general and administrative expenses   1,205,125    2,186,953    (981,828)   (44.9)%
Provision for credit losses   126,824    36,597    90,227    246.5%
Loss from operation   (1,331,523)   (1,995,437)   663,914    (33.3)%
Total other expense, net   (839,266)   (754,899)   (84,367)   11.2%
Loss before income taxes   (2,170,789)   (2,750,336)   579,547    (21.1)%
Total provision for income taxes   -    -    -    - 
Net Loss  $(2,170,789)  $(2,750,336)  $579,547    (21.1)%
Gross profit % of revenues   0.6%   7.5%          
Net Income % of revenues   (2,999.3)%   (90.1)%          

 

Revenue

 

Revenue for the three months ended September 30, 2025 decreased by 97.6% to $72,377 as compared to $3,052,727 for the three months ended September 30, 2024. Revenue declined due to cash constraints that restricted inventory purchases; as we were mainly selling our inventory on hand. The Company is seeking additional financing in fourth quarter to replenish inventory, and management expects the revenue situation to improve once inventory levels are restored.

 

For the three months ended September 30, 2025 and 2024, we had 24 and 59 customers, respectively. Average revenue per customer for the three months ended September 30, 2025 and 2024 were $3,016 and $51,741, respectively. Our revenue from top 5 customers for the three months ended September 30, 2025 was $62,179 compared to $2,303,692 for the three months ended September 30, 2024, representing a decrease of 97.3%. The lower average sale and decreased revenue from top 5 customer are reflective the impact of limited inventory availability.

 

Costs of Revenue 

 

Costs of revenue for the three months ended September 30, 2025 decreased 97.5% to $71,951 as compared to $2,824,614 for the three months ended September 30, 2024. Cost of revenue decreased primarily due to the decrease in revenue, which was in turn primarily driven by lower sales volume of our products due to limited inventory availability.

 

Gross Profit

 

Gross profit was $426 for the three months ended September 30, 2025 and $228,113 for the three months ended September 30, 2024, respectively. The gross margin for the three months ended September 30, 2025 decrease to 0.6% from 7.5% for the three months ended September 30, 2024. The decrease in gross margin was primarily driven by the sale of existing inventory, which carried lower margins.

 

43

 

 

Operating expenses

 

Operating expenses for the three months ended September 30, 2025 decreased 40.1% to $1,331,949 as compared to $2,223,550 for the three months ended September 30, 2024. The decrease was mainly due to following reasons:

 

Selling, General and Administrative Expenses 

 

Selling, general and administrative expenses for the three months ended September 30, 2025 decreased 44.9% to $1,205,125 as compared to $2,186,953 for the three months ended September 30, 2024. The decrease was mainly due to decreased Company’s stock compensation expenses of $763,929 as a result of completion of vesting periods of certain employees; decrease in professional fees of $93,082, mainly related to lower spending on public relations and SEC filing activities; and a decrease in payroll expenses of $216,283 resulting from a reduced headcount.

 

Provision for credit losses

 

Provision for credit losses for the three months ended September 30, 2025 increased 246.5% to $126,824 as compared to $36,597 for the three months ended September 30, 2024. The increase was primarily due to higher estimated credit risk associated with outstanding receivables during the period.

 

Other Expenses

 

Other expenses primarily consist of net interest expense, other finance expense related to our loans and net rental income. Other expenses for the three months ended September 30, 2025 was $839,266 as compared to other expense of $754,899 for the three months ended September 30, 2024. The increase was mainly due to the increase in non cash finance expense of $200,000, offset by the decrease in interest expenses of $179,329.

 

Interest expense for the three months ended of September 30, 2025 and 2024 were $559,140 and $738,468, respectively; decreased as a result of multiple high interest loans matured and the accrued interest decreased during three months ended of September 30, 2025. For the three months ended of September 30, 2025 and 2024, the short-term loan borrowing increase was approximately $0 and $489,970, respectively. As of September 30, 2025 and 2024, the short-term loan balances were approximately $2.6 million and $2.9 million, respectively.

 

Non-cash finance expense for the three months ended of September 30, 2025 and 2024 were $200,000 and $0, respectively. This increase is primarily due to the expensing of commitment shares to be issued under the Amended Equity Financing Agreement with GHS Investments dated July 25, 2025.

 

Rental income, net for the three months ended of September 30, 2025 and 2024 were $12,126 and $0, respectively.

 

Other income for the three months ended of September 30, 2025 was $90 and other expense for the three months ended of September 30, 2024 was $1,300, respectively.

  

Income Tax Expense

 

Our income tax expense was amounted to $0 and $0 for the three months September 30, 2025 and 2024, respectively.

 

The effective tax rate for the three months ended September 30, 2025 and 2024 were 0.0% and 0.0%. The effective tax rate differs from the federal and state statutory tax rate of 21.0% primarily due to the valuation allowance on the deferred tax assets from our operating losses.

 

Net Loss 

 

Net loss for the three months ended September 30, 2025 was $2,170,789 as compared to net loss of $2,750,336 for the three months ended September 30, 2024, representing a decrease of $579,547. The decrease was primarily due to decrease of gross profit, selling, general and administrative expenses.

 

44

 

 

For the Nine Months ended September 30, 2025 and 2024

 

The following table presents certain combined statement of operations information and presentation of that data as a percentage of change from year to year.

 

   For the
Nine Months
Ended
September 30,
       Percentage 
   2025   2024   Change   Change 
Revenues  $1,663,205   $8,662,414   $(6,999,209)   (80.8)%
Cost of revenues   1,458,521    7,669,764    (6,211,243)   (81.0)%
Gross profit   204,684    992,650    (787,966)   (79.4)%
Selling, general and administrative expenses   3,543,861    5,214,487    (1,670,626)   (32.0)%
Provision for credit losses   306,091    60,988    245,103    401.9%
Loss from operation   (3,645,268)   (4,282,825)   637,557    (14.9)%
Total other expense, net   (2,314,569)   (2,540,136)   225,567    (8.9)%
Loss before income taxes   (5,959,837)   (6,822,961)   863,124    (12.7)%
Total provision for income taxes   1,700    2,500    (800)   (32.0)%
Net Loss  $(5,961,537)  $(6,825,461)  $863,924    (12.7)%
Gross profit % of revenues   12.3%   11.5%          
Net Income % of revenues   (358.4)%   (78.8)%          

 

Revenue

 

Revenue for the nine months ended September 30, 2025 decreased 80.8% to $1,663,205 as compared to $8,662,414 for the nine months ended September 30, 2024. Revenue declined due to cash constraints that restricted inventory purchases; as we were mainly selling our inventory on hand. The Company is seeking additional financing in Q4 to replenish inventory, and management expects the revenue situation to improve once inventory levels are restored.

 

For the nine months ended September 30, 2025 and 2024, we had 68 and 114 customers, respectively. Average revenue per customer for the nine months ended September 30, 2025 and 2024 were $24,459 and $75,986, respectively. Our revenue from top 5 customers for the nine months ended September 30, 2025 was $986,685 compared to $5,443,321 for the nine months ended September 30, 2024, representing a decrease of 81.9%. The lower average sale and decreased revenue from top 5 customer are reflective the impact of limited inventory availability.

 

Costs of Revenue 

 

Costs of revenue for the nine months ended September 30, 2025 decreased 81.0% to $1,458,521 as compared to $7,669,764 for the nine months ended September 30, 2024. Cost of revenue decreased primarily due to the decrease in revenue, which was in turn primarily driven by lower sales volume of our products due to limited inventory availability.

 

Gross Profit

 

Gross profit was $204,684 for the nine months ended September 30, 2025 and $992,650 for the nine months ended September 30, 2024, respectively. The gross margin for the nine months ended September 30, 2025 increase to 12.3% from 11.5% for the nine months ended September 30, 2024. The increase in gross margin was primarily driven by higher sales of new, higher-margin products such as grow media products. Sales revenue from grow media and related products increased to $360,340 for the nine months ended September 30, 2025, compared to $192,221for the same period in 2024.

 

Operating expenses

 

Operating expenses for the nine months ended September 30, 2025 decreased 27.0% to $3,849,952 as compared to $5,275,475 for the nine months ended September 30, 2024. The decrease was mainly due to following reasons:

 

Selling, General and Administrative Expenses 

 

Selling, general and administrative expenses for the nine months ended September 30, 2025 decreased 32.0% to $3,543,861 as compared to $5,214,487 for the nine months ended September 30, 2024. The decrease was mainly due to decrease Company’s stock compensation expenses of $988,239 as a result of completion of vesting periods of certain employees; decrease in professional fees of $265,016, mainly related to lower spending on public relations and SEC filing activities; and a decrease in payroll expenses of $520,682 resulting from a reduced headcount.

 

45

 

 

Provision for credit losses

 

Provision for credit losses for the nine months ended September 30, 2025 increased 401.9% to $306,091 as compared to $60,988 for the nine months ended September 30, 2024. The increase was primarily due to higher estimated credit risk associated with outstanding receivables during the period.

 

Other Expenses

 

Other expenses primarily consist of net interest expense, other finance expense related to our loans and net rental income. Other expenses for the nine months ended September 30, 2025 was $2,314,569 as compared to other expense of $2,540,136 for the nine months ended September 30, 2024. The decrease was mainly due to the decrease in non cash finance expense of $800,000, offset by the increase of interest expenses of $535,040.

 

Interest expense for the nine months ended of September 30, 2025 and 2024 were $2,062,483 and $1,527,443, respectively; increased as a result of multiple convertible notes and high interest loans in 2025. The convertible notes and convertible notes – related party borrowing increased was approximately $1,993,300 and $797,500, respectively. As of September 30, 2025 and 2024, the short-term loan balances were approximately $2.6 million and $2.9 million, respectively. For the nine months ended September 30, 2024, 66.0% of the loans were from third-party lenders with interest rates ranging from 8.0% to 12.0%, while the remaining loans were receivables factoring loans with significantly higher interest rates ranging from 66.4% to 100.0%. In contrast, for the nine months ended September 30, 2025, 36.0% of the loans were from third-party lenders at 8.0% to 22.6%, with the remainder consisting of receivables factoring loans bearing interest rates between 84.0% and 97.0%. The increase in higher-rate factoring loans in the current year and the increase in overall loan balances contributed to the rise in interest expense.  

 

Non-cash finance expense for the nine months ended of September 30, 2025 and 2024 were $200,000 and $1,000,000, respectively. This decrease is primarily due to the expensing of 3,334 shares of common stock issued under a Letter Agreement dated November 15, 2023, in connection with the merger. These shares, valued at approximately $1.0 million, were issued to Tie (James) Li and Zhiyi Zhang for their guarantees related to the repayment of the Newtek Loan, which had a principal amount of $3,700,000. The value of the shares was expensed as non-cash finance expenses upon the completion of the merger in 2024.

 

Rental income, net for the nine months ended of September 30, 2025 and 2024 were $12,126 and $0, respectively.

 

Other expense for the nine months ended of September 30, 2025 was $11,870 and other income for the nine months ended of September 30, 2024 was $2,438.

 

Income Tax Expense

 

Our income tax expense was amounted to $1,700 and $2,500 for the nine months September 30, 2025 and 2024, respectively.

 

The effective tax rate for the nine months ended September 30, 2025 and 2024 were 0.0% and 0.0%. The effective tax rate differs from the federal and state statutory tax rate of 21.0% primarily due to the valuation allowance on the deferred tax assets from our operating losses.

 

Net Loss 

 

Net loss for the nine months ended September 30, 2025 was $5,961,537 as compared to net loss of $6,825,461 for the nine months ended September 30, 2024, representing a decrease of $863,924. The decrease was primarily due to decrease of selling, general and administrative expenses.

 

46

 

 

LIQUIDITY AND CAPITAL RESOURCES

 

Sources of Liquidity

 

In assessing liquidity, we monitor and analyze cash on-hand and operating expenditure commitments. Our liquidity needs are to meet working capital requirements and operating expense obligations. To date, we financed our operations primarily through debt financing from financial institution and related parties. As of September 30, 2025, we had $61,450 in cash which primarily consists of bank deposits, which are unrestricted as to withdrawal and use. Our working capital deficit was approximately $19.0 million as of September 30, 2025. 

 

We have experienced recurring losses from operations and negative cash flows from operating activities since 2022. For the three months ended September 30, 2025 and 2024, and for the nine months ended September 30, 2025 and 2024 we incurred substantial losses as shown in the financial statement section. Our actual revenue for the three months ended September 30, 2025 and 2024 was approximately $72,377 and $3.1 million, respectively. Our actual revenue for the nine months ended September 30, 2025 and 2024 was approximately $1.7 million and $8.7 million, respectively. Such volume and relatively low gross profit margins are not enough to support high administrative costs relating to our going public and expenses as a public company. We have raised equity capital twice in 2024 but utilized most proceeds towards repayment of debt incurred in the going-public merger, higher corporate costs and paying interest and principal on short-term loans. Due to the negative cash flow, our financial position is under pressure, and may potentially continue to have, an ongoing need to raise additional cash from outside sources to fund our expansion plan and related operations. Successful transition to attaining profitable operations is dependent upon achieving a level of revenues adequate to support our cost structure. In connection with our assessment of going concern considerations in accordance with Financial Accounting Standard Board’s Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that these conditions raise substantial doubt about our ability to continue as a going concern within one year after the date that these unaudited condensed consolidated financial statements are issued. If we are unable to realize our assets within the normal operating cycle of a twelve (12) month period, we may have to consider supplementing our available sources of funds through the following sources:

 

  financial support from our related parties and shareholders;

 

  other available sources of financing from banks and other financial institutions;

 

  equity financing through capital market

 

We have a $20 million equity financing program (“ELOC”) with GHS Investment and this was declared effective by SEC. The Company can draw on this facility for its working capital needs and others.

 

We have access to investors who are providing convertible note financing for public companies and we have been utilizing the convertible note for part of our financing needs.

 

Our shareholder also offers support for the Company. Big Lake Capital, LLC, a related party controlled by Tie Li (our Chairman and CEO) entered into a $2 million Convertible Promissory Note on April 11, 2025 with the initial tranche of $600,000. We have borrowed $652,800 for the nine months ended September 30, 2025 under this note and may borrow up to an additional amount of $1,347,200 under the note.

 

We have entered into a securities purchase agreement for $2 million with Y.K. Capital Management, Inc. on September 19, 2025. We have received an initial payment of $500,000 for the issuance of preferred shares and the remaining proceeds of $1.5 million are expected to be collected subsequent to the period end.

 

On October 20, 2025, we received an investment of $250,000 from Huanfu Cui, an Asian-based individual investor, which was followed with another $200,000 tranche on October 31, 2025. The investments are based on the Securities Purchase Agreement signed on October 29, 2025. This agreement calls for a total investment of $500,000, issuance of Series F Preferred shares which are convertible into common shares at a fixed price of $0.2813. If fully funded and converted, the Preferred Shares would be the equivalent of 1,777,778 common shares.

 

We can make no assurances that required financings will be available for the amounts needed, or on terms commercially acceptable to us, if at all. If one or all of these events does not occur or subsequent capital raises are insufficient to bridge financial and liquidity shortfall, there would likely be a material adverse effect on us and would materially adversely affect our ability to continue as a going concern.

 

The unaudited condensed consolidated financial statements have been prepared assuming that we will continue as a going concern and, accordingly, do not include any adjustments that might result from the outcome of this uncertainty.

 

47

 

 

Cash Flows

 

The following tables set forth our selected consolidated cash flow data for the periods indicated:

 

   For the Nine Months
Ended
September 30,
 
   2025   2024 
   US$   US$ 
Net cash used in operating activities   (1,805,482)   (3,170,717)
Net cash used in investing activities   (863,359)   (40,000)
Net cash provided by financing activities   2,309,845    3,029,142 
Effect of exchange rate changes   315    (71)
Net change in cash   (358,681)   (181,646)
Cash and cash equivalents, at the beginning of period   420,131    221,760 
Cash and cash equivalents, at the end of period   61,450    40,114 

  

Operating Activities

 

Net cash used in operating activities was approximately $1.8 million for the nine months ended September 30, 2025, which was mainly due to our net loss of approximately $6.0 million with non-cash items, including depreciation expense, provision for credit losses, amortization of debt issuance cost, stock compensation expense, non cash finance expense and amortization of operating right-of-use asset of approximately $1.4 million. Our cash outflow is mainly due to decrease in accounts payable of approximately $1.2 million due to decrease in our purchase from vendor. Our cash outflow is offset by cash inflow of approximately $1.1 million of inventory due to sold more on hand inventory, increase from other payable and accrued liabilities of approximately $1.9 million mainly consists of accrued professional fees and accrued interest on short term loans, long term loans and convertible notes. Additionally, approximately $0.8 million decreased in accounts receivable as our sales decreased.

 

Net cash used in operating activities was approximately $3.2 million for the nine months ended September 30, 2024, which was mainly due to our net loss of approximately $4.0 million after adjustment of non-cash items and increased accounts receivable of approximately $2.7 million due to increased revenue offset by cash inflow of approximately $1.3 million increased from accounts payable as we increased our purchase from vendors and approximately $1.7 million decreased in inventory as we used more on hand inventory.

 

Investing Activities

 

For the nine months ended September 30, 2025, net cash used in investing activities amount to approximately $900,000 which was primarily for deposit from investment of Future Tech of $721,000 and deposit from licensing fee of Datavault AI of $200,000.

 

For the nine months ended September 30, 2024, net cash used in investing activities amount to approximately $40,000 which was primarily for loan to Lakeshore of $40,000 prior to the Merger, offset by net proceed from reverse recapitalization of $197.

 

Financing Activities

 

Net cash provided by financing activities was approximately $2.3 million for the nine months ended September 30, 2025. The increase in net cash provided was primarily a result of proceeds from issuance of Series A and D preferred stock of approximately $0.7 million, net proceeds from exercise of warrants of approximately $0.9 million, net proceeds from short-term loan from third parties of approximately $0.4 million, net proceeds from convertible notes borrowing of approximately $2.0 million offset by repayments on short-term loan from third parties of approximately $0.8 million, repayments on convertible notes of approximately $0.7 million, repayments on short-term loan from related parties of approximately $0.2 million.

 

Net cash provided by financing activities was approximately $3.0 million for the nine months ended September 30, 2024. The main reason for the increase in net cash provided was primarily a result of net proceeds from short-term loan from third parties of $3.0 million, shares and warrants issued through July public offering of approximately $1.0 million, and convertible notes borrowing of approximately $0.8 million, offset by payments of deferred offering costs of approximately $0.3 million, repayments on long term loans which are mainly our car and mortgage loan of approximately $0.2 million, repayments on short-term loan from third parties of approximately $1.1 million, repayments on convertible notes of approximately $0.2 million.

 

Non-cash transactions

 

Non-cash transactions primarily consisted of asset acquisition via preferred stock issuance of approximately $9.8 million and asset acquisition via convertible note issuance of $3.0 million pursuant to the asset acquisition of Zak Properties, LLC, with preferred stock and a convertible note issued as consideration for the membership interests.

 

OFF-BALANCE SHEET ARRANGEMENTS

 

We do not have any off-balance sheet arrangements (as that term is defined in Item 303 of Regulation S-K) that are reasonably likely to have a current or future material effect on our financial condition, revenue or expenses, results of operations, liquidity, capital expenditures or capital resources.

 

48

 

 

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

 

We prepare our unaudited condensed consolidated financial statements in accordance with accounting principles generally accepted in the United States, or GAAP and pursuant to the rules and regulations of the Securities Exchange Commission (“SEC”). The preparation of unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Actual results could differ from those estimates. In some cases, changes in the accounting estimates are reasonably likely to occur from period to period. Accordingly, actual results could differ materially from our estimates. To the extent that there are material differences between these estimates and actual results, our financial condition and results of operations will be affected. We base our estimates on experience and other assumptions that we believe are reasonable under the circumstances, and we evaluate these estimates on an ongoing basis. We refer to accounting estimates of this type as critical accounting policies, which we discuss further below. While our significant accounting policies are more fully described in Note 3 to our unaudited condensed consolidated financial statements, we believe that the following accounting policies are critical to the process of making significant judgments and estimates in the preparation of our unaudited condensed consolidated financial statements.

 

Revenue recognition

 

We follow Accounting Standards Codification (“ASC”) 606 Revenue Recognition and recognizes revenue from product sales revenues, net of promotional discounts and return allowances, when the following revenue recognition criteria are met: a contract has been identified, separate performance obligations are identified, the transaction price is determined, the transaction price is allocated to separate performance obligations and revenue is recognized upon satisfying each performance obligation. 

 

We are a growing agriculture technology company providing CEA hardware products to growers in the controlled environment agriculture industry setting in North America.  Majority of our products were grow lights and related products for the indoor growing settings. Starting from first quarter of 2024, we also provide indoor grow containers to our customers.

 

Our contracts with customers where the amounts charged per product is fixed and determinable, the specific terms of the contracts were agreed on by us including payment terms which are typically 30 to 60 days for existing customers and prepaid for most new customers. In certain contracts involving sales to customers that entered into rebate programs who can get rebates with utility companies with utility companies for using LED lighting, payment term ranges from 60 to 120 days.

 

Our performance obligation is to deliver the products to customers. For indoor grow container products, we also involved in customization of the products to suit customer’s specific needs. The provision of customization and configuration to meet certain technical specification per US market and delivery of product is considered one performance obligation as the services provided are not distinct within the context of the contract whereas the customers can only obtain benefit when the services and products are provided together. At times, we may charge customers shipping and handling for delivery of products, control of goods does not transfer to the customer before shipment, therefore shipping is not a promised service to us and is not considered a separate performance obligation. Any fee charged for shipping would be included in the transaction price for the good.

 

Transaction prices are mostly fixed. In some contracts, when determining the transaction price, we adjust consideration for the effects of the time value of money if the timing of payments provides us with a significant benefit of financing. We does not assess whether a contract has a significant financing component if the expectation at contract inception is such that the period between payment by the customers and the transfer of the promised goods or services to the licensees will be one year or less. For customers that entered into rebate programs with utility companies, transaction price may depend on level of energy saving the products achieved. We estimated the amount of consideration using either the expected value of the most likely amount depending on which method we expects to better predict the amount of consideration to which it will receive with a constraint applied such that a significant reversal of revenue is not probable.

 

We transfer the risk of loss or damage upon shipment, therefore, revenue from product sales is recognized at a point in time when control of product transfer to customer and we have no further obligation to provide services related to such product evidenced by customer signing acceptances upon receipt of goods. Return allowances, which reduce product revenue by our best estimate of expected product returns, are estimated using historical experience. 

 

49

 

 

We evaluate the criteria of ASC 606 — Revenue Recognition Principal-Agent Considerations in determining whether it is appropriate to record the gross amount of product sales and related costs, or the net amount earned as commissions. We ship the products according to shipping terms on the purchase order or sales order. Once delivery is complete, we then send an invoice to the customer according to the quantity and price of shipment.

 

We evaluate the indicators of control in accordance with ASU 2016-08: 1) We are the most visible entity to customers and assumes fulfilment risk and risks related to the acceptability of products, including addressing customer inquiries directly and handling of product returns or refunds directly if any. For grow light products, we have our own brand for marketing. For indoor grow containers products, we are also involved in the design and technical specification of the products to meet requirement in the US market. 2) We assume inventory risk either through storing the products in our own warehouses; or for drop shipments directly from vendors, we take the title from vendors through inspection and acceptance and are responsible for product damage during shipment period prior to acceptance of our customers and are also responsible for product return if the customer is not satisfied with the products. 3) We determine the resale price of the products. 4) We are the party that direct the use of the inventory and can prevent the vendor from transferring the product to a customer or to redirect the products to a different customer, after evaluating the above scenario, we consider ourselves the principal of these arrangements and records revenue on a gross basis.

 

Payments received prior to the delivery of goods to customers or picked up by the customers are recorded as contract liabilities. 

 

We periodically provide incentive offers to our customers to encourage purchases. Such offers include current discount offers, such as percentage discounts off current purchases and other similar offers.

 

Current discount offers, when accepted by our customers, are treated as a reduction to the transaction price of the related transaction. 

 

Sales discounts are recorded in the period in which the related sale is recognized. Sales return allowances are recorded upon recognizing the related sales.

 

Accounts receivable, net

 

Starting from January 1, 2023, the Company adopted ASU No.2016-13 “Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” (“ASC Topic 326”). The Company used a modified retrospective approach, and the adoption does not have an impact on our consolidated financial statements. During the ordinary course of business, the Company extends unsecured credit to its customers. Accounts receivable are stated at the amount the Company expects to collect from customers. An allowance for expected credit loss is recorded in the period in which loss is determined to be probable based on lifetime expected losses considering historical, current, and forecasted conditions. Amounts deem uncollectible are written off against the allowance after all collection efforts have ceased.

 

Inventory

 

Inventory consists of finished goods ready for sale and is stated at the lower of cost and net realizable value. We value our inventory using the weighted average costing method. We include a part of cost of goods sold any freight incurred to ship the product from our vendors to warehouses. Outbound freight costs related to shipping costs to customers are considered period costs and reflected in cost of revenue. We regularly review inventory and consider forecasts of future demand, market conditions and product obsolescence. 

 

If the estimated realizable value of the inventory is less than cost, we make provisions in order to reduce our carrying value to our estimated market value. We also review inventory for slow moving and obsolescence and records allowance for obsolescence.

 

50

 

 

Long-lived assets impairment

 

The Company reviews the impairment of its long-lived assets on an annual basis and whenever events or changes in circumstances indicate that the carrying amount of an asset or group of assets may not be fully recoverable. These events or changes in circumstances may include but are not limited to, a significant deterioration of operating results, a change in the regulatory environment, changes in business plans, or adverse changes in anticipated future cash flows. If an impairment indicator is present, the Company evaluates the recoverability by a comparison of the carrying amount of the assets to future undiscounted net cash flows expected to result from the use and eventual disposition of the assets. If the assets are determined to be impaired, the impairment recognized is the excess of the carrying amount over the fair value of the assets. Fair value is generally determined by the discounted cash flow method. The discount rate used in any estimate of discounted cash flows is the rate commensurate with a similar investment of similar risk. As of September 30, 2025 and 2024, we determined there was no impairment as we estimated disposal value of our assets (mainly two buildings) exceed carrying value.

 

Recently issued accounting pronouncements

 

In December 2023, the FASB issued Accounting Standards Update No. 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures” (“ASU 2023-09”), which modifies the rules on income tax disclosures to require entities to disclose (1) specific categories in the rate reconciliation, (2) the income or loss from continuing operations before income tax expense or benefit (separated between domestic and foreign) and (3) income tax expense or benefit from continuing operations (separated by federal, state and foreign). ASU 2023-09 also requires entities to disclose their income tax payments to international, federal, state and local jurisdictions, among other changes. The guidance is effective for annual periods beginning after December 15, 2024. Early adoption is permitted for annual financial statements that have not yet been issued or made available for issuance. ASU 2023-09 should be applied on a prospective basis, but retrospective application is permitted. We are currently evaluating the potential impact of adopting this new guidance on our consolidated financial statements and related disclosures.

 

In November 2024, the FASB issued ASU 2024-03, Income Statement–Reporting Comprehensive Income–Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses (“ASU 2024-03”), which requires the disaggregation of certain expenses in the notes of the financials, to provide enhanced transparency into the expense captions presented on the face of the income statement. ASU 2024-03 is effective for annual reporting periods beginning after December 15, 2026 and interim periods beginning after December 15, 2027 and may be applied either prospectively or retrospectively. The Company is currently evaluating the impact that ASU 2024-03 will have on its related disclosures.

 

In November 2024, the FASB issued ASU 2024-04, Debt–Debt with Conversion and Other Options (Subtopic 470-20): Induced Conversion of Convertible Debt Instruments (“ASU 2024–04”), which clarifies the requirements for determining whether certain settlements of convertible debt instruments should be accounted for as an induced conversion. ASU 2024-04 is effective for annual reporting periods beginning after December 15, 2025, and interim reporting periods within those annual reporting periods. Early adoption is permitted for all entities that have adopted the amendments in Update 2020-06, which includes the Company. Adoption can be on a prospective or retrospective basis. The Company adopted ASU 2024-04 effective January 1, 2025 on a prospective basis.

 

In July 2025, the FASB issued ASU 2025-05 Financial Instruments – Credit Losses (Subtopic 326) (“ASU 2025-05”), simplifies the Current Expected Credit Loss (CECL) model for receivables and contract assets by offering a practical expedient to use current conditions for forecasts and an accounting policy election to consider post-balance sheet collections, allowing for early adoption for financial statements not yet issued. The guidance is effective for annual reporting periods beginning after December 15, 2025, but early adoption is permitted. The Company plans to adopt the ASU prospectively for the year ended December 31, 2025.

 

Except as mentioned above, we do not believe other recently issued but not yet effective accounting standards, if currently adopted, would have a material effect on our unaudited condensed consolidated balance sheets, statements of income and comprehensive income and statements of cash flows.

 

51

 

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

As a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and in Item 10(f)(1) of Regulation S-K, we are electing scaled disclosure reporting obligations and therefore are not required to provide the information requested by this item.

 

ITEM 4. CONTROLS AND PROCEDURES.

 

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s (“SEC”) rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.

  

Evaluation of Disclosure Controls and Procedures 

 

As required by Rules 13a-15 and 15d-15 under the Exchange Act, our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of September 30, 2025. Based upon their evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures (as defined in Rules 13a-15 (e) and 15d-15 (e) under the Exchange Act) were not effective as of September 30, 2025, due solely to the material weakness in our internal control over financial reporting related to (i) a lack of effective risk assessment process; (ii) a lack of effective overall control environment; (iii) a lack of controls over monitoring; (iv) a lack of human resources within finance and accounting functions leading to lack of segregation of duties; (v) a lack of information technology control design and operating effectiveness; (vi) a lack of controls or ineffectively designed controls impacting financial reporting; (vii) an inadequate control over proper revenue recognition and purchase cutoff; and (viii) a lack of controls over income tax. We plan to continue to take remedial measures including (i) hiring more qualified accounting personnel with relevant U.S. generally accepted accounting principles (“GAAP”) and SEC reporting experience and qualifications to strengthen the financial reporting function and to set up a financial and system control framework; (ii) implementing regular and continuous GAAP accounting and financial reporting training programs for our accounting and financial reporting personnel; (iii) engaging an external consulting firm to assist us with assessment of Sarbanes-Oxley compliance requirements and improvement of overall internal control; and (iv) appointing independent directors, and strengthening corporate governance.

 

We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

  

Changes in Internal Control Over Financial Reporting

 

There were no changes in our internal control over financial reporting that occurred during our most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

52

 

 

PART II. OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

From time to time, claims are made against us in the ordinary course of business, which could result in litigation. Claims and associated litigation are subject to inherent uncertainties and unfavorable outcomes could occur, such as monetary damages, fines, penalties or injunctions prohibiting us from selling one or more products or engaging in other activities. There were no reportable litigation events and there have been no material developments to litigation events previously disclosed in our SEC filings during the quarter ended September 30, 2025.

 

ITEM 1A. RISK FACTORS

 

As a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934, as amended, and in item 10(f)(1) of Regulation S-K, we are electing scaled disclosure reporting obligations and therefore are not required to provide the information requested by this item. In any event, there have been no material changes in our risk factors as previously disclosed in our final prospectus, dated July 15, 2025, filed with the SEC on July 17, 2025.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

(A) Unregistered Sales of Equity Securities

 

On July 24, 2025, the Company entered into debt-to-equity conversion agreements (the “Agreements”) with Tie (James) Li (“Mr. Li”), Zhiyi Zhang (“Mr. Zhiyi Zhang”), George Yutuc (“Mr. Yutuc”), and Peng Zhang (“Mr. Peng Zhang”). Pursuant to the Agreements, wages and salaries owed and unpaid to Mr. Li, Mr. Zhiyi Zhang, and Mr. Yutuc were converted into shares of common stock of the Company based on the trading price of $0.1305, the price at the end of the signing date of the Agreements. Pursuant to the Agreement with Mr. Li, the parties agreed that his unpaid wages and salaries through July 23, 2025, or $673,476, be converted into 5,160,739 shares of common stock of the Company. Pursuant to the Agreement with Mr. Zhiyi Zhang, the parties agreed that his unpaid wages and salaries through July 23, 2025, or $406,691, be converted into 3,111,408 shares of common stock of the Company. Pursuant to the Agreement with Mr. Yutuc, the parties agreed that 50% of his wages and salaries from February 2025 to June 30, 2025, or $52,083, be converted into 399,106 shares of common stock of the Company. Mr. Li is the Company’s chief executive officer, Mr. Zhang is the Company’s president, and Mr. Yutuc is the Company’s chief financial officer. Pursuant to the Agreement with Mr. Peng Zhang, debt owed on a note issued to Mr. Peng Zhang by the Company in an outstanding amount of $560,000 was converted into 4,291,188 shares of common stock of the Company based on the trading price of $0.1305, the price at the end of the signing date of the Agreement.

 

On August 5, 2025, the Company entered into a securities purchase agreement (the “SPA”) with Firstfire Global Opportunities Fund, LLC, a Delaware limited liability company (“FirstFire”), pursuant to which the Company sold, and FirstFire purchased, (i) a convertible promissory note in the principal amount of $172,500 (the “Note”), and (ii) 200,000 shares of Class A common stock, par value $0.0001, of the Company (the “Commitment Shares”), for an aggregate purchase price of $150,000 (the “Transaction”). The Note matures 12 months following the issue date, accrues interest of 10% per annum (with the first 12 months of interest guaranteed and earned in full as of issuance of the Note), and is unsecured. The Note is convertible into shares of the Company’s common stock at the election of the holder at a conversion price equal to 75% of the lowest traded price during the 10 trading days prior to the conversion date, subject to adjustment as set forth in the Note, including upon the Company failing to make amortization payments or upon an event of default; provided, however, that the holder may not convert the Note to the extent that such conversion would result in the holder’s beneficial ownership of the Company’s common stock being in excess of 4.99% of the Company’s issued and outstanding common stock.

 

On September 18, 2025, the Company entered into a Membership Interest Purchase Agreement (the “Purchase Agreement”) with Big Lake Capital LLC (“Big Lake”), pursuant to which, the Company agreed to purchase from Big Lake all of the membership interests of Zak Properties, LLC, an Ohio limited liability company (“Zak Properties”), which in turn owns certain real property located in the State of Ohio, commonly known as 405 Madison Ave. The Company’s Chief Executive Officer and Chairman, Tie (James) Li, is the sole member of Zak Properties prior to the sale. The purchase price for Zak Properties (the “Purchase Price”) was $17,500,000, and was paid by the Company as follows: (i) on October 16, 2025, the Company issued 5,000 shares of Series B Preferred Stock (valued at $5,000,000) of the Company which (a) can be converted into Common Stock, par value $0.0001 per share, of the Company (“Common Stock”) at $0.1180 per share and (b) have certain voting rights equal to twenty (20) votes per one (1) share of Series B Preferred Stock; (ii) on October 16, 2025, the Company issued 9,500 shares of Series C Preferred Stock (valued at $9,500,000) of the Company which are convertible into shares of Common Stock at $0.1180 per share; and (iii) on September 18, 2025, the Company issued a convertible promissory note (the “Note”) in the principal amount of $3,000,000 in favor of Big Lake with a term of two years from the date of issuance and interest in the amount of 10% per annum.

 

53

 

 

On September 19, 2025, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with Y. K. Capital Management, Inc. (the “Series D Investor”), whereby the Series D Investor agreed to purchase 2,000 shares of Series D preferred stock, $0.0001 par value per share (the “Series D Shares”), at a purchase price of $1,000 per Series D Share. On the initial closing date of October 16, 2025, the Series D Investor purchased five hundred (500) Series D Shares for a purchase price of $500,000. The second closing will be for the purchase of five hundred (500) Series D Shares for the aggregate purchase price of $500,000 before October 30, 2025 and the third and final closing will be for the purchase of one thousand (1,000) Series D Shares for the aggregate purchase price of $1,000,000 prior to the Company’s application for uplisting to the NYSE or Nasdaq. The Series D Shares have a stated value of $1,000 per share (the “Stated Value”), and shall bear dividends at the rate of 8% per annum, for so long as the Series D Shares have not been redeemed or converted. The Series D Shares are convertible into shares of Common Stock of the Company at a conversion price of $0.1180 as set forth in in the Certificate of Designations previously filed with the State of Delaware.

 

On October 10, 2025, the Company entered into a Securities Purchase Agreement (the “SPA”) with GHS Investments, LLC, a Nevada limited liability company (the “Series A Investor”) (the “Investor”), whereby the Investor agreed to purchase 50 shares of the Company’s existing Series A preferred stock, $0.0001 par value per share (the “Series A Shares”), in consideration of the Series A Investor’s consent for the Company to enter into previously disclosed transactions including: (A) creating the Series B Convertible Preferred Stock, Series C Convertible Preferred Stock and Series D Convertible Preferred Stock, (B) issuing 5,000 shares of the Series B Stock (which contain 20-1 super voting rights), 9,500 shares of the Series C Stock in a transaction pursuant to which the Company will acquire certain assets owned by James Li, the Company’s Chief Executive Officer, and (C) issuing a promissory note in favor of an affiliate of James Li in the aggregate principal amount of $3,000,000. The Series A Shares were issued on October 16, 2025 and have a stated value of $1,200 per share (the “Stated Value”), and bear dividends at the rate of 12% per annum, for so long as the Series A Shares have not been redeemed or converted. The Series A Shares are convertible into shares of Common Stock of the Company at a conversion price of $0.112.

 

In connection with the foregoing, the Company relied on the exemption from the registration requirements provided by Section 4(a)(2) of the Securities Act and/or Regulation D promulgated thereunder. No underwriters were used in the transactions above.

 

(B) Use of Proceeds

 

Not applicable.

 

(C) Issuer Purchases of Equity Securities

 

None.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not Applicable. 

 

ITEM 5. OTHER INFORMATION

 

NONE.

 

54

 

 

ITEM 6. EXHIBITS

 

EXHIBIT INDEX

 

Exhibit No.   Description
3.1   Certificate of Designation for the Series B Preferred Stock (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed with the Securities & Exchange Commission on October 7, 2025)
3.2   Amendment No. 1 to Certificate of Designation for the Series B Preferred Stock (incorporated by reference to Exhibit 3.2 to Company’s Current Report on Form 8-K filed with the Securities & Exchange Commission on October 7, 2025)
3.3   Certificate of Designation for the Series C Preferred Stock (incorporated by reference to Exhibit 3.3 to the Company’s Current Report on Form 8-K filed with the Securities & Exchange Commission on October 7, 2025)
3.4   Certificate of Designation for the Series B Preferred Stock (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed with the Securities & Exchange Commission on October 7, 2025)
3.5   Amendment No. 1 Certificate of Designation for the Series A Preferred Stock (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed with the Securities & Exchange Commission on October 10, 2025)
3.6   Certificate of Designation for the Series D Preferred Stock (incorporated by reference to Exhibit 3.2 to the Company’s Current Report on Form 8-K filed with the Securities & Exchange Commission on October 10, 2025)
3.7   Amendment No. 1 Certificate of Designation for the Series D Preferred Stock (incorporated by reference to Exhibit 3.3 to the Company’s Current Report on Form 8-K filed with the Securities & Exchange Commission on October 10, 2025)
10.1   Form of Debt to Equity Conversion Agreement, dated July 24, 2025 (incorporated by reference to Exhibit 10.1 to Company’s Current Report on Form 8-K filed with the Securities & Exchange Commission on July 28, 2025 (Accession No. 0001213900-25-068271))
10.2   Debt Equity Conversion Agreement, by and between the Company and the noteholder, date July 24, 2025 (incorporated by reference to Exhibit 10.2 to Company’s Current Report on Form 8-K filed with the Securities & Exchange Commission on July 28, 2025 (Accession No. 0001213900-25-068271))
10.3   Amended Equity Financing Agreement dated July 25, 2025 (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the Securities & Exchange Commission on July 28, 2025 (Accession No. 0001213900-25-068249))
10.4   Membership Interest Purchase Agreement dated September 18, 2025 (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the Securities & Exchange Commission on October 7, 2025)
10.5   Securities Purchase Agreement dated September 19, 2025 (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the Securities & Exchange Commission on October 10, 2025)
10.6   Securities Purchase Agreement dated October 10, 2025 (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed with the Securities & Exchange Commission on October 10, 2025)
31.1**   Certification of Chief Executive Officer pursuant to Exchange Act Rules 13a-14 and Rule 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2**   Certification of Chief Financial Officer pursuant to Exchange Act Rules 13a-14 and Rule 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1**   Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101   Interactive Data Files
101.INS   Inline XBRL Instance Document
101.SCH   Inline XBRL Taxonomy Extension Schema Document
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

 

  ** Filed herewith.

 

  ** Exhibits 32.1 and 32.2 are being furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section, nor shall such exhibits be deemed to be incorporated by reference in any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise specifically stated in such filing.

 

55

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  NATURE’S MIRACLE HOLDING INC.
   
Dated: November 14, 2025 /s/ Tie (James) Li
  Tie (James) Li
  Chief Executive Officer
(Principal Executive Officer)
   
Dated: November 14, 2025 /s/ George Yutuc
  George Yutuc
  Chief Financial Officer
(Principal Financial and Accounting Officer)

 

56

 

NONE NONE On October 23, 2023, the Merchants entered into a standard merchant cash advance agreement with Factor H. The Company sold $768,500 of its accounts receivable balances on a recourse basis for credit approved accounts. The net purchase price of $503,500 was remitted to the Company, after the deduction of the total fees of $26,500. The Company agreed to pay a weekly installment of $22,814.84 for 32 weeks with a final extra payment of $38,500. The effective interest rate of this agreement was 85.36%. For the three and nine months ended September 30, 2024, the Company paid $181,950 and $409,443 principal of the loan. On May 2, 2024, the Merchants entered into another standard merchant cash advance agreement with Factor H. The Company sold $1,240,150 of its accounts receivable balances on a recourse basis for credit approved accounts. The net purchase price of $807,500 was remitted to the Company, after the deduction of the total fees of $42,500. The Company agreed to pay a weekly installment of $41,000 for 31 weeks. The effective interest rate of this agreement was 93.05%. The Company use this loan to pay off $175,314 previous loan with Factor H that dated on October 23, 2023. For the three and nine months ended September 30, 2024, the Company paid $240,656 and $310,781 principal of the loan. On November 18, 2024, the Merchants entered into another standard merchant cash advance agreement with Factor H. The Company sold $1,167,200 of its accounts receivable balances on a recourse basis for credit approved accounts. The net purchase price of $752,000 was remitted to the Company, after the deduction of the total fees of $48,000. The Company agreed to pay a weekly installment of $32,000 for 37 weeks. The effective interest rate of this agreement was 94.98%. The Company use this loan to pay off $566,150 previous loan with Factor H that dated on May 2, 2024. For the three and nine months ended September 30, 2025, the Company paid $5,000 and $38,194 principal of the loan. On December 30, 2024, the Merchants entered into a business loan and security agreement (the “Agreement”) with Maximcash Solutions LLC (the “Maxim”). Under the Agreement, the Maxim loaned $311,000 to the Company, which includes an $11,000 origination fee deducted at the time of funding. This loan carries an interest rate of 51.64% and an annual percentage rate of 59.40%. The loan matures on January 14, 2026. The Company will repay the Loan in 26 biweekly payments of $15,430, with a total repayment amount of $401,190 over a 12-month term. The loan is secured by all present and after-acquired property of the Company. As security to the loan, the Company shall issue 311,000 shares of its common stock to Maximin in the event of a loan default. For the three and nine months ended September 30, 2025, the Company paid $47,617 and $175,752 principal of the loan. On July 8, 2025, Maxim filed a complaint against the Company in the Third Judicial Court of Utah pertaining to the loan agreement dated December 30, 2024 as a result of a failure to make the required repayment pursuant to the loan agreement. The claimed amount was $230,738 plus daily interest and attorney fees resulting in a $30,089 loss on debt settlement. On August 6, 2025, the Company entered into a Standstill Agreement with Maxim, which expired on October 6, 2025 to further negotiate the term of the loan. On August 7, the Company wired an interest payment of $61,720 to Maxim as agreed in the Standstill Agreement. On August 29, 2024, the Merchants entered into a standard merchant cash advance agreement with Factor I. The Company sold $213,000 of its accounts receivable balances on a recourse basis for credit approved accounts. The net purchase price of $142,500 was remitted to the Company, after the deduction of the total fees of $7,500. The Company agreed to pay a weekly installment of $8,192 for 26 weeks. The effective interest rate of this agreement was 84.22%. For the three and nine months ended September 30, 2024, the Company paid $15,015 and $15,015 principal of the loan. On December 12, 2024, the Merchants entered into another standard merchant cash advance agreement with Factor I. The Company sold $319,500 of its accounts receivable balances on a recourse basis for credit approved accounts. The net purchase price of $213,750 was remitted to the Company, after the deduction of the total fees of $11,250. The Company agreed to pay a weekly installment of $13,313 for 24 weeks. The effective interest rate of this agreement was 84.03%. The Company use this loan to pay off $90,116 previous loan with Factor I that dated on August 29, 2024. For the three and nine months ended September 30, 2025, the Company paid $0 and $79,287 principal of the loan. On July 31, 2025, Factor I filed a settlement agreement for Stay of Prosecution in the Seventeenth Judicial Court in Broward County, Florida, pursuant to which both parties agreed to pay a weekly installment of $10,000 for 18 weeks commencing on August 5, 2025 to December 2, 2025, followed by a final installment of $6,572 on December 9, 2025. The Company used this settlement agreement to pay off a $163,063 previous loan with Factor I dated on December 12, 2024, resulting in a $23,509 loss on debt settlement. For the three and nine months ended September 30, 2025, the Company paid $20,000 and $20,000 principal of the loan. The loan was paid off in October 2025. On September 27, 2024, the Merchants entered into a standard merchant cash advance agreement with Factor J. The Company sold $72,500 of its accounts receivable balances on a recourse basis for credit approved accounts. The net purchase price of $47,470 was remitted to the Company, after the deduction of the total fees of $2,530. The Company agreed to pay a weekly installment of $3,021 for 24 weeks. The effective interest rate of this agreement was 88.98%. For the three and nine months ended September 30, 2025, the Company paid $0 and $28,838 principal of the loan. On February 11, 2025, the Merchants entered into another standard merchant cash advance agreement with Factor J. The Company sold $94,250 of its accounts receivable balances on a recourse basis for credit approved accounts. The net purchase price $61,070 was remitted to the company, after the deduction of the total fees $3,930. The Company agreed to pay a weekly installment of $6,732 for 14 weeks. The effective interest rate of this agreement was 89.54%. The Company use this loan to pay off $18,125 previous loan with Factor J that dated on February 10, 2025. For the three and nine months ended September 30, 2025, the Company paid $2,368 and $22,815 principal of the loan. On September 30, 2024, the Merchants entered into a standard merchant cash advance agreement with Factor K. The Company sold $181,250 of its accounts receivable balances on a recourse basis for credit approved accounts. The net purchase price of $115,955 was remitted to the Company, after the deduction of the total fees of $9,045. The Company agreed to pay a weekly installment of $7,552 for 24 weeks. The effective interest rate of this agreement was 94.36%. For the three and nine months ended September 30, 2025, the Company paid $0 and $66,404 principal of the loan. On February 11, 2025, the Merchants entered into another standard merchant cash advance agreement with Factor K. The company sold $147,000 of its accounts receivable balances on a recourse basis for credit approved accounts. The net purchase price $92,605 was remitted to the company, after the deduction of the total fees $7,395. The Company agreed to pay a weekly installment of $10,500 for 14 weeks. The effective interest rate of this agreement was 96.04%. The Company use this loan to pay off $37,760 previous loan with Factor K that dated on September 30, 2024. For the three and nine months ended September 30, 2025, the Company paid $0 and $23,785 principal of the loan. On July 16, 2025, Factor K filed a complaint in Court in Monroe County, New York referring to an outstanding balance of $100,588 after payments of $46,551 on its loan agreement with the Company, dated February 11, 2025. The total claimed amount is $129,463 plus interest from June 30, 2025 and attorney fees. On July 22, 2025, Factor K and the Company entered into a Stipulation of Settlement Agreement pursuant to which each party agreed to a settlement amount and remittance schedule that commencing on July 23, 2025 through November 11, 2025. The Company used this settlement agreement to pay off a $95,500 previous loan with Factor K dated on December 12, 2024, resulting in a $33,963 loss on debt settlement. For the three and nine months ended September 30, 2025, the Company paid $73,800 and $73,800 principal of the loan. The loan was paid off in October 2025. On February 7, 2025, the Merchants entered into a standard merchant cash advance agreement with Wave advance Inc (the “Factor L”). The Company sold $183,750 of its accounts receivable balances on a recourse basis for credit approved accounts. The net purchase price of $107,500 was remitted to the Company, after the deduction of the total fees of $8,750. The Company agreed to pay a weekly installment of $13,125 for 14 weeks. The effective interest rate of this agreement was 113.58%. For the three and nine months ended September 30, 2025, the Company paid $0 and $116,250 principal of the loan. On February 25, 2025, the Merchant entered into another standard merchant cash advance agreement with Factor L. The Company sold $280,770 of its accounts receivable balance on a recourse basis for credit approved accounts. The net purchase price $177,630 was remitted to the company, after the deduction of the total fees of $13,370. The Company agreed to pay a weekly installment of $17,550 for 16 weeks. The effective interest rate of this agreement was 95.63%. The Company use this loan to pay off $157,500 previous loan with Factor L that dated on February 7, 2025 resulting in $20,000 of gain on debt settlement. For the three and nine months ended September 30, 2025, the Company paid $0 and $39,067 principal of the loan. On August 1, 2025, the Company and Factor L signed a settlement agreement that required payments from August 5 to October 27, 2025, for an aggregate amount of $201,170. The Company agreed to pay a weekly installment of $18,000 for 11 weeks from August 5, 2025 to October 20, 2025, followed by a final installment of $3,170 on October 27, 2025. The Company use this settlement agreement to pay off a $198,670 previous loan with Factor I dated on February 25, 2025, resulting in a $2,500 loss on debt settlement. For the three and nine months ended September 30, 2025, the Company paid $52,000 and $52,000 principal of the loan. These receivable purchase agreements were accounted for as secured borrowing under ASC 860 since there is no legal, actual, effective transfer of the receivables to the Factors. Rather, the Factors only have generally claim against the receivable pools not a particular receivable. As of September 30, 2025 and December 31, 2024, outstanding balance amounted to $1,056,639 and $988,336, respectively. On February 10, March 28, June 5, June 27, September 22, December 22, 2023 and February 20, 2024, Lakeshore entered into seven promissory notes with RedOne to which Lakeshore borrowed an aggregate principal amount of $380,000 with zero interest rate. On July 11, 2023, Lakeshore entered into a loan agreement with Deyin Chen (Bill) to which Lakeshore borrowed a principal amount of $125,000 with an annual interest rate of 8%. This loan was extended to March 11, 2024 with interest waived pursuant to a Side Letter to the loan agreements dated December 8, 2023. A payment of $75,000 was made upon close of the Merger on March 11, 2024 and the loan balance of $50,000 owed to Deyin Chen (Bill) was assigned to RedOne and the Company assumed the outstanding balance. The loan bears interest of 8% per annum. $50,000 was paid on July 29, 2024 and $150,000 was paid on November 11, 2024. The balance of $230,000, originally due by December 11, 2024, was revised to be paid in two equal installments: the first installment of $115,000 no later than March 31, 2025, and the second installment of $115,000 no later than June 30, 2025. Both installments were extended to July 15, 2025, subsequently extended to September 10, 2025. On June 6, 2024, the Merchants entered into a subordinated business loan and security agreement with Agile Capital Funding, LLC and Agile Lending, LLC for the principal amount of $288,750, including the administrative agent fee of $13,750. The Company agreed to pay a weekly installment of $15,056 for 28 weeks. The effective interest rate of this agreement was 90.22%. The collateral consists of the Company’s right, title and interest in and to including the Company’s financial assets, goods, accounts, equipment, inventory, contract rights or rights to payment of money. The Company received the net proceeds on June 7, 2024. For the three and nine months ended September 30, 2024, the Company paid $255,808 and $275,000 principal of the loan. On September 25, 2024, the Merchants entered into another subordinated business loan and security agreement with Agile Capital Funding, LLC and Agile Lending, LLC for the principal amount of $315,000, including the administrative agent fee of $15,000. The Company agreed to pay a weekly installment of $16,425 for 28 weeks. The effective interest rate of this agreement was 90.22%. The Company use this loan to pay off $195,806 previous loan with Agile Capital Funding, LLC and Agile Lending, LLC that dated on June 6, 2024. For the three and nine months ended September 30, 2024, the Company paid $0 and $0 principal of the loan. On November 21, 2024, the Merchants entered into another subordinated business loan and security agreement with Agile Capital Funding, LLC and Agile Lending, LLC for the principal amount of $575,000, including the administrative agent fee of $28,750. The Company agreed to pay a weekly installment of $29,982 for 28 weeks. The effective interest rate of this agreement was 90.80%. The Company use this loan to pay off $331,388 previous loan with Agile Capital Funding, LLC and Agile Lending, LLC dated on September 25, 2024. For the three and nine months ended September 30, 2025, the Company paid $16,880 and $93,656 principal of the loan. In December 2022, the Company signed two loans with Tie (James) Li, the Company’s CEO, for the total principal amount of $610,000 with 8% interest rate. This loan is originally required to be paid in full before June 1, 2023, the Company initially extended it to November 15, 2023. The Company made $500,000 payments towards the loan on June 16, 2023 and paid each $50,000 on July 29, 2024 and January 14, 2025. The $110,000 loan was further extended to February 15, 2024, subsequently extended to August 15, 2024 and April 15, 2025, and finally extended to October 16, 2025. The Company made $10,000 payments towards the loan on July 31, 2025 resulting in its full settlement. The loan balance as of September 30, 2025 and December 31, 2024 was $0 and $60,000, respectively. Accrued interest on this loan as of September 30, 2025 and December 31, 2024 was $1,012 and $547, respectively. On July 11, 2023, Lakeshore signed one loan with Tie (James) Li for a principal amount of $125,000 with 8% interest rate. This loan was required to be paid in full before November 11, 2023. On December 8, 2023, Lakeshore entered into a side letter to this loan agreement to extend the repayment to March 11, 2024 and agree to waive any and all interest and penalties that may have accrued commencing on November 11, 2023. This loan was subsequently extended to September 15, 2024 and April 15, 2025, and finally extended to October 16, 2025. The Company made $100,000 payments towards the loan on January 14, 2025, and $25,000 payments towards the loan on July 15 and July 25, 2025 resulting in its full settlement. The loan balance as of September 30, 2025 and December 31, 2024 was $0 and $125,000, respectively. As of September 30, 2025, accrued interest on this loan was $3,512. On January 17, 2023, the Company and NMCayman entered into a loan agreement for the principal amount of $318,270 with 8% interest rate. This loan is originally required to be paid in full before July 17, 2023, the Company initially extended it to November 15, 2023, further extended to February 15, 2024, subsequently extended to August 15, 2024 and April 15, 2025, and finally extended to October 16, 2025. On November 19, 2024, the Company entered into a debt-to-equity conversion agreement with NMCayman, under which $299,714 balance of this debt and $277,786 balance of another debt (see below) will be converted into 218,750 shares of common stock for James at a conversion price of $2.64 per share. The Company made $18,556 payments towards the loan in July 2025 resulting in its full settlement. As of September 30, 2025 and December 31, 2024, the loan balance was $0 and $18,556, respectively. As of September 30, 2025 and December 31, 2024, accrued interest on this loan was $47,042 and $46,180, respectively. On January 17, 2023, the Company and NMCayman entered into a loan agreement for the principal amount of $294,985 with 8% interest rate. This loan is originally required to be paid in full before July 17, 2023, the Company initially extended it to November 15, 2023, further extended to February 15, 2024, subsequently extended to August 15, 2024 and April 15, 2025, and finally extended to October 16, 2025. On November 19, 2024, the Company entered into a debt-to-equity conversion agreement with NMCayman, under which $277,786 balance of this debt and $299,714 balance of another debt will be converted into 218,750 shares of common stock for James at a conversion price of $2.64 per share. The Company made $17,199 payments towards the loan in July 2025 resulting in its full settlement. As of September 30, 2025 and December 31, 2024, the loan balance was $0 and $17,199, respectively. As of September 30, 2025 and December 31, 2024, the accrued interest on this loan was $43,248 and $42,449, respectively. In connection with the Merger, the Company, Lakeshore and NMI further entered into a Letter Agreement on November 15, 2023, a total of 4,168 shares of the Company’s common stock will be issued upon closing of the Merger in connection with certain transactions relating to the Merger: (i) 1,667 shares to Tie (James) Li and 1,667 shares to Zhiyi (Jonathan) Zhang (or 3,334 shares in the aggregate) in connection with their guarantees of the repayment of the Newtek Loan, which was loaned to a subsidiary of NMI with the principal amount of $3,700,000; (ii) 417 shares to Tie (James) Li and 417 shares to Deyin (Bill) Chen (or 834 shares in the aggregate) in connection with their loans to Lakeshore, each with the principal amount of $125,000 under separate but similar loan agreements); At the Close of Merger, additional shares of 533 and 833 were issued to Tie (James) Li and Prosperity Spring International Investment Management in connection with their loans to Lakeshore. The shares were valued $300 per share, of which $1.0 million (3,334 shares awarded pertaining to loan guarantee for the Newtek loan) was expensed as finance expense in the Company unaudited condensed consolidated statements of operations during the year ended December 31, 2024. $660,000 was expensed in Lakeshore’s statements of operations and carried over as retained deficit after the Merger. The shares in connection with the loans have been issued during the close of the Merger. P5Y http://fasb.org/srt/2025#ChiefExecutiveOfficerMember 0001947861 false Q3 --12-31 0001947861 2025-01-01 2025-09-30 0001947861 nmhi:CommonStockParValue00001PerShareMember 2025-01-01 2025-09-30 0001947861 nmhi:WarrantsToPurchaseCommonStockAtAnExercisePriceOf1150PerShareMember 2025-01-01 2025-09-30 0001947861 2025-11-14 0001947861 2025-09-30 0001947861 2024-12-31 0001947861 us-gaap:RelatedPartyMember 2025-09-30 0001947861 us-gaap:RelatedPartyMember 2024-12-31 0001947861 2025-07-01 2025-09-30 0001947861 2024-07-01 2024-09-30 0001947861 2024-01-01 2024-09-30 0001947861 us-gaap:PreferredStockMember 2024-12-31 0001947861 us-gaap:CommonStockMember 2024-12-31 0001947861 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001947861 us-gaap:RetainedEarningsMember 2024-12-31 0001947861 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0001947861 us-gaap:PreferredStockMember 2025-01-01 2025-03-31 0001947861 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001947861 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001947861 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001947861 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-03-31 0001947861 2025-01-01 2025-03-31 0001947861 us-gaap:PreferredStockMember 2025-03-31 0001947861 us-gaap:CommonStockMember 2025-03-31 0001947861 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001947861 us-gaap:RetainedEarningsMember 2025-03-31 0001947861 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-31 0001947861 2025-03-31 0001947861 us-gaap:PreferredStockMember 2025-04-01 2025-06-30 0001947861 us-gaap:CommonStockMember 2025-04-01 2025-06-30 0001947861 us-gaap:AdditionalPaidInCapitalMember 2025-04-01 2025-06-30 0001947861 us-gaap:RetainedEarningsMember 2025-04-01 2025-06-30 0001947861 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-04-01 2025-06-30 0001947861 2025-04-01 2025-06-30 0001947861 us-gaap:PreferredStockMember 2025-06-30 0001947861 us-gaap:CommonStockMember 2025-06-30 0001947861 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0001947861 us-gaap:RetainedEarningsMember 2025-06-30 0001947861 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-06-30 0001947861 2025-06-30 0001947861 us-gaap:PreferredStockMember 2025-07-01 2025-09-30 0001947861 us-gaap:CommonStockMember 2025-07-01 2025-09-30 0001947861 us-gaap:AdditionalPaidInCapitalMember 2025-07-01 2025-09-30 0001947861 us-gaap:RetainedEarningsMember 2025-07-01 2025-09-30 0001947861 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-07-01 2025-09-30 0001947861 us-gaap:PreferredStockMember 2025-09-30 0001947861 us-gaap:CommonStockMember 2025-09-30 0001947861 us-gaap:AdditionalPaidInCapitalMember 2025-09-30 0001947861 us-gaap:RetainedEarningsMember 2025-09-30 0001947861 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-09-30 0001947861 us-gaap:PreferredStockMember 2023-12-31 0001947861 us-gaap:CommonStockMember 2023-12-31 0001947861 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001947861 us-gaap:RetainedEarningsMember 2023-12-31 0001947861 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001947861 2023-12-31 0001947861 us-gaap:PreferredStockMember 2024-01-01 2024-03-31 0001947861 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001947861 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001947861 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001947861 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0001947861 2024-01-01 2024-03-31 0001947861 us-gaap:PreferredStockMember 2024-03-31 0001947861 us-gaap:CommonStockMember 2024-03-31 0001947861 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001947861 us-gaap:RetainedEarningsMember 2024-03-31 0001947861 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001947861 2024-03-31 0001947861 us-gaap:PreferredStockMember 2024-04-01 2024-06-30 0001947861 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0001947861 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0001947861 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0001947861 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-04-01 2024-06-30 0001947861 2024-04-01 2024-06-30 0001947861 us-gaap:PreferredStockMember 2024-06-30 0001947861 us-gaap:CommonStockMember 2024-06-30 0001947861 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001947861 us-gaap:RetainedEarningsMember 2024-06-30 0001947861 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0001947861 2024-06-30 0001947861 us-gaap:PreferredStockMember 2024-07-01 2024-09-30 0001947861 us-gaap:CommonStockMember 2024-07-01 2024-09-30 0001947861 us-gaap:AdditionalPaidInCapitalMember 2024-07-01 2024-09-30 0001947861 us-gaap:RetainedEarningsMember 2024-07-01 2024-09-30 0001947861 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-07-01 2024-09-30 0001947861 us-gaap:PreferredStockMember 2024-09-30 0001947861 us-gaap:CommonStockMember 2024-09-30 0001947861 us-gaap:AdditionalPaidInCapitalMember 2024-09-30 0001947861 us-gaap:RetainedEarningsMember 2024-09-30 0001947861 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-09-30 0001947861 2024-09-30 0001947861 nmhi:NaturesMiracleIncMember 2024-03-11 0001947861 nmhi:MergerAgreementMember 2024-03-11 0001947861 srt:DirectorMember nmhi:NaturesMiracleIncMember 2025-09-30 0001947861 nmhi:VisiontechGroupIncMember 2022-06-01 0001947861 nmhi:VisiontechGroupIncMember nmhi:StockholdersMember 2022-06-01 0001947861 nmhi:NaturesMiracleIncMember 2022-06-01 0001947861 nmhi:HydromanMember 2022-06-01 0001947861 nmhi:HydromanMember us-gaap:CommonStockMember 2022-06-01 2022-06-01 0001947861 nmhi:PhotonTechnologyCanadaLtdMember 2022-08-18 0001947861 nmhi:PhotonTechnologyCanadaLtdMember 2022-08-18 2022-08-18 0001947861 nmhi:PromissoryNoteAgreementMember nmhi:VisiontechGroupIncMember 2021-08-27 2021-08-27 0001947861 nmhi:PromissoryNoteAgreementMember nmhi:VisiontechGroupIncMember 2021-08-27 0001947861 us-gaap:CommercialLoanMember 2022-01-10 0001947861 2022-01-10 2022-01-10 0001947861 nmhi:UnsecuredPromissoryNoteMember 2021-08-27 2021-08-27 0001947861 2024-11-18 2024-11-18 0001947861 nmhi:ReverseSplitProcessMember us-gaap:CommonStockMember 2024-11-18 0001947861 nmhi:ReverseSplitProcessMember us-gaap:CommonStockMember 2024-11-18 2024-11-18 0001947861 2024-01-01 2024-12-31 0001947861 nmhi:ELOCMember 2025-09-30 0001947861 srt:ChiefExecutiveOfficerMember 2025-04-11 0001947861 nmhi:ConvertiblePromissoryNoteMember 2025-04-11 0001947861 nmhi:BigLakeCapitalLLCMember 2025-07-01 2025-09-30 0001947861 nmhi:BigLakeCapitalLLCMember 2025-01-01 2025-09-30 0001947861 nmhi:BigLakeCapitalLLCMember 2025-09-30 0001947861 nmhi:SecuritiesPurchaseAgreementMember 2025-09-19 2025-09-19 0001947861 nmhi:SecuritiesPurchaseAgreementMember 2025-01-01 2025-09-30 0001947861 nmhi:ConvertiblePromissoryNoteMember us-gaap:SubsequentEventMember 2025-10-01 2025-10-01 0001947861 us-gaap:SubsequentEventMember 2025-10-01 2025-10-01 0001947861 us-gaap:SubsequentEventMember 2025-10-01 0001947861 us-gaap:SubsequentEventMember 2025-10-20 0001947861 nmhi:HuanfuCuiMember us-gaap:SubsequentEventMember 2025-10-31 0001947861 nmhi:SeriesFPreferredSharesMember us-gaap:SubsequentEventMember 2025-10-29 0001947861 nmhi:FutureTechIncorporatedMember 2024-11-22 0001947861 nmhi:FutureTechIncorporatedMember 2025-09-30 0001947861 srt:MinimumMember 2025-09-30 0001947861 srt:MaximumMember 2025-09-30 0001947861 us-gaap:MachineryAndEquipmentMember 2025-09-30 0001947861 us-gaap:ComputerEquipmentMember 2025-09-30 0001947861 us-gaap:TrucksMember 2025-09-30 0001947861 us-gaap:BuildingMember 2025-09-30 0001947861 nmhi:GrowLightMember 2025-07-01 2025-09-30 0001947861 nmhi:GrowLightMember 2024-07-01 2024-09-30 0001947861 nmhi:GrowLightMember 2025-01-01 2025-09-30 0001947861 nmhi:GrowLightMember 2024-01-01 2024-09-30 0001947861 nmhi:IndoorGrowContainersMember 2025-07-01 2025-09-30 0001947861 nmhi:IndoorGrowContainersMember 2024-07-01 2024-09-30 0001947861 nmhi:IndoorGrowContainersMember 2025-01-01 2025-09-30 0001947861 nmhi:IndoorGrowContainersMember 2024-01-01 2024-09-30 0001947861 nmhi:GrowMediaAndOthersMember 2025-07-01 2025-09-30 0001947861 nmhi:GrowMediaAndOthersMember 2024-07-01 2024-09-30 0001947861 nmhi:GrowMediaAndOthersMember 2025-01-01 2025-09-30 0001947861 nmhi:GrowMediaAndOthersMember 2024-01-01 2024-09-30 0001947861 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2025-09-30 0001947861 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2025-07-01 2025-09-30 0001947861 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2025-01-01 2025-09-30 0001947861 nmhi:NMIMember 2024-03-11 0001947861 nmhi:NaturesMiracleHoldingIncMember 2024-03-11 0001947861 us-gaap:WarrantMember 2024-03-11 0001947861 nmhi:PublicWarrantsMember 2024-03-11 0001947861 nmhi:PrivateWarrantsMember 2024-03-11 0001947861 nmhi:NaturesMiracleHoldingIncMember 2024-03-11 2024-03-11 0001947861 nmhi:NMIMember 2024-03-11 2024-03-11 0001947861 2024-03-11 2024-03-11 0001947861 nmhi:LakeshoreMember 2024-03-11 0001947861 2024-03-11 0001947861 nmhi:ReverseRecapitalizationMember 2024-03-11 2024-03-11 0001947861 nmhi:ReverseRecapitalizationMember 2024-03-11 0001947861 nmhi:BigLakeMember 2025-09-18 2025-09-18 0001947861 nmhi:BigLakeMember us-gaap:SeriesBPreferredStockMember 2025-09-18 2025-09-18 0001947861 nmhi:BigLakeMember us-gaap:CommonStockMember 2025-09-18 2025-09-18 0001947861 nmhi:BigLakeMember us-gaap:CommonStockMember 2025-09-18 0001947861 nmhi:BigLakeMember us-gaap:SeriesCPreferredStockMember 2025-09-18 2025-09-18 0001947861 nmhi:BigLakeMember 2025-09-18 2025-09-18 0001947861 nmhi:BigLakeMember nmhi:PromissoryNoteMember 2025-09-18 2025-09-18 0001947861 nmhi:BigLakeMember nmhi:SeriesBAndCPreferredStockMember 2025-09-18 2025-09-18 0001947861 nmhi:BigLakeMember nmhi:InsuranceCostOfPreferredStockMember 2025-09-18 2025-09-18 0001947861 nmhi:BigLakeMember nmhi:ConvertibleNotesMember 2025-09-18 2025-09-18 0001947861 nmhi:BigLakeMember 2025-09-18 0001947861 nmhi:IluminarLightingLLCMember 2023-04-11 2023-04-11 0001947861 2023-04-11 2023-04-11 0001947861 us-gaap:TransportationEquipmentMember 2025-09-30 0001947861 us-gaap:TransportationEquipmentMember 2024-12-31 0001947861 us-gaap:MachineryAndEquipmentMember 2024-12-31 0001947861 us-gaap:BuildingMember 2024-12-31 0001947861 us-gaap:BuildingImprovementsMember 2025-09-30 0001947861 us-gaap:BuildingImprovementsMember 2024-12-31 0001947861 us-gaap:LandMember 2025-09-30 0001947861 us-gaap:LandMember 2024-12-31 0001947861 nmhi:ShortTermLoanFactorHMember nmhi:StandardMerchantCashAdvanceAgreementMember 2023-10-23 2023-10-23 0001947861 nmhi:ShortTermLoanFactorHMember nmhi:StandardMerchantCashAdvanceAgreementMember 2023-10-23 0001947861 nmhi:ShortTermLoanFactorHMember nmhi:StandardMerchantCashAdvanceAgreementMember 2024-07-01 2024-09-30 0001947861 nmhi:ShortTermLoanFactorHMember nmhi:StandardMerchantCashAdvanceAgreementMember 2024-01-01 2024-09-30 0001947861 nmhi:ShortTermLoanFactorHMember nmhi:StandardMerchantCashAdvanceAgreementMember 2024-05-02 2024-05-02 0001947861 nmhi:ShortTermLoanFactorHMember nmhi:StandardMerchantCashAdvanceAgreementMember 2024-05-02 0001947861 nmhi:ShortTermLoanFactorHOneMember nmhi:StandardMerchantCashAdvanceAgreementMember 2024-07-01 2024-09-30 0001947861 nmhi:ShortTermLoanFactorHOneMember nmhi:StandardMerchantCashAdvanceAgreementMember 2024-01-01 2024-09-30 0001947861 nmhi:ShortTermLoanFactorHMember nmhi:StandardMerchantCashAdvanceAgreementMember 2024-11-18 2024-11-18 0001947861 nmhi:ShortTermLoanFactorHMember nmhi:StandardMerchantCashAdvanceAgreementMember 2024-11-18 0001947861 nmhi:ShortTermLoanFactorHMember nmhi:StandardMerchantCashAdvanceAgreementMember 2025-07-01 2025-09-30 0001947861 nmhi:ShortTermLoanFactorHMember nmhi:StandardMerchantCashAdvanceAgreementMember 2025-01-01 2025-09-30 0001947861 nmhi:ShortTermLoanFactorIMember nmhi:StandardMerchantCashAdvanceAgreementMember 2024-08-29 2024-08-29 0001947861 nmhi:ShortTermLoanFactorIMember nmhi:StandardMerchantCashAdvanceAgreementMember 2024-08-29 0001947861 nmhi:ShortTermLoanFactorIMember nmhi:StandardMerchantCashAdvanceAgreementMember 2024-07-01 2024-09-30 0001947861 nmhi:ShortTermLoanFactorIMember nmhi:StandardMerchantCashAdvanceAgreementMember 2024-01-01 2024-09-30 0001947861 nmhi:ShortTermLoanFactorIMember nmhi:StandardMerchantCashAdvanceAgreementMember 2024-12-12 2024-12-12 0001947861 nmhi:ShortTermLoanFactorIMember nmhi:StandardMerchantCashAdvanceAgreementMember 2024-12-12 0001947861 nmhi:ShortTermLoanFactorIMember nmhi:StandardMerchantCashAdvanceAgreementMember 2025-07-01 2025-09-30 0001947861 nmhi:ShortTermLoanFactorIMember nmhi:StandardMerchantCashAdvanceAgreementMember 2025-01-01 2025-09-30 0001947861 nmhi:ShortTermLoanFactorIMember nmhi:SettlementAgreementMember 2025-07-31 2025-07-31 0001947861 srt:ScenarioForecastMember nmhi:ShortTermLoanFactorIMember nmhi:SettlementAgreementMember 2025-12-09 2025-12-09 0001947861 nmhi:ShortTermLoanFactorIMember nmhi:SettlementAgreementMember 2024-12-12 2024-12-12 0001947861 nmhi:ShortTermLoanFactorIMember nmhi:SettlementAgreementMember 2025-07-01 2025-09-30 0001947861 nmhi:ShortTermLoanFactorIMember nmhi:SettlementAgreementMember 2025-01-01 2025-09-30 0001947861 nmhi:ShortTermLoanFactorJMember nmhi:StandardMerchantCashAdvanceAgreementMember 2024-09-27 2024-09-27 0001947861 nmhi:ShortTermLoanFactorJMember nmhi:StandardMerchantCashAdvanceAgreementMember 2024-09-27 0001947861 nmhi:ShortTermLoanFactorJMember nmhi:StandardMerchantCashAdvanceAgreementMember 2025-07-01 2025-09-30 0001947861 nmhi:ShortTermLoanFactorJMember nmhi:StandardMerchantCashAdvanceAgreementMember 2025-01-01 2025-09-30 0001947861 nmhi:ShortTermLoanFactorJMember nmhi:StandardMerchantCashAdvanceAgreementMember 2025-02-11 2025-02-11 0001947861 nmhi:ShortTermLoanFactorJMember nmhi:StandardMerchantCashAdvanceAgreementMember 2025-02-11 0001947861 nmhi:ShortTermLoanFactorJOneMember nmhi:StandardMerchantCashAdvanceAgreementMember 2025-07-01 2025-09-30 0001947861 nmhi:ShortTermLoanFactorJOneMember nmhi:StandardMerchantCashAdvanceAgreementMember 2025-01-01 2025-09-30 0001947861 nmhi:ShortTermLoanFactorKMember nmhi:StandardMerchantCashAdvanceAgreementMember 2024-09-30 2024-09-30 0001947861 nmhi:ShortTermLoanFactorKMember nmhi:StandardMerchantCashAdvanceAgreementMember 2024-09-30 0001947861 nmhi:ShortTermLoanFactorKMember nmhi:StandardMerchantCashAdvanceAgreementMember 2025-07-01 2025-09-30 0001947861 nmhi:ShortTermLoanFactorKMember nmhi:StandardMerchantCashAdvanceAgreementMember 2025-01-01 2025-09-30 0001947861 nmhi:ShortTermLoanFactorKMember nmhi:StandardMerchantCashAdvanceAgreementMember 2025-02-11 2025-02-11 0001947861 nmhi:ShortTermLoanFactorKMember nmhi:StandardMerchantCashAdvanceAgreementMember 2025-02-11 0001947861 nmhi:ShortTermLoanFactorKOneMember nmhi:StandardMerchantCashAdvanceAgreementMember 2025-07-01 2025-09-30 0001947861 nmhi:ShortTermLoanFactorKOneMember nmhi:StandardMerchantCashAdvanceAgreementMember 2025-01-01 2025-09-30 0001947861 nmhi:ShortTermLoanFactorKMember 2025-07-16 0001947861 stpr:NY nmhi:ShortTermLoanFactorKMember 2025-07-16 2025-07-16 0001947861 nmhi:ShortTermLoanFactorKMember nmhi:StipulationOfSettlementAgreementMember 2024-12-12 2024-12-12 0001947861 nmhi:ShortTermLoanFactorKMember nmhi:StipulationOfSettlementAgreementMember 2025-07-01 2025-09-30 0001947861 nmhi:ShortTermLoanFactorKMember nmhi:StipulationOfSettlementAgreementMember 2025-01-01 2025-09-30 0001947861 nmhi:ShortTermLoanFactorLMember nmhi:StandardMerchantCashAdvanceAgreementMember 2025-02-07 2025-02-07 0001947861 nmhi:ShortTermLoanFactorLMember nmhi:StandardMerchantCashAdvanceAgreementMember 2025-02-07 0001947861 nmhi:ShortTermLoanFactorLMember nmhi:StandardMerchantCashAdvanceAgreementMember 2025-07-01 2025-09-30 0001947861 nmhi:ShortTermLoanFactorLMember nmhi:StandardMerchantCashAdvanceAgreementMember 2025-01-01 2025-09-30 0001947861 nmhi:ShortTermLoanFactorLMember nmhi:StandardMerchantCashAdvanceAgreementMember 2025-02-25 2025-02-25 0001947861 nmhi:ShortTermLoanFactorLMember nmhi:StandardMerchantCashAdvanceAgreementMember 2025-02-25 0001947861 nmhi:ShortTermLoanFactorLOneMember nmhi:StandardMerchantCashAdvanceAgreementMember 2025-07-01 2025-09-30 0001947861 nmhi:ShortTermLoanFactorLOneMember nmhi:StandardMerchantCashAdvanceAgreementMember 2025-01-01 2025-09-30 0001947861 nmhi:ShortTermLoanFactorLMember nmhi:SettlementAgreementMember 2025-08-01 2025-08-01 0001947861 nmhi:ShortTermLoanFactorLMember us-gaap:SubsequentEventMember nmhi:SettlementAgreementMember 2025-08-05 2025-10-20 0001947861 nmhi:ShortTermLoanFactorLMember us-gaap:SubsequentEventMember nmhi:SettlementAgreementMember 2025-10-27 2025-10-27 0001947861 nmhi:ShortTermLoanFactorLMember nmhi:SettlementAgreementMember 2025-02-25 2025-02-25 0001947861 nmhi:ShortTermLoanFactorLMember nmhi:SettlementAgreementMember 2025-07-01 2025-09-30 0001947861 nmhi:ShortTermLoanFactorLMember nmhi:SettlementAgreementMember 2025-01-01 2025-09-30 0001947861 nmhi:ShortTermLoanFactorLMember 2025-01-01 2025-09-30 0001947861 nmhi:ShortTermLoanFactorLMember 2024-01-01 2024-12-31 0001947861 nmhi:LoanMember nmhi:LoanAgreementWithIndependentThirdPartyMember 2023-10-30 0001947861 nmhi:LoanMember nmhi:LoanAgreementWithIndependentThirdPartyMember 2023-10-30 2023-10-30 0001947861 nmhi:LoanMember nmhi:LoanAgreementWithIndependentThirdPartyMember 2025-09-30 0001947861 nmhi:LoanMember nmhi:LoanAgreementWithIndependentThirdPartyMember 2024-12-31 0001947861 nmhi:LoanMember nmhi:LoanAgreementWithPengZhangMember 2024-03-07 0001947861 nmhi:LoanMember nmhi:LoanAgreementWithPengZhangMember 2024-01-01 2024-12-31 0001947861 nmhi:DebtToEquityConversionAgreementUnderPengZhangMember 2024-11-19 2024-11-19 0001947861 nmhi:LoanMember nmhi:DebtToEquityConversionAgreementUnderPengZhangMember 2024-11-19 0001947861 nmhi:DebtToEquityConversionAgreementUnderPengZhangMember 2025-09-30 0001947861 nmhi:DebtToEquityConversionAgreementUnderPengZhangMember 2024-12-31 0001947861 nmhi:SevenPromissoryNotesMember nmhi:RedOneInvestmentLimitedMember 2023-02-10 0001947861 nmhi:SevenPromissoryNotesMember nmhi:RedOneInvestmentLimitedMember 2023-03-28 0001947861 nmhi:SevenPromissoryNotesMember nmhi:RedOneInvestmentLimitedMember 2023-06-05 2023-06-05 0001947861 nmhi:SevenPromissoryNotesMember nmhi:RedOneInvestmentLimitedMember 2023-06-27 2023-06-27 0001947861 nmhi:SevenPromissoryNotesMember nmhi:RedOneInvestmentLimitedMember 2023-09-22 2023-09-22 0001947861 nmhi:SevenPromissoryNotesMember nmhi:RedOneInvestmentLimitedMember 2023-12-22 2023-12-22 0001947861 nmhi:SevenPromissoryNotesMember nmhi:RedOneInvestmentLimitedMember 2024-02-20 2024-02-20 0001947861 nmhi:SevenPromissoryNotesMember nmhi:RedOneInvestmentLimitedMember 2023-02-10 2023-02-10 0001947861 nmhi:SevenPromissoryNotesMember nmhi:RedOneInvestmentLimitedMember 2023-03-28 2023-03-28 0001947861 nmhi:LoanMember nmhi:DeyinChenBillMember 2023-07-11 0001947861 nmhi:LoanMember nmhi:LakeshoreMember 2023-07-11 0001947861 nmhi:DeyinChenBillMember 2024-03-11 2024-03-11 0001947861 nmhi:LoanMember nmhi:DeyinChenBillMember 2024-03-11 2024-03-11 0001947861 nmhi:LoanMember nmhi:DeyinChenBillMember 2024-07-29 2024-07-29 0001947861 nmhi:DeyinChenBillMember 2024-07-29 2024-07-29 0001947861 nmhi:DeyinChenBillMember 2024-11-11 2024-11-11 0001947861 2024-11-11 0001947861 nmhi:FirstInstallmentMember 2025-03-31 0001947861 nmhi:SecondInstallmentMember 2025-06-30 0001947861 nmhi:SubordinatedBusinessLoanMember nmhi:SecurityAgreementWithAgileCapitalFundingLLCAndAgileLendingLLCMember 2024-06-06 0001947861 nmhi:SecurityAgreementWithAgileCapitalFundingLLCAndAgileLendingLLCMember 2024-06-06 0001947861 nmhi:SubordinatedBusinessLoanMember nmhi:SecurityAgreementWithAgileCapitalFundingLLCAndAgileLendingLLCMember 2024-06-06 2024-06-06 0001947861 nmhi:SubordinatedBusinessLoanMember nmhi:SecurityAgreementWithAgileCapitalFundingLLCAndAgileLendingLLCMember 2024-07-01 2024-09-30 0001947861 nmhi:SubordinatedBusinessLoanMember nmhi:SecurityAgreementWithAgileCapitalFundingLLCAndAgileLendingLLCMember 2024-01-01 2024-09-30 0001947861 nmhi:SubordinatedBusinessLoanMember nmhi:SecurityAgreementWithAgileCapitalFundingLLCAndAgileLendingLLCMember 2024-09-25 0001947861 nmhi:SubordinatedBusinessLoanMember nmhi:AgileCapitalFundingLLCAndAgileLendingLLCMember nmhi:SecurityAgreementWithAgileCapitalFundingLLCAndAgileLendingLLCMember 2024-09-25 2024-09-25 0001947861 nmhi:SubordinatedBusinessLoanMember nmhi:AgileCapitalFundingLLCAndAgileLendingLLCMember nmhi:SecurityAgreementWithAgileCapitalFundingLLCAndAgileLendingLLCMember 2024-09-25 0001947861 nmhi:SubordinatedBusinessLoanOneMember nmhi:SecurityAgreementWithAgileCapitalFundingLLCAndAgileLendingLLCMember 2024-07-01 2024-09-30 0001947861 nmhi:SubordinatedBusinessLoanOneMember nmhi:SecurityAgreementWithAgileCapitalFundingLLCAndAgileLendingLLCMember 2024-01-01 2024-09-30 0001947861 nmhi:SubordinatedBusinessLoanMember nmhi:SecurityAgreementWithAgileCapitalFundingLLCAndAgileLendingLLCMember 2024-11-21 0001947861 nmhi:SubordinatedBusinessLoanMember nmhi:SecurityAgreementWithAgileCapitalFundingLLCAndAgileLendingLLCMember 2024-11-21 2024-11-21 0001947861 nmhi:SubordinatedBusinessLoanMember nmhi:SecurityAgreementWithAgileCapitalFundingLLCAndAgileLendingLLCMember 2025-07-01 2025-09-30 0001947861 nmhi:SubordinatedBusinessLoanMember nmhi:SecurityAgreementWithAgileCapitalFundingLLCAndAgileLendingLLCMember 2025-01-01 2025-09-30 0001947861 nmhi:VisiontechAndClassicPlanPremiumFinancingIncMember 2024-12-01 0001947861 nmhi:LoanMember nmhi:VisiontechAndClassicPlanPremiumFinancingIncMember 2024-12-01 0001947861 nmhi:VisiontechAndClassicPlanPremiumFinancingIncMember 2025-07-01 2025-09-30 0001947861 nmhi:VisiontechAndClassicPlanPremiumFinancingIncMember 2025-01-01 2025-09-30 0001947861 nmhi:BusinessLoanMember nmhi:SecurityAgreementWithMaximcashSolutionsLLCMember 2024-12-30 0001947861 nmhi:BusinessLoanMember nmhi:SecurityAgreementWithMaximcashSolutionsLLCMember 2024-12-30 2024-12-30 0001947861 nmhi:BusinessLoanMember nmhi:SecurityAgreementWithMaximcashSolutionsLLCMember 2025-07-01 2025-09-30 0001947861 nmhi:BusinessLoanMember nmhi:SecurityAgreementWithMaximcashSolutionsLLCMember 2025-01-01 2025-09-30 0001947861 2025-07-08 2025-07-08 0001947861 nmhi:AutoLoansMember 2025-09-30 0001947861 nmhi:AutoLoansMember 2024-12-31 0001947861 us-gaap:VehiclesMember 2021-02-27 2021-02-27 0001947861 nmhi:AutoLoansMember 2021-02-27 2021-02-27 0001947861 nmhi:AutoLoansMember 2021-06-08 2021-06-08 0001947861 nmhi:AutoLoansMember 2022-09-28 2022-09-28 0001947861 nmhi:AutoLoansMember 2025-07-01 2025-09-30 0001947861 nmhi:AutoLoansMember 2025-01-01 2025-09-30 0001947861 nmhi:AutoLoansMember 2024-07-01 2024-09-30 0001947861 nmhi:AutoLoansMember 2024-01-01 2024-09-30 0001947861 nmhi:BuildingLoanMember 2025-09-30 0001947861 nmhi:BuildingLoanMember 2024-12-31 0001947861 nmhi:BuildingLoanMember 2022-01-10 2022-01-10 0001947861 nmhi:BuildingLoanMember 2025-01-01 2025-09-30 0001947861 nmhi:BuildingLoanMember 2025-07-01 2025-09-30 0001947861 nmhi:SecuredBusinessLoanMember 2024-07-01 2024-09-30 0001947861 nmhi:SecuredBusinessLoanMember 2024-01-01 2024-09-30 0001947861 nmhi:SecuredBusinessLoanMember 2025-09-30 0001947861 nmhi:SecuredBusinessLoanMember 2024-12-31 0001947861 nmhi:SecuredBusinessLoanMember 2023-06-14 2023-06-14 0001947861 nmhi:SecuredBusinessLoanMember 2025-07-01 2025-09-30 0001947861 nmhi:SecuredBusinessLoanMember 2025-01-01 2025-09-30 0001947861 nmhi:BuildingLoanMember 2024-07-01 2024-09-30 0001947861 nmhi:BuildingLoanMember 2024-01-01 2024-09-30 0001947861 nmhi:FactorHMember 2025-09-30 0001947861 nmhi:FactorHMember 2024-12-31 0001947861 nmhi:FactorIMember 2025-09-30 0001947861 nmhi:FactorIMember 2024-12-31 0001947861 nmhi:FactorJMember 2025-09-30 0001947861 nmhi:FactorJMember 2024-12-31 0001947861 nmhi:FactorKMember 2025-09-30 0001947861 nmhi:FactorKMember 2024-12-31 0001947861 nmhi:FactorLMember 2025-09-30 0001947861 nmhi:FactorLMember 2024-12-31 0001947861 nmhi:JieZhangMember 2025-09-30 0001947861 nmhi:JieZhangMember 2024-12-31 0001947861 nmhi:PengZhangMember 2025-09-30 0001947861 nmhi:PengZhangMember 2024-12-31 0001947861 nmhi:RedOneInvestmentLimitedMember 2025-09-30 0001947861 nmhi:RedOneInvestmentLimitedMember 2024-12-31 0001947861 nmhi:AgileCapitalFundingLLCMember 2025-09-30 0001947861 nmhi:AgileCapitalFundingLLCMember 2024-12-31 0001947861 nmhi:ClassicPlanPremiumFinancingIncMember 2025-09-30 0001947861 nmhi:ClassicPlanPremiumFinancingIncMember 2024-12-31 0001947861 nmhi:MaximcashSolutionsLLCMember 2025-09-30 0001947861 nmhi:MaximcashSolutionsLLCMember 2024-12-31 0001947861 nmhi:OtherLoansMember 2025-09-30 0001947861 nmhi:OtherLoansMember 2024-12-31 0001947861 nmhi:AutoLoansMember 2025-09-30 0001947861 nmhi:BuildingLoanMember 2025-09-30 0001947861 nmhi:BusinessLoanTwoThousandTwentyFiveMember 2025-09-30 0001947861 nmhi:ConvertibleNoteAgreementsMember us-gaap:InvestorMember 2024-07-03 0001947861 nmhi:ConvertibleNoteAgreementsMember 2024-07-03 0001947861 nmhi:ConvertibleNoteAgreementsMember us-gaap:InvestorMember 2024-11-19 2024-11-19 0001947861 nmhi:ConvertibleNoteAgreementsMember 2024-11-19 2024-11-19 0001947861 nmhi:ConvertibleNoteAgreementsMember 2024-11-19 0001947861 nmhi:ConvertibleNoteAgreementsMember us-gaap:InvestorMember 2025-01-01 2025-09-30 0001947861 nmhi:June2025Member 2025-09-30 0001947861 nmhi:September2025Member 2025-09-30 0001947861 nmhi:September2025Member 2025-01-01 2025-09-30 0001947861 2025-08-12 2025-08-12 0001947861 nmhi:DebttoEquityConversionAgreementsMember 2025-09-30 0001947861 nmhi:DebttoEquityConversionAgreementsMember 2024-12-31 0001947861 2024-07-17 0001947861 2024-07-17 2024-07-17 0001947861 us-gaap:WarrantMember 2024-07-17 0001947861 us-gaap:WarrantMember us-gaap:PrivatePlacementMember 2024-07-17 0001947861 us-gaap:InvestorMember 2024-07-19 2024-07-19 0001947861 nmhi:ConvertibleNotesMember 2025-01-01 2025-09-30 0001947861 nmhi:ConvertibleNotesMember 2024-07-30 2024-07-30 0001947861 nmhi:PromissoryNoteMember nmhi:DiagonalLendingLLCMember 2024-08-13 0001947861 nmhi:PromissoryNoteMember nmhi:DiagonalLendingLLCMember 2024-08-13 2024-08-13 0001947861 nmhi:DiagonalLendingLLCMember 2024-08-13 2024-08-13 0001947861 nmhi:DiagonalLendingLLCMember 2024-08-13 2024-08-13 0001947861 nmhi:ConvertiblePromissoryNoteMember nmhi:DiagonalLendingLLCMember 2024-08-13 0001947861 nmhi:DiagonalLendingLLCMember 2025-04-16 2025-04-16 0001947861 nmhi:DiagonalLendingLLCMember 2025-04-21 2025-04-21 0001947861 nmhi:ConvertiblePromissoryNoteMember nmhi:DiagonalLendingLLCMember 2025-06-30 0001947861 nmhi:ConvertiblePromissoryNoteMember nmhi:DiagonalLendingLLCMember 2024-12-31 0001947861 nmhi:ConvertiblePromissoryNoteMember nmhi:DiagonalLendingLLCMember 2024-09-18 0001947861 nmhi:ConvertiblePromissoryNoteMember 2024-09-18 2024-09-18 0001947861 nmhi:ConvertibleNoteAgreementsMember 2024-09-18 0001947861 nmhi:ConvertibleNoteAgreementsMember 2024-09-18 2024-09-18 0001947861 nmhi:ConvertiblePromissoryNoteMember nmhi:DiagonalLendingLLCMember 2024-09-18 2024-09-18 0001947861 nmhi:ConvertiblePromissoryNoteMember nmhi:DiagonalLendingLLCMember 2025-05-05 2025-05-05 0001947861 nmhi:ConvertiblePromissoryNoteMember nmhi:DiagonalLendingLLCMember 2025-05-09 2025-05-09 0001947861 nmhi:ConvertiblePromissoryNoteMember nmhi:DiagonalLendingLLCMember 2025-06-04 2025-06-04 0001947861 nmhi:ConvertiblePromissoryNoteMember 2025-06-30 0001947861 nmhi:ConvertiblePromissoryNoteMember 2024-12-31 0001947861 nmhi:ConvertiblePromissoryNoteMember nmhi:DiagonalLendingLLCMember 2024-10-14 0001947861 nmhi:DiagonalLendingLLCMember 2024-10-14 0001947861 nmhi:ConvertiblePromissoryNoteMember nmhi:DiagonalLendingLLCMember 2024-10-14 2024-10-14 0001947861 nmhi:ConvertiblePromissoryNoteMember nmhi:DiagonalLendingLLCMember 2025-06-05 2025-06-05 0001947861 nmhi:ConvertiblePromissoryNoteMember nmhi:DiagonalLendingLLCMember 2025-06-10 2025-06-10 0001947861 nmhi:ConvertiblePromissoryNoteMember nmhi:DiagonalLendingLLCMember 2025-06-12 2025-06-12 0001947861 nmhi:PromissoryNoteMember nmhi:DiagonalLendingLLCMember 2025-06-30 0001947861 nmhi:PromissoryNoteMember nmhi:DiagonalLendingLLCMember 2024-12-31 0001947861 nmhi:ConvertibleNoteAgreementsMember us-gaap:InvestorMember 2024-11-18 0001947861 nmhi:ConvertibleNoteAgreementsMember 2024-11-18 0001947861 us-gaap:InvestorMember us-gaap:CommonStockMember 2024-11-19 2024-11-19 0001947861 nmhi:ConvertibleNotesMember 2024-11-19 0001947861 nmhi:ConvertibleNotesMember us-gaap:InvestorMember 2025-06-30 0001947861 nmhi:ConvertibleNotesMember us-gaap:InvestorMember 2024-12-31 0001947861 nmhi:ConvertibleNotesMember 2024-12-17 0001947861 nmhi:ConvertibleNotesMember 2024-12-17 2024-12-17 0001947861 2024-12-17 0001947861 us-gaap:WarrantMember 2024-12-17 0001947861 nmhi:ConvertibleNotesMember 2024-12-31 0001947861 nmhi:ConvertibleNotesMember us-gaap:InvestorMember 2025-01-15 2025-01-15 0001947861 2025-01-01 2025-06-30 0001947861 nmhi:ConvertiblePromissoryNoteMember nmhi:DiagonalLendingLLCMember 2024-12-12 0001947861 nmhi:ConvertiblePromissoryNoteMember 2024-12-12 2024-12-12 0001947861 nmhi:ConvertiblePromissoryNoteMember nmhi:DiagonalLendingLLCMember 2024-12-12 2024-12-12 0001947861 nmhi:ConvertiblePromissoryNoteMember nmhi:DiagonalLendingLLCMember 2025-06-20 2025-06-20 0001947861 2025-07-31 2025-07-31 0001947861 nmhi:ConvertibleNotesMember 2025-07-31 2025-07-31 0001947861 nmhi:DiagonalLendingLLCMember 2025-09-30 0001947861 nmhi:DiagonalLendingLLCMember 2024-12-31 0001947861 nmhi:BlackIceAdvisorsLLCMember 2025-03-26 0001947861 nmhi:BlackIceAdvisorsLLCMember 2025-03-26 2025-03-26 0001947861 nmhi:ConvertiblePromissoryNoteMember nmhi:DiagonalLendingLLCMember 2025-05-07 0001947861 nmhi:DiagonalLendingLLCMember 2025-05-07 2025-05-07 0001947861 2025-05-07 2025-05-07 0001947861 nmhi:DiagonalLendingLLCMember 2025-05-07 0001947861 nmhi:DiagonalLendingLLCThreeMember 2025-06-10 0001947861 nmhi:ConvertiblePromissoryNoteMember nmhi:DiagonalLendingLLCMember 2025-06-10 0001947861 nmhi:DiagonalLendingLLCMember 2025-06-10 2025-06-10 0001947861 nmhi:DiagonalLendingLLCMember 2025-06-10 0001947861 nmhi:DiagonalLendingLLCMember 2025-07-23 0001947861 2025-07-23 0001947861 2025-07-23 2025-07-23 0001947861 nmhi:DiagonalLendingLLCMember 2025-09-30 0001947861 nmhi:DiagonalLendingLLCMember 2025-01-01 2025-09-30 0001947861 nmhi:DiagonalLendingLLCOneMember 2025-09-30 0001947861 nmhi:DiagonalLendingLLCMember 2025-09-19 0001947861 2025-09-19 0001947861 2025-09-19 2025-09-19 0001947861 nmhi:ConvertibleNotesMember 2025-09-30 0001947861 nmhi:CFICapitalLLCMember 2025-07-10 0001947861 2025-07-10 0001947861 2025-07-10 2025-07-10 0001947861 nmhi:CFICapitalLLCMember 2025-09-18 0001947861 2025-09-18 0001947861 2025-09-18 2025-09-18 0001947861 nmhi:LabrysFundIILPMember 2025-07-30 0001947861 2025-07-30 0001947861 2025-07-30 2025-07-30 0001947861 nmhi:LabrysFundIILPMember 2025-09-30 0001947861 nmhi:FirstfireGlobalOpportunitiesFundLLCMember 2025-08-05 0001947861 2025-08-05 0001947861 2025-08-05 2025-08-05 0001947861 nmhi:GlobalOpportunitiesFundLLCMember 2025-09-30 0001947861 nmhi:AESCapitalManagementLLCMember 2025-08-04 0001947861 nmhi:AESCapitalManagementLLCMember 2025-08-04 2025-08-04 0001947861 nmhi:AESCapitalManagementLLCMember 2025-09-30 0001947861 nmhi:LambdaVenturePartnersCapitalLLCMember 2025-08-04 0001947861 nmhi:LambdaVenturePartnersCapitalLLCMember 2025-08-04 2025-08-04 0001947861 nmhi:LambdaVenturePartnersCapitalLLCMember 2025-09-30 0001947861 nmhi:ActusFundLLCMember 2025-08-15 0001947861 nmhi:ActusFundLLCMember 2025-08-15 2025-08-15 0001947861 nmhi:ActusFundLLCMember 2025-09-30 0001947861 nmhi:VisiontechMember nmhi:UniNetGlobalIncMember 2024-06-30 0001947861 nmhi:UniNetGlobalIncMember 2024-06-30 0001947861 nmhi:UniNetGlobalIncMember 2025-01-01 2025-09-30 0001947861 nmhi:UniNetGlobalIncMember 2024-11-19 0001947861 nmhi:UniNetGlobalIncMember 2024-11-19 2024-11-19 0001947861 nmhi:JonathanZhangMember 2024-11-19 0001947861 nmhi:UniNetGlobalIncMember 2025-09-30 0001947861 nmhi:UniNetGlobalIncMember 2024-12-31 0001947861 nmhi:CustomersMember nmhi:IluminarLightingLLCMember 2023-04-11 0001947861 nmhi:IluminarLightingLLCMember 2023-04-11 2023-04-11 0001947861 nmhi:IluminarLightingLLCMember 2025-07-01 2025-09-30 0001947861 nmhi:IluminarLightingLLCMember 2025-01-01 2025-09-30 0001947861 nmhi:IluminarLightingLLCMember 2024-07-01 2024-09-30 0001947861 nmhi:IluminarLightingLLCMember 2024-01-01 2024-09-30 0001947861 nmhi:IluminarLightingLLCMember 2025-09-30 0001947861 nmhi:IluminarLightingLLCMember 2024-12-31 0001947861 nmhi:JonathanMember 2025-09-30 0001947861 nmhi:JonathanMember 2024-12-31 0001947861 nmhi:MrTieJamesLiOneMember 2025-09-30 0001947861 nmhi:MrTieJamesLiOneMember 2024-12-31 0001947861 srt:ChiefExecutiveOfficerMember nmhi:MrTieJamesLiMember 2022-01-01 2022-12-31 0001947861 nmhi:NMCaymanMember 2025-09-30 0001947861 nmhi:NMCaymanMember 2024-12-31 0001947861 nmhi:YangWeiMember 2021-01-01 2021-12-31 0001947861 nmhi:YangWeiMember 2025-09-30 0001947861 nmhi:YangWeiMember 2024-12-31 0001947861 nmhi:ZhiyiJonathanZhangMember 2022-01-01 2022-12-31 0001947861 nmhi:ZhiyiJonathanZhangMember 2023-05-19 2023-05-19 0001947861 nmhi:ZhiyiJonathanZhangMember 2023-09-04 2023-09-04 0001947861 nmhi:ZhiyiJonathanZhangMember 2024-07-01 2024-07-01 0001947861 nmhi:ZhiyiJonathanZhangMember 2024-01-01 2024-12-31 0001947861 nmhi:ZhiyiJonathanZhangMember 2023-10-11 2023-10-11 0001947861 nmhi:ZhiyiJonathanZhangMember 2025-01-01 2025-09-30 0001947861 nmhi:ZhiyiJonathanZhangMember 2025-09-30 0001947861 nmhi:ZhiyiJonathanZhangMember 2024-12-31 0001947861 nmhi:JamesLiMember 2024-09-01 2024-09-30 0001947861 nmhi:NaturesMiracleCaliforniaIncMember nmhi:JamesLiMember 2025-01-01 2025-09-30 0001947861 nmhi:JamesLiMember 2025-09-30 0001947861 nmhi:MrTieJamesLiMember 2025-09-30 2025-09-30 0001947861 nmhi:ZhiyiJonathanZhangMember 2025-09-30 2025-09-30 0001947861 us-gaap:RelatedPartyMember 2025-01-01 2025-09-30 0001947861 us-gaap:RelatedPartyMember 2024-01-01 2024-12-31 0001947861 nmhi:LoanMember nmhi:ZhiyiJonathanZhangMember 2022-11-29 0001947861 nmhi:ZhiyiJonathanZhangMember 2023-01-01 2023-12-31 0001947861 nmhi:LoanMember nmhi:ZhiyiJonathanZhangMember 2025-01-01 2025-09-30 0001947861 nmhi:LoanMember nmhi:ZhiyiJonathanZhangMember 2024-01-01 2024-12-31 0001947861 nmhi:LoanMember nmhi:MrTieJamesLiMember 2022-12-31 0001947861 nmhi:MrTieJamesLiMember 2023-06-16 2023-06-16 0001947861 nmhi:MrTieJamesLiMember 2024-07-29 2024-07-29 0001947861 nmhi:MrTieJamesLiMember 2024-02-15 2024-02-15 0001947861 nmhi:MrTieJamesLiMember 2025-07-31 0001947861 nmhi:MrTieJamesLiMember 2025-09-30 0001947861 nmhi:MrTieJamesLiMember 2024-12-31 0001947861 nmhi:LoanTwoMember nmhi:MrTieJamesLiMember 2025-01-01 2025-09-30 0001947861 nmhi:LoanTwoMember nmhi:MrTieJamesLiMember 2024-01-01 2024-12-31 0001947861 nmhi:OneLoanMember nmhi:MrTieJamesLiMember 2023-07-11 0001947861 nmhi:OneLoanMember nmhi:MrTieJamesLiMember 2025-01-14 2025-01-14 0001947861 nmhi:OneLoanMember nmhi:MrTieJamesLiMember 2025-07-15 2025-07-15 0001947861 nmhi:OneLoanMember nmhi:MrTieJamesLiMember 2025-07-25 2025-07-25 0001947861 nmhi:OneLoanMember nmhi:MrTieJamesLiMember 2025-09-30 0001947861 nmhi:OneLoanMember nmhi:MrTieJamesLiMember 2024-12-31 0001947861 nmhi:LoanMember nmhi:MrTieJamesLiMember 2025-01-01 2025-09-30 0001947861 nmhi:LoanMember nmhi:NaturesMiracleHoldingIncMember 2023-01-17 0001947861 2024-11-19 0001947861 nmhi:NMCaymanMember 2024-11-19 2024-11-19 0001947861 nmhi:LoanMember 2024-11-19 0001947861 nmhi:LoanMember 2025-07-31 0001947861 nmhi:LoanMember 2025-09-30 0001947861 nmhi:LoanMember 2024-12-31 0001947861 nmhi:LoanMember 2025-01-01 2025-09-30 0001947861 nmhi:LoanMember 2024-01-01 2024-12-31 0001947861 nmhi:LoanMember nmhi:NMCaymanMember 2023-01-17 0001947861 nmhi:NMCaymanMember 2024-11-19 0001947861 nmhi:LoanMember nmhi:NMCaymanMember 2024-11-19 0001947861 nmhi:NMCaymanMember 2025-07-31 0001947861 nmhi:LoanMember nmhi:NMCaymanMember 2025-01-01 2025-09-30 0001947861 nmhi:LoanMember nmhi:NMCaymanMember 2024-01-01 2024-12-31 0001947861 nmhi:ConvertibleNotesRelatedPartyMember nmhi:BigLakeCapitalLLCMember 2025-04-11 2025-04-11 0001947861 nmhi:ConvertibleNotesRelatedPartyMember nmhi:BigLakeCapitalLLCMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2025-04-11 2025-04-11 0001947861 nmhi:BigLakeCapitalLLCMember 2025-04-11 0001947861 nmhi:BigLakeCapitalLLCMember 2025-04-11 2025-04-11 0001947861 nmhi:BigLakeBigLakeMember 2025-04-11 2025-04-11 0001947861 nmhi:ConvertiblePromissoryNoteMember 2025-01-01 2025-09-30 0001947861 nmhi:ZakPropertiesMember 2025-09-30 0001947861 nmhi:ZakPropertiesMember 2025-01-01 2025-09-30 0001947861 nmhi:ZhiyiZhangMember 2025-09-30 0001947861 nmhi:ZhiyiZhangMember 2024-12-31 0001947861 nmhi:TieLiMember 2025-09-30 0001947861 nmhi:TieLiMember 2024-12-31 0001947861 nmhi:GHSInvestmentsLLCMember us-gaap:SeriesAPreferredStockMember 2025-05-07 2025-05-07 0001947861 nmhi:GHSInvestmentsLLCMember us-gaap:SeriesAPreferredStockMember 2025-05-07 0001947861 us-gaap:SeriesAPreferredStockMember 2025-05-07 2025-05-07 0001947861 us-gaap:SeriesAPreferredStockMember 2025-05-07 0001947861 nmhi:YKCapitalManagementIncMember us-gaap:SeriesDPreferredStockMember 2025-09-19 2025-09-19 0001947861 us-gaap:SeriesDPreferredStockMember 2025-09-19 0001947861 us-gaap:SeriesDPreferredStockMember 2025-09-19 2025-09-19 0001947861 us-gaap:SeriesDPreferredStockMember 2025-10-29 2025-10-29 0001947861 nmhi:YKCapitalManagementIncMember us-gaap:SeriesDPreferredStockMember us-gaap:SubsequentEventMember 2025-10-29 2025-10-29 0001947861 us-gaap:SeriesDPreferredStockMember us-gaap:SubsequentEventMember 2025-10-30 2025-10-30 0001947861 us-gaap:SeriesDPreferredStockMember 2025-01-01 2025-09-30 0001947861 us-gaap:SeriesDPreferredStockMember 2025-09-30 0001947861 us-gaap:PreferredStockMember 2025-01-01 2025-09-30 0001947861 us-gaap:SeriesAPreferredStockMember us-gaap:SubsequentEventMember 2025-10-10 2025-10-10 0001947861 us-gaap:SeriesBPreferredStockMember us-gaap:SubsequentEventMember 2025-10-10 2025-10-10 0001947861 us-gaap:SeriesCPreferredStockMember us-gaap:SubsequentEventMember 2025-10-10 2025-10-10 0001947861 srt:ChiefExecutiveOfficerMember us-gaap:SubsequentEventMember 2025-10-10 0001947861 us-gaap:SeriesAPreferredStockMember 2025-01-01 2025-09-30 0001947861 us-gaap:SeriesAPreferredStockMember 2025-09-30 0001947861 nmhi:SeriesAAndDPreferredSharesMember 2025-01-01 2025-09-30 0001947861 us-gaap:SeriesAPreferredStockMember us-gaap:SubsequentEventMember 2025-10-31 0001947861 us-gaap:SeriesDPreferredStockMember us-gaap:SubsequentEventMember 2025-10-31 0001947861 nmhi:LetterAgreementMember 2023-11-15 0001947861 nmhi:NewtekLoanMember 2024-12-31 0001947861 nmhi:NewtekLoanMember 2024-01-01 2024-12-31 0001947861 nmhi:NewtekLoanMember 2025-01-01 2025-09-30 0001947861 nmhi:YorkvilleMember 2023-04-10 2023-04-10 0001947861 us-gaap:CommonStockMember 2023-04-10 0001947861 nmhi:YAGlobalIISPVLLCMember 2025-01-01 2025-09-30 0001947861 nmhi:YAGlobalIISPVLLCMember 2025-09-30 0001947861 nmhi:YAGlobalIISPVLLCMember 2024-11-22 2024-11-22 0001947861 nmhi:YAGlobalIISPVLLCMember 2024-11-22 0001947861 nmhi:IncentivePlan2024Member 2025-01-01 2025-09-30 0001947861 nmhi:IncentivePlan2024Member us-gaap:CommonStockMember 2025-01-01 2025-09-30 0001947861 nmhi:CharlesHausmanMember us-gaap:CommonStockMember 2023-08-23 2023-08-23 0001947861 nmhi:JamesLiMember us-gaap:CommonStockMember 2023-08-23 2023-08-23 0001947861 nmhi:ZhiyiZhangMember us-gaap:CommonStockMember 2023-08-23 2023-08-23 0001947861 nmhi:MrCarpenterMember 2023-09-20 2023-09-20 0001947861 2023-09-17 2023-09-17 0001947861 2025-02-25 2025-02-25 0001947861 nmhi:GeorgeYutucMember 2025-01-01 2025-09-30 0001947861 nmhi:KirkCollinsMember 2025-01-01 2025-09-30 0001947861 nmhi:AmberWangMember 2025-01-01 2025-09-30 0001947861 2024-04-02 2024-04-02 0001947861 nmhi:MZHCILLCMember 2024-04-02 2024-04-02 0001947861 us-gaap:RestrictedStockMember nmhi:MZHCILLCMember 2024-04-02 2024-04-02 0001947861 2024-04-02 0001947861 nmhi:MZHCILLCMember 2024-05-07 2024-05-07 0001947861 nmhi:AltaWaterfordLLCMember 2024-10-25 2024-10-25 0001947861 nmhi:AltaWaterfordLLCMember 2024-10-25 0001947861 nmhi:TwoThousandTwentyFourIncentivePlanMember 2024-10-25 2024-10-25 0001947861 nmhi:TwoThousandTwentyFourIncentivePlanMember 2024-10-25 0001947861 nmhi:PXSPACCapitalIncMember nmhi:TwoThousandTwentyFourIncentivePlanMember 2024-11-18 2024-11-18 0001947861 nmhi:PXSPACCapitalIncMember nmhi:TwoThousandTwentyFourIncentivePlanMember 2024-11-18 0001947861 nmhi:TwoThousandTwentyFourIncentivePlanMember 2024-11-18 2024-11-18 0001947861 nmhi:TwoThousandTwentyFourIncentivePlanMember 2024-11-18 0001947861 nmhi:TwoThousandTwentyFourIncentivePlanMember 2025-07-01 2025-09-30 0001947861 nmhi:TwoThousandTwentyFourIncentivePlanMember 2025-01-01 2025-09-30 0001947861 nmhi:RootVenturesLLCMember nmhi:TwoThousandTwentyFourIncentivePlanMember 2025-07-22 2025-07-22 0001947861 nmhi:RootVenturesLLCMember nmhi:TwoThousandTwentyFourIncentivePlanMember 2025-07-22 0001947861 2024-07-19 2024-07-19 0001947861 2024-07-19 0001947861 2024-07-29 0001947861 us-gaap:IPOMember 2024-07-29 0001947861 us-gaap:IPOMember 2024-07-29 2024-07-29 0001947861 us-gaap:CommonStockMember us-gaap:IPOMember 2024-07-29 0001947861 2024-07-29 2024-07-29 0001947861 nmhi:EFHuttonLLCMember 2024-07-29 0001947861 nmhi:DBoralCapitalLLCMember 2024-11-07 2024-11-07 0001947861 nmhi:DBoralCapitalLLCMember 2024-11-07 0001947861 us-gaap:CommonStockMember nmhi:DBoralCapitalLLCMember 2024-11-07 0001947861 nmhi:SeriesBWarrantsMember nmhi:DBoralCapitalLLCMember 2024-11-07 0001947861 nmhi:PreFundedWarrantMember nmhi:DBoralCapitalLLCMember 2024-11-07 0001947861 nmhi:SeriesAWarrantMember nmhi:DBoralCapitalLLCMember 2024-11-07 0001947861 nmhi:GHSInvestmentsLLCMember nmhi:EquityFinancingAgreementMember 2025-05-06 2025-05-06 0001947861 2025-05-06 2025-05-06 0001947861 2025-07-25 2025-07-25 0001947861 srt:MinimumMember nmhi:EquityFinancingAgreementMember 2025-07-25 2025-07-25 0001947861 srt:MaximumMember nmhi:EquityFinancingAgreementMember 2025-07-25 2025-07-25 0001947861 nmhi:ZakPropertiesMember 2025-01-01 2025-09-30 0001947861 us-gaap:SeriesBPreferredStockMember 2025-01-01 2025-09-30 0001947861 us-gaap:SeriesBPreferredStockMember 2025-09-30 0001947861 us-gaap:SeriesCPreferredStockMember 2025-01-01 2025-09-30 0001947861 us-gaap:WarrantMember 2025-09-30 0001947861 nmhi:PublicWarrantsMember 2025-09-30 0001947861 nmhi:PrivateWarrantsMember 2025-09-30 0001947861 us-gaap:WarrantMember us-gaap:CommonStockMember 2025-09-30 0001947861 us-gaap:CommonStockMember 2024-07-17 0001947861 nmhi:SeriesAWarrantMember 2024-07-29 0001947861 nmhi:SeriesAWarrantMember us-gaap:CommonStockMember 2024-07-29 0001947861 nmhi:SeriesAWarrantMember 2025-09-30 0001947861 nmhi:SeriesAWarrantMember 2025-01-01 2025-09-30 0001947861 nmhi:SeriesAWarrantMember 2024-11-30 0001947861 2024-11-01 2024-11-30 0001947861 nmhi:SeriesAWarrantMember 2024-11-12 0001947861 nmhi:SeriesAPrefundedWarrantsMember 2024-11-12 0001947861 nmhi:SeriesBWarrantsMember 2024-11-12 0001947861 nmhi:SeriesBPrefundedWarrantsMember 2024-11-12 0001947861 nmhi:PreFundedWarrantMember 2024-11-12 0001947861 us-gaap:WarrantMember 2025-01-01 2025-09-30 0001947861 srt:MinimumMember nmhi:SeriesAWarrantMember 2025-09-30 0001947861 srt:MaximumMember nmhi:SeriesBWarrantsMember 2025-09-30 0001947861 nmhi:PreFundedWarrantMember 2025-09-30 0001947861 nmhi:ConvertibleNoteRelatedPartyMember nmhi:BigLakeCapitalLLCMember 2025-09-30 0001947861 nmhi:ConvertibleNoteRelatedPartyMember 2025-01-01 2025-09-30 0001947861 nmhi:ConvertibleNoteRelatedPartyMember 2025-09-30 0001947861 nmhi:August2025ConvertibleNoteMember nmhi:AuctusFundLLCMember 2025-08-15 2025-08-15 0001947861 nmhi:August2025ConvertibleNoteMember nmhi:AuctusFundLLCMember 2025-08-15 0001947861 nmhi:August2025ConvertibleNoteMember nmhi:AuctusFundLLCMember 2025-01-01 2025-09-30 0001947861 nmhi:August2025ConvertibleNoteMember nmhi:AuctusFundLLCMember 2025-09-30 0001947861 nmhi:SeriesBWarrantsMember 2024-12-31 0001947861 nmhi:SeriesBWarrantsMember 2024-12-01 2024-12-31 0001947861 nmhi:SeriesAWarrantMember 2025-01-13 0001947861 nmhi:SeriesBWarrantsMember 2025-01-13 0001947861 nmhi:SeriesAWarrantMember 2025-01-31 0001947861 nmhi:SeriesBWarrantsMember 2025-01-31 0001947861 nmhi:SeriesBWarrantsMember 2025-01-01 2025-01-31 0001947861 2025-01-01 2025-01-31 0001947861 nmhi:LakeshoresSharesOutstandingPriorToReverseRecapitalizationMember us-gaap:CommonStockMember 2024-03-11 2024-03-11 0001947861 nmhi:PrivateRightsMember us-gaap:CommonStockMember 2024-03-11 2024-03-11 0001947861 nmhi:ConversionOfTheLakeshoresPublicSharesAndRightsMember us-gaap:CommonStockMember 2024-03-11 2024-03-11 0001947861 nmhi:SharesIssuedToServiceProvidersMember us-gaap:CommonStockMember 2024-03-11 2024-03-11 0001947861 nmhi:CommitmentFeeMember us-gaap:CommonStockMember 2024-03-11 2024-03-11 0001947861 nmhi:LakeshoreLoansMember us-gaap:CommonStockMember 2024-03-11 2024-03-11 0001947861 nmhi:NMILoansMember us-gaap:CommonStockMember 2024-03-11 2024-03-11 0001947861 nmhi:ConversionOfNMIsSharesIntoTheCompanysOrdinarySharesMember us-gaap:CommonStockMember 2024-03-11 2024-03-11 0001947861 us-gaap:CommonStockMember 2024-03-11 0001947861 us-gaap:WarrantMember 2024-12-30 0001947861 us-gaap:WarrantMember 2024-12-31 2024-12-31 0001947861 us-gaap:WarrantMember 2025-01-01 2025-03-31 0001947861 us-gaap:WarrantMember 2025-03-31 0001947861 us-gaap:WarrantMember 2025-04-01 2025-06-30 0001947861 us-gaap:WarrantMember 2025-06-30 0001947861 us-gaap:WarrantMember 2025-07-01 2025-09-30 0001947861 country:US 2025-09-30 0001947861 country:US 2024-12-31 0001947861 nmhi:CustomerAMember us-gaap:SalesRevenueProductLineMember us-gaap:CustomerConcentrationRiskMember 2025-07-01 2025-09-30 0001947861 nmhi:CustomerAMember us-gaap:SalesRevenueProductLineMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-09-30 0001947861 nmhi:CustomerAMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-09-30 0001947861 nmhi:CustomerCMember us-gaap:SalesRevenueProductLineMember us-gaap:CustomerConcentrationRiskMember 2025-07-01 2025-09-30 0001947861 nmhi:CustomerCMember us-gaap:SalesRevenueProductLineMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-09-30 0001947861 nmhi:CustomerCMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-09-30 0001947861 nmhi:CustomerMMember us-gaap:SalesRevenueProductLineMember us-gaap:CustomerConcentrationRiskMember 2025-07-01 2025-09-30 0001947861 nmhi:CustomerMMember us-gaap:SalesRevenueProductLineMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-09-30 0001947861 nmhi:CustomerMMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-09-30 0001947861 nmhi:CustomerNMember us-gaap:SalesRevenueProductLineMember us-gaap:CustomerConcentrationRiskMember 2025-07-01 2025-09-30 0001947861 nmhi:CustomerNMember us-gaap:SalesRevenueProductLineMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-09-30 0001947861 nmhi:CustomerNMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-09-30 0001947861 nmhi:IluminarLightingLLCMember us-gaap:SalesRevenueProductLineMember us-gaap:CustomerConcentrationRiskMember 2025-07-01 2025-09-30 0001947861 nmhi:IluminarLightingLLCMember us-gaap:SalesRevenueProductLineMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-09-30 0001947861 nmhi:IluminarLightingLLCMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-09-30 0001947861 nmhi:IluminarLightingLLCMember us-gaap:SalesRevenueProductLineMember us-gaap:CustomerConcentrationRiskMember 2024-07-01 2024-09-30 0001947861 nmhi:IluminarLightingLLCMember us-gaap:SalesRevenueProductLineMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-09-30 0001947861 nmhi:IluminarLightingLLCMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-12-31 0001947861 nmhi:CustomerAMember us-gaap:SalesRevenueProductLineMember us-gaap:CustomerConcentrationRiskMember 2024-07-01 2024-09-30 0001947861 nmhi:CustomerAMember us-gaap:SalesRevenueProductLineMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-09-30 0001947861 nmhi:CustomerAMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-12-31 0001947861 nmhi:CustomerCMember us-gaap:SalesRevenueProductLineMember us-gaap:CustomerConcentrationRiskMember 2024-07-01 2024-09-30 0001947861 nmhi:CustomerCMember us-gaap:SalesRevenueProductLineMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-09-30 0001947861 nmhi:CustomerCMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-12-31 0001947861 nmhi:PurchaseMember us-gaap:SupplierConcentrationRiskMember nmhi:VendorAMember 2025-07-01 2025-09-30 0001947861 nmhi:PurchaseMember us-gaap:SupplierConcentrationRiskMember nmhi:VendorAMember 2025-01-01 2025-09-30 0001947861 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember nmhi:VendorAMember 2025-01-01 2025-09-30 0001947861 nmhi:PurchaseMember us-gaap:SupplierConcentrationRiskMember nmhi:VendorEMember 2025-07-01 2025-09-30 0001947861 nmhi:PurchaseMember us-gaap:SupplierConcentrationRiskMember nmhi:VendorEMember 2025-01-01 2025-09-30 0001947861 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember nmhi:VendorEMember 2025-01-01 2025-09-30 0001947861 nmhi:PurchaseMember us-gaap:SupplierConcentrationRiskMember nmhi:IluminarLightingLLCMember 2025-07-01 2025-09-30 0001947861 nmhi:PurchaseMember us-gaap:SupplierConcentrationRiskMember nmhi:IluminarLightingLLCMember 2025-01-01 2025-09-30 0001947861 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember nmhi:IluminarLightingLLCMember 2025-01-01 2025-09-30 0001947861 nmhi:PurchaseMember us-gaap:SupplierConcentrationRiskMember nmhi:MegaphotonIncMember 2025-07-01 2025-09-30 0001947861 nmhi:PurchaseMember us-gaap:SupplierConcentrationRiskMember nmhi:MegaphotonIncMember 2025-01-01 2025-09-30 0001947861 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember nmhi:MegaphotonIncMember 2025-01-01 2025-09-30 0001947861 nmhi:PurchaseMember us-gaap:SupplierConcentrationRiskMember nmhi:VendorAMember 2024-07-01 2024-09-30 0001947861 nmhi:PurchaseMember us-gaap:SupplierConcentrationRiskMember nmhi:VendorAMember 2024-01-01 2024-09-30 0001947861 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember nmhi:VendorAMember 2024-01-01 2024-12-31 0001947861 nmhi:PurchaseMember us-gaap:SupplierConcentrationRiskMember nmhi:VendorBMember 2024-07-01 2024-09-30 0001947861 nmhi:PurchaseMember us-gaap:SupplierConcentrationRiskMember nmhi:VendorBMember 2024-01-01 2024-09-30 0001947861 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember nmhi:VendorBMember 2024-01-01 2024-12-31 0001947861 nmhi:PurchaseMember us-gaap:SupplierConcentrationRiskMember nmhi:VendorEMember 2024-07-01 2024-09-30 0001947861 nmhi:PurchaseMember us-gaap:SupplierConcentrationRiskMember nmhi:VendorEMember 2024-01-01 2024-09-30 0001947861 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember nmhi:VendorEMember 2024-01-01 2024-12-31 0001947861 nmhi:PurchaseMember us-gaap:SupplierConcentrationRiskMember nmhi:VendorFMember 2024-07-01 2024-09-30 0001947861 nmhi:PurchaseMember us-gaap:SupplierConcentrationRiskMember nmhi:VendorFMember 2024-01-01 2024-09-30 0001947861 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember nmhi:VendorFMember 2024-01-01 2024-12-31 0001947861 nmhi:PurchaseMember us-gaap:SupplierConcentrationRiskMember nmhi:MegaphotonIncMember 2024-07-01 2024-09-30 0001947861 nmhi:PurchaseMember us-gaap:SupplierConcentrationRiskMember nmhi:MegaphotonIncMember 2024-01-01 2024-09-30 0001947861 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember nmhi:MegaphotonIncMember 2024-01-01 2024-12-31 0001947861 us-gaap:LeaseAgreementsMember 2025-09-30 0001947861 us-gaap:LeaseAgreementsMember 2024-12-31 0001947861 stpr:CA 2021-05-15 0001947861 stpr:CA 2021-05-15 2021-05-15 0001947861 2022-06-16 0001947861 nmhi:McLovinsPetFoodIncMember 2022-06-16 2023-06-15 0001947861 2023-06-16 2024-06-15 0001947861 2024-06-16 2025-06-15 0001947861 2023-05-28 0001947861 nmhi:McLovinsPetFoodIncMember 2024-04-11 2024-04-11 0001947861 2024-05-01 2025-04-30 0001947861 srt:ScenarioForecastMember 2025-05-01 2026-04-30 0001947861 srt:ScenarioForecastMember 2026-05-01 2027-04-30 0001947861 nmhi:VisiontechGroupIncMember 2024-07-20 0001947861 2024-07-20 0001947861 2025-03-11 0001947861 2025-08-08 0001947861 2023-08-22 2023-08-22 0001947861 2024-08-29 2024-08-29 0001947861 nmhi:FutureTechIncorporatedMember 2024-11-22 2024-11-22 0001947861 nmhi:ConvertiblePromissoryNoteMember us-gaap:SubsequentEventMember 2025-10-01 0001947861 us-gaap:SubsequentEventMember 2025-10-08 0001947861 us-gaap:SeriesAPreferredStockMember us-gaap:SubsequentEventMember 2025-10-08 0001947861 us-gaap:SeriesBPreferredStockMember us-gaap:SubsequentEventMember 2025-10-08 0001947861 us-gaap:SeriesCPreferredStockMember us-gaap:SubsequentEventMember 2025-10-08 0001947861 us-gaap:SeriesDPreferredStockMember us-gaap:SubsequentEventMember 2025-10-08 0001947861 nmhi:ConvertiblePromissoryNoteMember us-gaap:SubsequentEventMember 2025-10-10 2025-10-10 0001947861 us-gaap:SeriesAPreferredStockMember us-gaap:SubsequentEventMember 2025-10-10 0001947861 srt:MinimumMember us-gaap:SubsequentEventMember 2025-10-28 2025-10-28 0001947861 srt:MaximumMember us-gaap:SubsequentEventMember 2025-10-28 2025-10-28 0001947861 srt:MinimumMember us-gaap:SubsequentEventMember 2025-10-28 0001947861 srt:MaximumMember us-gaap:SubsequentEventMember 2025-10-28 0001947861 nmhi:DiagonalLendingLLCMember us-gaap:SeriesAPreferredStockMember us-gaap:SubsequentEventMember 2025-10-31 0001947861 nmhi:MrCuiMember nmhi:SeriesFPreferredSharesMember us-gaap:SubsequentEventMember 2025-10-29 0001947861 nmhi:MrCuiMember us-gaap:SubsequentEventMember 2025-10-29 2025-10-29 0001947861 nmhi:MrCuiMember us-gaap:SubsequentEventMember 2025-10-29 0001947861 us-gaap:SubsequentEventMember 2025-11-06 2025-11-06 0001947861 us-gaap:SubsequentEventMember 2025-11-06 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure iso4217:CAD iso4217:USD compsci:item

FAQ

How did Nature’s Miracle (NMHI) perform financially in Q3 2025?

In Q3 2025, Nature’s Miracle generated revenue of $72,377, down from $3,052,727 in Q3 2024. Operating expenses of $1,331,949 led to an operating loss of $1,331,523, and after interest and other items, the net loss was $2,170,789 for the quarter and $5,961,537 for the nine months ended September 30, 2025.

What is Nature’s Miracle (NMHI)’s liquidity and debt position as of September 30, 2025?

As of September 30, 2025, the company had $61,450 in cash and cash equivalents, a working capital deficit of about $19.0 million, total liabilities of $30,186,035, and total assets of $22,054,710, resulting in a stockholders’ deficit of $8,944,930. Short‑term loans and convertible notes make up a significant portion of its obligations.

Does Nature’s Miracle (NMHI) face a going‑concern risk?

Yes. Management states that recurring operating losses since 2022, negative operating cash flow of $1,805,482 for the nine months ended September 30, 2025, limited cash, and a large working capital deficit “raise substantial doubt” about the company’s ability to continue as a going concern within one year.

What major transaction did NMHI complete with Zak Properties in 2025?

On September 18, 2025, NMHI acquired all membership interests of Zak Properties, LLC, which owns real estate at 405 Madison Ave in Ohio, for a total consideration of $17,500,000. The price was paid via Series B and C preferred stock valued at $14,440,000 and a $3,000,000 convertible promissory note to Big Lake, an entity under common control with the CEO.

What financing arrangements does Nature’s Miracle (NMHI) have in place to support operations?

The company references a $20 million equity financing program with GHS Investment (from which it received $151,551 year‑to‑date), a $2 million related‑party convertible note with $1,347,200 still available, a $2 million securities purchase agreement with Y.K. Capital Management, and a $500,000 Series F Preferred share agreement with an individual investor, alongside additional convertible note financing.

How did NMHI’s asset base change in 2025?

Total assets increased to $22,054,710 from $11,311,819 at December 31, 2024, mainly due to the Zak Properties transaction, which raised property and equipment to $17,131,049, including a building, building improvements and land in Ohio.

What are the main revenue streams for Nature’s Miracle (NMHI)?

The company’s revenue is primarily from grow lights and related CEA products. For the nine months ended September 30, 2025, grow light revenue was $1,302,865, while grow media and other products contributed $360,340. Indoor grow containers did not generate material revenue in that period.
Nature's Miracle Holding

OTC:NMHI

NMHI Rankings

NMHI Latest News

NMHI Latest SEC Filings

NMHI Stock Data

1.84M
10.18M
106.51%
0%
6.02%
Specialty Industrial Machinery
Farm Machinery & Equipment
Link
United States
UPLAND